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Abstract  
 
 
In the early stages of downstream process development there is typically only limited 
availability of process material.  Novel methods to obtain information from fewest 
experiments are essential to make informed choices between processing alternatives at 
the earliest stage.  Design of chromatographic separation initially involves scouting of 
appropriate matrix type, mobile phase compositions followed by test runs at lab scale and 
verified at pilot scale.   
 
Traditional small-scale methods for chromatography development focus on the screening 
of separation media and feedstock conditions.  It is still necessary to predict 
chromatography performance at different scales and operating conditions.  In this work a 
new method has been developed to predict performance of larger scale columns using an 
ultra scale-down approach. The strategy breaks traditional geometric scaling rules, using 
models to correct for the differences in performance and also for prediction of the effect 
of changes in operating conditions.  Micro-scale columns were used to scale down lab 
scale runs further challenging the traditional scale down strategies. 
 
The characteristics of antibody fragments in E.coli lysate were identified in terms of pH, 
precipitation and ionic strength to determine good binding conditions.  Chromatography 
studies were carried out at laboratory scale (1 mL) to investigate the flowrate effects on 
the adsorption of antibody fragments on a strong cation exchange resin.  The effect was 
successfully predicted using a general rate model, which describes the physical and 
chemical forces of resin-protein interactions but with modifications to allow for 
deviations noted in experimental performance possibly due to fouling and long loading 
times changing the rate of protein transfer.  Further studies were carried out using micro-
scale tip chromatography, mimicking the results obtained at 1 mL scale.  A similar effect 
of flowrate was observed and the scale up factor to predict the performance of laboratory 
1 mL scale from 40 μL micro-scale was investigated. 
 
 
 
 
 3
 4
 
 
 
 
 
 
 
 
Acknowledgement  
 
 
 
Firstly I wish to thank my supervisors Professor Mike Hoare and advisor Dr. Dan 
Bracewell for their guidance and invaluable advices throughout the project.  I would also 
like to express my gratitude towards my family for their support.  Without them this PhD 
would not be successful.      
 
I would also like to acknowledge all biochemical engineers who helped and supported 
me during the course of my PhD.  On a personal level I would like to thank all members 
of the department especially the cheerful people from vineyard office, Roberts 107 and 
colonnades office.  
Table of contents  
 
Abstract………………………………………………………………………….......….…3 
Acknowledgements……………………………………………………………......……...4 
Table of contents……………………………………………………………….................5 
List of figures………………………………………………………………………...........9 
List of tables……………………………………………………………………......…....16 
Nomenclature……………………………………………………………………............19 
 
1. Introduction................................................................................................................. 20 
1.1 Antibodies and antibody fragments .................................................................... 20 
1.1.1 Function of antibodies ................................................................................... 20 
1.1.2 Antibody structure......................................................................................... 21 
1.1.3 Antibodies in Biotechnology.......................................................................... 26 
1.1.4 Biotechnological applications of antibodies and antibody fragments ....... 29 
1.2 Developing biopharmaceuticals........................................................................... 30 
1.2.1 Upstream processing...................................................................................... 31 
1.2.2 Downstream process – purification strategies ................................................. 33 
1.2.3 Validation........................................................................................................ 42 
1.2.4 Validation of chromatography...................................................................... 43 
1.3 Modelling ............................................................................................................... 45 
1.3.1 Whole process modelling............................................................................... 45 
1.3.2 Unit operation modelling............................................................................... 45 
1.4 Scale-down methods.............................................................................................. 46 
1.4.1 Ultra scale-down............................................................................................. 47 
1.4.2 High throughput screening ........................................................................... 47 
1.5 Chromatography – scale down and modelling ................................................... 48 
1.5.1 Modelling ........................................................................................................ 49 
1.5.2 Scale up ........................................................................................................... 50 
1.6 Introduction to project ......................................................................................... 50 
 
 5
Chapter 2 - Materials and Methods .............................................................................. 52 
2.1. E.coli lysate feedstock preparation.................................................................... 52 
2.1.1. Chemicals................................................................................................. 52 
2.1.2. Fermentation ........................................................................................... 52 
2.1.3. Centrifugation ......................................................................................... 55 
2.1.4. Heat lysis .................................................................................................. 55 
2.1.5. Centrifugation ......................................................................................... 55 
2.1.6. Concentration .......................................................................................... 56 
2.1.7. Filtration .................................................................................................. 58 
2.2. Protein G assay.................................................................................................... 58 
2.2.2. Precipitation analysis.............................................................................. 60 
2.3. Measuring chromatographic performance....................................................... 62 
2.3.1. Adsorption isotherm ............................................................................... 62 
2.3.2. Breakthrough curve................................................................................ 64 
 
3. Theoretical considerations ......................................................................................... 68 
3.1 Isotherm ................................................................................................................. 68 
3.1.1 Calculations for experimental isotherm....................................................... 69 
3.1.2 Isotherm for a complex protein system........................................................ 70 
3.2 General Rate Model .............................................................................................. 72 
3.2.1 Predicting events within a column................................................................ 72 
3.2.1.2 Continuity Equation inside the Macropores ............................................ 74 
3.2.1.3 Boundary conditions ..................................................................................... 75 
3.2.2 Application of the general rate model .......................................................... 76 
3.2.3 Adsorption kinetics ........................................................................................ 79 
3.2.4 Transport parameters ................................................................................... 80 
3.3 Breakthrough curve.............................................................................................. 82 
3.4 Calculations for HiTrap column and PhyNexus microtips............................... 82 
3.5 Chapter summary ................................................................................................. 85 
 
4. Experimental Results..................................................................................................86 
 6
4.1 Introduction...........................................................................................................86 
4.2 Assay technique .....................................................................................................86 
4.1.2. Lysate .............................................................................................................88 
4.2.  Batch adsorption .................................................................................................91 
4.2.1. Dry resin weight ............................................................................................91 
4.2.2. Isotherm .........................................................................................................94 
4.4. Characterisation of E.coli lysate .........................................................................99 
4.5. Breakthrough curves .........................................................................................102 
4.4.1 Millilitre-Scale ..............................................................................................102 
4.4.2 Micro-scale....................................................................................................113 
4.6 Conclusion – Experimental results....................................................................120 
 
5. Results II - Modelling ...............................................................................................121 
5.1. Introduction.......................................................................................................121 
       5.1.1 Reading guide ……………………………………………………… ..122 
5.2. Modelling of 1 mL scale data ...........................................................................123 
5.2.1. Preliminary test of Sensitive parameter sensitivities .........................124 
5.2.2 Increasing fitted parameters ................................................................128 
5.2.3 Including effects on adsorption during loading .................................130 
5.2.4 Using modelling to predict chromatographic performance..............132 
5.3 40 μL scale ...........................................................................................................136 
5.3.1 Calculating parameters using general rate model ....................................136 
5.4 Bead diffusivity as a function of bead saturation.............................................145 
5.5 Understanding the physics of a microtip ..........................................................150 
5.6.1 Bead diffusivity as a function of saturation of bead layer........................159 
5.7 Conclusion ...........................................................................................................168 
 
Chapter 6 – Case studies ..............................................................................................169 
6.1 Introduction.........................................................................................................169 
6.2 Case study I..........................................................................................................170 
6.3 Case study II ........................................................................................................173 
 7
 8
 
 
Chapter 7 - Conclusion .................................................................................................178 
7.1 Modelling using USD method ............................................................................178 
7.2 millilitre scale vs micro-scale .............................................................................182 
 
 
Chapter 8 – Future Work.................................................................................................184 
8.1 Improving the model............................................................................................184 
8.2 Understanding chromatography through the modelling .................................186 
8.3 Re-design of the small scale experimental system.............................................186 
 
 
Appendix………………………………………………………………………….........191 
 
Reference………………………………………………………………………......…...194 
 
 
List of figures  
 
Figure 1.1 Structure of an antibody. .................................................................................24 
 
Figure 1.2 Forms of an antibody that are being produced recombinantly ........................27 
 
Figure 1.3 Gantt chart visualising the approval stages and development of an antibody in the 
biopharmaceutical industry. ......................................................................................31 
 
Figure 1.4 Two major routes for antibody purification from a feedstock. An affinity process 
(left) and non-affinity process. (right) ......................................................................39 
 
Figure 1.5 Upstream and downstream unit operation and its corresponding functions....40 
 
Figure 1.6 A typical path of a drug candidate will follow from identification to launch .43 
 
Figure 2.1 Steps to prepare E.coli lysate...........................................................................54 
 
 
Figure 2.2 Flow diagram of the concentration of E.coli lysate using an ultrafiltration 
membrane..................................................................................................................57 
 
Figure 2.3 A photo shoot of the setup of the micro-scale experiment. .............................66 
 
     
Figure 3.1 Inputs required to be identified to simulate a breakthrough curve with the general 
rate model..................................................................................................................77 
 
Figure 3.2 Inputs that are required to be entered into the general rate model to initiate a 
solving routine to calculate general rate parameters and adsorption kinetics...........78 
 
 
 9
Figure 3.3 calculations for the mid sectional radius of a conic frustum ...........................83 
 
 
Figure 3.4 Geometry of a 1mL HiTrap column (left) and the resin bed of  a 40 μL PhyNexus 
microtip (right)..........................................................................................................84 
 
Figure 4.1 Standard curve of pure Fab’ fragments with area (mAU*t) plotted against 
concentration (μg mL ).-1 ...........................................................................................87 
 
 
Figure 4.2 Calculation of concentration of Fab’ fragment containing samples using standard 
curves obtained from using pure and E.coli lysate samples .....................................89 
 
 
Figure 4.3 Standard curve (area (mAU*t) vs concentration (μg mL )) of E.coli lysate at 50 
μg mL , 35 μg mL  17 μg mL  5 μg mL and 2.5 μg mL .
-1
-1 -1
, 
-1
, 
-1
 
-1
. ..............................90 
 
 
Figure 4.4 Graph showing the dry resin weight against the volume of 25% resin emulsion 
dosed.. .......................................................................................................................93 
 
 
Figure 4.5 Isotherms of E.coli lysate at (+) pH 7 fitted using Langmuir isotherm and 
sigmoidal trends. .......................................................................................................96 
 
 
Figure 4.6 Isotherms of E.coli lysate on SP Sepharose FF at (+) pH 5 and (○) 7.  The pH 5 
isotherm was fitted using Langmuir isotherm while the pH 7 isotherm was fitted with a 
sigmoidal trend..........................................................................................................97 
 
 
Figure 4.7  Comparison of the composition of E.coli lysate at different pH values using 
reducing SDS page..................................................................................................100 
 
 
 10
Figure 4.8 Concentration of Fab’ fragments in supernatant phase of clarified E.coli lysate at 
(▲) 2 mS cm  and (■) 15 mS cm  at different pH.  The original concentration of the 
clarified E.coli lysate was 495 μg mL  before pH adjustments..
-1 -1
-1 ...........................101 
 
 
Figure 4.9 Breakthrough curves of Fab’ antibody in E.coli lysate at pH 7.0 running through a 
HiTrap 1mL SP Sepharose FF column at (■) 72.5 cm h  (0.5 mL min ) and (♦) 155 cm 
h  (1 mL min ).
-1 -1
-1 -1 ......................................................................................................104 
 
 
Figure 4.10 Breakthrough curves of Fab’ antibody in E.coli lysate at pH 5.0 running through 
a HiTrap 1mL SP Sepharose FF column at (●) 155 cm h (1 mL min ), (+) 232 cm h
(1.5 mL min ) and (▲) 300 cm h  (2 mL min ).
-1 -1 -1 
-1 -1 -1 .................................................106 
 
 
Figure 4.11 SDS-PAGE image illustrating the composition of eluate from a protein G 
column loaded with E.coli Fab’ lysate....................................................................107 
 
 
Figure 4.12 SDS-PAGE study of Fab’ separation from E.coli lysate using with SP Sepharose 
FF strong cation exchange resin. ............................................................................108 
 
 
Figure 4.13 Breakthrough curves of Fab’ antibody in E.coli lysate at pH 5 running through a 
HiTrap 1mL SP Sepharose FF column at (□) 155 cm h , (○) 232 cm h  and (◊) 310 cm 
h )..
-1 -1 
-1 .........................................................................................................................112 
 
 
Figure 4.14  Breakthrough curves of Fab’ antibody in E.coli lysate at pH 5 running through a 
40 μL PhyNexus microtip at 310 cm h ..-1 ...............................................................115 
 
 
Figure 4.15 Breakthrough curves of Fab’ antibody in E.coli lysate at pH 5 running through a 
40 μL PhyNexus microtip at 232 cm h .-1 ................................................................116 
 
 
 11
Figure 4.16 Breakthrough curves of Fab’ antibody in E.coli lysate at pH 5 running through a 
40μL PhyNexus microtip at 155 cmh ..-1 .................................................................117 
 
 
Figure 4.17 Breakthrough curves of Fab’ antibody in E.coli lysate at pH 5 running through a 
40 μL PhyNexus microtip with SP Sepharose FF resin at ( ) 310 cm h , (+) 232 cm h
 and (
-1 -
1 ) 310 cm h .1 ..............................................................................................118 
 
 
Figure 4.18 Comparison between breakthrough curves of Fab’ antibody in E.coli lysate at 
pH 5 running through a 40 μL PhyNexus microtip and 1 mL HiTrap column with SP 
Sepharose FF resin.  . ..............................................................................................119 
 
 
Figure 5.1 Comparison of model fit of the breakthrough curve using three fitted parameters..
.................................................................................................................................126 
 
 
Figure 5.2 Graph showing the effects of bead diffusivity, axial dispersion and mass transfer 
coefficient on the shape of a breakthrough curve. ..................................................127 
 
 
Figure 5.3 Model fitting of experimental breakthrough curve  (see figure 5.1) using five 
fitted parameters (Q , K , K , D  and K).max ads dis b .......................................................129 
 
 
Figure 5.4 Model fitting of experimental breakthrough curve (see figure 5.1) using five fitted 
parameters and equation 5.1 at 1 mL scale (Q , K , K , D  and K).max ads dis b ..............131 
 
 
Figure 5.5 Predicted (-□-) breakthrough curves of 232 cm h (a) and 155 cm h (b)  using 
equation 5.1 (see table 5.3 for values) compared against millilitre-scale experimental 
data (-●-).
-1 -1  
................................................................................................................134 
 
 12
Figure 5.6  Model fitting of 310 cm h  (a) and predicted (-□-) breakthrough curves of 232 
cm h (b) and 155 cm h (c) using equation 5.2 (see table 5.4 for values) compared 
against millilitre-scale experimental data (-●-).
-1
-1 -1  
......................................................135 
 
 
Figure 5.7 Model fitting (-)of 310 cm h (a) breakthrough curves of 232 cm h (b) and 155 
cm h (c) using equation 5.2 (see table 5.4 for values) compared against 40 μL scale 
experimental data (◊).
-1 -1 
-1  
.............................................................................................138 
 
 
Figure 5.8 Model fitting (-) of 310 cm h (a) breakthrough curves of 232 cm h (b) and 155 
cm h (c) using equation 5.2 and with bed voidage set at 0.45 (see table 5.6 for values) 
compared against 40 μL scale experimental data (◊).
-1 -1 
-1  
.............................................140 
 
 
Figure 5.9 Model fitting of 310 cm h (a) and predicted (-) breakthrough curves of 232 cm h
(b) and 155 cm h (c) using equation 5.2 (see table 5.7 for values) compared against 40 
μL scale experimental data (◊)..
-1 -
1 -1  
..............................................................................141 
 
 
Figure 5.10 Scale up prediction of a 1 mL scale breakthrough curve running at 310 cm h
using parameters obtained from 40 μL scale running at the same linear velocity with 
equation 5.2.  (+) is the predicted breakthrough curve and (
-1 
) is the experimental 
breakthrough curve. ................................................................................................143 
 
 
Figure 5.11 A comparison between breakthrough curves and bead diffusivity at 1 mL and 40 
µL scale using the equation  aQTb exD  11107  .. .......................................144 
 
 
Figure 5.12 Use of model fitting of breakthrough data for 1 mL scale column to predict the 
effect of change of flowrate.. ..................................................................................146 
 
Figure 5.13 Use of model fitting of breakthrough data for a 40 µL scale column to predict 
the effect of change of flowrate. .............................................................................149 
 13
 
Figure 5.14 Effect of change of bead diffusivity relationship on model fitting of 
breakthrough data for 40 uL scale column to predict the effect of change of flowrate. 
Model based on equation 5.3 was used to obtain the adsorption parameters of an 
experimental breakthrough curve of a 40 uL column ran at 310 cm h (a).-1 ...........152 
 
 
Figure 5.15 Effect of change of bed voidage relationship on model fitting of breakthrough 
data for 40 uL scale column to predict the effect of change of flowrate. Model based on 
equation 5.3 was used to obtain the adsorption parameters (including bed voidage) of an 
experimental breakthrough curve of a 40 uL column ran at 310 cm h (a).-1 ...........154 
 
 
Figure 5.16 Prediction of a 1 mL column (□) breakthrough curve at 310 cm h using 
parameters obtained from a 40 μL scale column at the same linear velocity (refer to 
table 5.1 for values).  
-1 
..............................................................................................156 
 
 
Figure 5.17 Predicted 1 mL column breakthrough curves (□) at 310 cm h , 232 cm h  and 
155 cm h  parameters obtained by fitting a 40 μL micro-tip experimental breakthrough 
curve (●) at 310 cm h  but changing values of bead diffusivity constant “a” from 1.66 
to 4.69 x 10 .
-1 -1
-1
-1
-3 .........................................................................................................158 
 
 
Figure 5.18 Bead diffusivity profile calculated with equation 5.3 at 1 mL and 40 μL scale 
with no correction to the value of constant “a”.......................................................161 
 
 
Figure 5.19 Bead diffusivity profile calculated with equation 5.3 at 1 mL and 40 μLscale 
with corrections to the value of constant “a”.  . ......................................................162 
 
 
Figure 5.20 Bead diffusivity profile calculated with equation 5.5 at 1 mL and 40 μL scale 
both scale shares the same value for constant “a”.  ...............................................163 
 14
Figure 5.21 Predicted 1 mL column breakthrough curves at 310 cm h , 232 cm h  and 155 
cm h  with bead diffusivity constant re-calculated using equation 5.5..
-1 -1
-1 ................165 
 
 
Figure 5.22 Model fitting (-) of 40 μL scale experimental breakthrough curve using five 
fitted parameters and equation 5.5. .........................................................................167 
 
 
Figure 6.1 Breakthrough curve obtained using E.coli homogenate containing Fab’ fragments 
and SP Sepharose FF resin......................................................................................171 
 
 
Figure 6.2 Fitting of the E.coli homogenate breakthrough curve.  ................................172 
 
 
Figure 7.1 Development pathway of the general rate model to fit and predict breakthrough 
curves at millilitre scale data...................................................................................180 
 
Figure 7.2 Development pathway of the general rate model to fit and predict breakthrough 
curves at millilitre scale data from micro-scale data.................................. ……… 181 
 
 
Figure 8.1 A sketch of one syringe pump device connected to multiple PhyNexus microtips
................................................................................................................................. 186 
 
Figure 8.2 An example of a window of operation of a micro-tip.  Load and flowrate are the 
process parameters while throughput and yield are the success criteria................. 189 
 
 
 
 15
List of Tables   
 
 
Table 2.1 Experimental and sample collection time for micro-scale breakthrough curves 
using a 40 μL micro-tip at different flowrates. .........................................................66 
 
Table 3.1 Experimental and sample collection time for micro-scale breakthrough curves 
using a 40 μL micro-tip at different flowrates. .........................................................83 
 
Table 4.1 Summary of dry resin weight experiment.  The table shows the pipetted volume of 
resin emulsion, its corresponding matrix volume at 25% (v/v), the dry resin weight and mass 
of matrix per volume of matrix pipetted…………………………………………………92 
 
Table 4.2 Summary of isotherm parameters (Q , K K and n) obtained through curve 
fitting of experimental isotherms.
max d, a 
.............................................................................98 
 
 
Figure 5.1 Comparison of model fit of the breakthrough curve using three fitted parameters. 
Q , K  and K  – see table 5.1 and experimental data (-●-) obtained using load rate 
of 2 mL min on a 1 mL HiTrap column.
max ads dis
-1 ...............................................................126 
 
 
Figure 5.2 Graph showing the effects of bead diffusivity, axial dispersion and mass transfer 
coefficient on the shape of a breakthrough curve. ..................................................127 
 
 
Figure 5.3 Model fitting of experimental breakthrough curve  (see figure 5.1) using five 
fitted parameters (Q , K , K , D  and K).max ads dis b .......................................................129 
 
 
Figure 5.4 Model fitting of experimental breakthrough curve (see figure 5.1) using five fitted 
parameters and equation 5.1 at 1 mL scale (Q , K , K , D  and K).max ads dis b ..............131 
 
 
Figure 5.5 Predicted (-□-) breakthrough curves of 232 cm h (a) and 155 cm h (b)  using 
equation 5.1 (see table 5.3 for values) compared against millilitre-scale experimental 
data (-●-).
-1 -1  
................................................................................................................134 
 16
Figure 5.6  Model fitting of 310 cm h  (a) and predicted (-□-) breakthrough curves of 232 
cm h (b) and 155 cm h (c) using equation 5.2 (see table 5.4 for values) compared 
against millilitre-scale experimental data (-●-)
-1
-1 -1  
.......................................................135 
 
 
Figure 5.7 Model fitting (-)of 310 cm h (a) breakthrough curves of 232 cm h (b) and 155 
cm h (c) using equation 5.2 (see table 5.4 for values) compared against 40 μL scale 
experimental data (◊).
-1 -1 
-1  
.............................................................................................138 
 
 
Figure 5.8 Model fitting (-) of 310 cm h (a) breakthrough curves of 232 cm h (b) and 155 
cm h (c) using equation 5.2 and with bed voidage set at 0.45 (see table 5.6 for values) 
compared against 40 μL scale experimental data (◊)
-1 -1 
-1  
..............................................140 
 
 
Figure 5.9 Model fitting of 310 cm h (a) and predicted (-) breakthrough curves of 232 cm h
(b) and 155 cm h (c) using equation 5.2 (see table 5.7 for values) compared against 40 
μL scale experimental data (◊).
-1 -
1 -1  
...............................................................................141 
 
 
Figure 5.10 Scale up prediction of a 1 mL scale breakthrough curve running at 310 cm h
using parameters obtained from 40 μL scale running at the same linear velocity with 
equation 5.2.  (+) is the predicted breakthrough curve and (
-1 
) is the experimental 
breakthrough curve. ................................................................................................143 
 
 
Figure 5.11 A comparison between breakthrough curves and bead diffusivity at 1 mL and 40 
µL scale using the equation.....................................................................................144 
 
 
Figure 5.12 Use of model fitting of breakthrough data for 1 mL scale column to predict the 
effect of change of flowrate. ...................................................................................146 
 
 
Figure 5.13 Use of model fitting of breakthrough data for a 40 µL scale column to predict 
the effect of change of flowrate ..............................................................................149 
 
 
Figure 5.14 Effect of change of bead diffusivity relationship on model fitting of 
breakthrough data for 40 uL scale column to predict the effect of change of flowrate.
.................................................................................................................................152 
 
 
Figure 5.15 Effect of change of bed voidage relationship on model fitting of breakthrough 
data for 40 uL scale column to predict the effect of change of flowrate. ...............154 
 17
Figure 5.16 Prediction of a 1 mL column (□) breakthrough curve at 310 cm h using 
parameters obtained from a 40 μL scale column at the same linear velocity (refer to 
table 5.1 for values).  
-1 
..............................................................................................156 
 
 
Figure 5.17 Predicted 1 mL column breakthrough curves (□) at 310 cm h , 232 cm h  and 
155 cm h  parameters obtained by fitting a 40 μL micro-tip experimental breakthrough 
curve (●) at 310 cm h  but changing values of bead diffusivity constant “a” from 1.66 
to 4.69 x 10 ..
-1 -1
-1
-1
-3 ........................................................................................................158 
 
 
Figure 5.18 Bead diffusivity profile calculated with equation 5.3 at 1 mL and 40 μL scale 
with no correction to the value of constant “a”.......................................................161 
 
 
Figure 5.19 Bead diffusivity profile calculated with equation 5.3 at 1 mL and 40 μLscale 
with corrections to the value of constant “a”.. ........................................................162 
 
 
Figure 5.20 Bead diffusivity profile calculated with equation 5.5 at 1 mL and 40 μL scale 
both scale shares the same value for constant “a”. .................................................163 
 
 
Figure 5.21 Predicted 1 mL column breakthrough curves at 310 cm h , 232 cm h  and 155 
cm h  with bead diffusivity constant re-calculated using equation 5.5..
-1 -1
-1 ................165 
 
 
Figure 5.22 Model fitting (-) of 40 μL scale experimental breakthrough curve using five 
fitted parameters and equation 5.5. .........................................................................167 
 
 
Table 6.1 Fitted parameters of a Fab’ fragment – nuclease homogenate………….. …..169 
 
 
Table 8.1 Variables that have influence in the performance of chromatography........... 181 
 
 
 
 
 
 
 18
Nomenclature  
 
C protein breakthrough concentration mg mL-1 
C0  initial protein concentration mg mL-1 
Cbi bulk phase concentration of component i mol m-3 
Cfi Feed concentration profile of component I, a tie dependent variable mol m-3 
Cpi 
Concentration of component i in the stagnant fluid phase inside 
particle macropores mol m-3 
Dax Axial or radial dispersion coefficient of component i m2 s-1 
Db intra-particle bead diffusivity  m2 s-1 
dm molecular diameter m 
Dm  molecular diffusivity  
dp pore diameter m 
Fab'  fragment antigen binding with hinge sequence  
kads Adsorption rate constant  
m3 mol-1 
s-1 
Kd Langmuir constant   
kd Desorption rate constant for component i s-1 
ki film mass transfer coefficient of component i m s-1 
P modified protein breakthrough concentration mg mL-1 
P0 modified protein concentration mg mL-1 
Qeq Dynamic binding capacity  mg mL-1 
Qmax Maximum binding capacity mg mL-1 
R coordinates for particle  
Rp Particle radius m 
t Time s 
v Interstitial velocity cm h-1 
Vl volume of liquid  mL 
Vm  volume of resin mL 
Z Axial coordinate  
εb Bed void volume fraction  
εp Partical porosity  
λ dm/Dp  
τ tortuosity  
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1. Introduction   
 
The purpose of the project was to reduce the number of experiments required to be 
performed when optimising an adsorption step of chromatography by using computer 
modelling.  In addition to minimising experimental effort, the project also opens the 
opportunity to scale-down the unit operation using micro-scale chromatography columns; 
reduce the amount of feedstock required to explore a design space and at the same time 
shorten the time required to complete one experiment due to the fact that a smaller 
column is used. 
 
The technology aims to narrow down a large design space, allowing subsequent 
optimisation experiment upon points that are closer to the operating hot spot hence 
making process optimisation more efficient in terms of feed stock utilisation.  This is 
especially useful during early process development where feedstock and time is limited. 
 
Because antibodies and its recombinant forms are popular therapeutic choices, therefore 
Fab’ fragments expressed by an E.coli system was used in this project to mimic a real 
process feed-stream.   
 
1.1 Antibodies and antibody fragments 
 
1.1.1 Function of antibodies  
 
Antibodies are a major protein component of the vertebrate immune system.  This system 
can be roughly divided into two types of immunity; Cellular immunity and humoral 
immunity.  Cellular immunity is mediated by T lymphocytes of T cells.  The system 
guards against intracellular pathogens for example viruses and bacteria, and hinders fungi, 
parasites, cancerous cells and foreign tissues. Humoral immunity is mediated by the 
group of proteins of interest – antibodies.  Antibodies are also known as immunoglobulin 
and are produced by B lymphocytes and B cells.  This type of immunity is most effective 
against bacterial infections and extra cellular viral infections (Voet, 1995). 
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Antibodies bind to pathogenic or foreign bodies in order to fulfil their biological function.  
The specific binding site of an antibody is called an antigen, with great specificity and 
strength.  Antibodies can bind their targets with affinities between 108 and 1011 M-1.  
Once bound to the target antigen, antibodies contribute to immunity in three main ways, 
depending on the antibody isotype.  Firstly they can halt pathogens from entering or 
damaging host cells by binding to them and blocking contact with cells and tissues.  This 
structural mode of action is known as neutralization.  Secondly they can trigger the 
pathogen’s destruction by activating the complement pathways (Ravetch, 2001).Thirdly 
they can coat the pathogen and trigger a range of effector functions such as phagocytosis 
by phagocytes, degranulation by mast cells and neutrophils, and release of cytokines and 
cytotoxic molecules by natural killer cells (Janeway, 2001). The appropriate immune 
mechanisms for distinct pathogens are selected by the isotype of antibody.   
 
Human antibodies come in five different isotypes or classes: IgA, IgD, IgE, IgG and IgM.  
These are described in Table 1.1.  There are also four further subclasses of IgG and two 
of IgA.  Although different isotypes have different effector functions and biological 
functions, mediated by differences in the structure of specific constant region of the 
protein, they all bind antigens in the same way and share a common immunoglobulin 
fold.   
 
 
 
1.1.2 Antibody structure  
 
The basic unit of each antibody is the immunoglobulin (Ig) monomer.  This is a Y shaped 
tetrameric molecule consisting of four polypeptide chains; two identical heavy (H) chains 
and two identical light (L) chains.  These are connected by disulphide bonds.  Each chain 
is composed of a number of domains known as Ig domains, each consisting of about 70-
110 amino acid residues.  They fold in a characteristic β-sheet pattern known as the Ig 
fold, where two domains are held together in a sandwich shape by conserved cysteines 
and non-covalent bonds.  The structure is shown in Figure 1.1.  The H and L chains 
consist of a mixture of constant (C) and variable domains (V).  Each H chain has three 
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constant regions (CH1, CH2, and CH3) and a single variable region (VH).  Each L chain 
has a single constant region (CL) and a single variable region (VL) (Voet, 1995). 
 
The variable domains, located at the N-terminal tip of the Ig monomer, are extremely 
variable in amino acid sequence, and form the unique antigen-recognition site of each 
antibody.  VL and VH are not uniformly variable however; as all variable chains share 
conserved amino acid residues to form the Ig fold.  Variability is focused into three short 
hypervariable sequences, each a few residues in length.  These hypervariable sequences 
line the antigen-binding sites, and determine the antibodies binding specificity.  
Therefore they are also known as complementarily-determining regions (CDRs) 
(Janeway, 2001). 
 
There are two measures of the strength of binding of any particular antibody for its 
antigen: affinity and avidity.  Affinity measures the strength with which a single Fab 
binds to an antigen.  However, as an antibody, and indeed an antigen, may possess 
multiple binding sites that may contribute to increase the strength of antibody-antigen 
binding, the term avidity is used to describe the total strength at which a particular 
antibody binds its antigen. Avidity is the combined strength of multiple bond 
interactions; therefore the avidity of an antibody may be several orders of magnitude 
higher than its affinity, especially in the case of multimeric antibody isotypes such as 
IgM.   
 
The constant regions are different between antibody isotypes and determine the 
antibodies structure and effector functions.  For example, IgM constant region cause 
association of five Ig monomers to form a pentamer.  The IgE constant region can initiate 
mast cell degranulation when complexed with an antigen.   
 
A typical Ig monomer is depicted in Fig. 1.1, illustrating all the regions discussed above.  
Also depicted are the three regions of the protein: Fc, Fab, and Fv.  These are defined by 
proteolytic digestion of the Ig monomer.  Treatment of the Ig monomer with the enzyme 
papain results in the cleavage of the molecule at the hinge region (also shown) into two 
Fab fragments and one Fc fragment.  The Fc region contains only constant domains, and 
is named historically ‘fragment crystallisable’.  Fc region is responsible for the immune 
response for a given antigen; this is achieved by binding to a specific class of Fc 
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receptors and other immune molecules, for example complement proteins.   The Fab 
fragments, which each consist of one complete light chain and CH1 and VH from the 
heavy chain, contain the antibody binding site.  Hence they are known as ‘fragment 
antigen binding’.  The Fab fragment can be further cleaved by enzymatic approaches
yielding the Fv (fragment variable) fragment.  This fragment contains only the variable 
domains of the H and L chains (Brinkmann et al, 1997).  It is the smallest antibody 
fragment that retains antigen binding activity, but generally Fv fragments by themselves 
are unstable as the V
, 
on 
shuber et al, 1990) 
H and VL domains can dissociate, often accompanied by aggregati
(Glock
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Table 1.1 A list of antibody isotypes and their corresponding functions and 
number of Ig monomers 
Isotype Function No. of Ig 
monomers 
IgA Prevents colonization of mucosal zones by 
pathogens (Underdown, 1986) 
Two (dimer) 
IgD B cells antigen receptor (Geisberger, 
2006) 
One (monomer) 
IgE Protects against parasitic worms.  Binds to 
allergens and induces histamine release by 
mast cells (Gerald Pier, 2004) 
One (monomer) 
IgG Fights antigens by providing majority of 
antibody based immunity against foreign 
bodies. Found in four subtypes (Gerald 
Pier, 2004) 
One (monomer) 
IgM Expressed on the surface of B cells as 
well as in secreted form.  Eliminates 
pathogens in early phase of adaptive 
immune response before sufficient IgG 
can be produced (Geisberger, 2006; 
Gerald Pier, 2004) 
Five (pentamer) 
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Figure 1.1 Structure of an antibody. See text for details. 
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1.1.3 Antibodies in Biotechnology 
 
Antibodies have many structural and functional features that make them valuable 
reagents for research, therapy, and other biotechnological applications.  Their key 
property is their ability to form highly specific interactions with a wide variety of ligands.  
Functional domains providing specific antigen-binding (Fab or Fv) or effector functions 
(Fc) can be exchanged between molecules, expressed as separate biologically active 
fragments, or expressed as components of novel fusion proteins (Morrison, 1992; Chester, 
1995). 
 
Either polyclonal or monoclonal antibodies are used in biotechnology.  Polyclonal 
antibodies are multiple variant forms of antibody binding the same target;  they are 
produced by different V (D) J recombination in different producing cells, or clones.  
Monoclonal antibodies are identical in their protein 10 structure, all produced from a 
single clone. 
 
Monoclonal antibodies are more commonly used in biotechnology as they can be fully 
characterised, defined and optimised.   
 
As well as whole antibodies, antibody fragments, such as Fab or Fv, are also commonly 
used in biotechnology (Joosten et al., 2003) as they can be more easily produced in 
recombinant systems, have reduced molecular weight, and lack the effector functions of 
the Fc region.  These usually have a single binding interaction with an antigen they tend 
to be monovalent.  Hence, although they would have the same binding affinity as the 
antibody from which they are derived, they have less avidity than whole antibody with 
multiple Fab regions.   
 
Antibody fragments were historically produced by enzymatic cleavage of whole 
antibodies, but are now more commonly produced by recombinant organisms,  A variety 
of antibody fragment configurations have been developed.  For example, the basic Fab 
region can be produced as two separate polypeptide chains.  Fab’ (Figure 1.2) fragments 
are standard Fab fragments but with the heavy chain extended to include one or more 
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hinge region cysteine residues.  In order to increase binding avidity the di-Fab (F(ab’)2) 
can be created by linking two Fab’ arms with a disulphide bond (Carter, 2006) or 
thioester bridge (Rodrigues, 1993) or by constructing a linear (F(ab’)2 comprising 
tandem repeats of the heavy chain fragment VH-CH1-VHCH1 (Zapata, 1995).  The Fv 
region has also been produced recombinantly, although the lack of cross-linking cystein
residues causes a tendency to dissociate into V
e 
, 
 to 
, 1995). 
H and VL upon dilution (Glockshuber
1990).  Therefore both a single chain Fv (scFv), with a polypeptide linker inserted 
between the VH and VL domains, and a disulphide stabilized Fv have been designed
increase stability (Raag
 
As well as simple antibody fragments, the basic antibody monomer has been rearranged 
and engineered to form a myriad of different structures.  The creation and isolation of 
specific antibodies to specific antigens in biotechnology is a complex matter.  Antibodies 
were first produced in a polyclonal form, purified from the blood of animals immunised 
against the desired antigen.  The development of hybridoma technology allowed the 
conversion of B cells from immunised mice into cell lines that can proliferate and 
produce monoclonal antibody indefinitely (Kohler, 1975).  The immunogenicity of these 
antibodies in humans, and the complexity of protein engineering in mammalian cells then 
lead to the development of antibody genetic manipulation in bacteria.  Although the 
complex structure and large size of IgG molecules makes expression in bacteria 
exceedingly difficult, the Fab region (Better et al., 1998) or a single chain Fv fragment 
(Skerra, 1988) can be produced.  These methods allowed antibodies to be cloned, 
expressed and optimised with respect to affinity, stability and specificity.  They can also 
be ‘humanised’ by the transfer of antigen binding sites into a human antibody framework 
(Carter, 2006).  This retains antibody binding specificity while reducing the potential of 
immunogenicity.  The development of display technologies permitted precise control 
over antibody selection conditions by the use of bacteriophages or yeast to create 
antibodies, rather than mice.  These techniques rely on rapid cloning of immunoglobulin 
gene segments to create libraries of antibodies with slightly different amino acid 
sequences.  These are then ‘displayed’ at the surface of the yeast or bacteriophage to 
allow affinity selection of the desired antibodies (Hoogenboom, 2005; Sidhu, 2006).  
Most recently a bacterial E.coli system has been developed that allows combination of 
full-length IgG and surface-displayed molecules, to further speed antibody development 
(Mazor et al., 2007). 
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Figure 1.2 Forms of an antibody that are being produced recombinantly taken from review by 
Hollinger & Hudson, Nature Biotechnology (2005) vol 23, 1126-36 
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1.1.4 Biotechnological applications of antibodies and antibody fragments 
 
The three major areas of application of antibodies are medical diagnosis, medical therapy 
and scientific research.  Several immunodiagnostic methods based on detection of typical 
disease biomarkers are used to diagnose infectious diseases, for example ELISA, 
immunofluorescence, Western blot, immunodiffusion, and immunoelectrophoresis.  Two 
examples are the detection of indicators of cancer (Krauss, 2003) and rheumatoid arthritis 
(Bizzaro, 2007). 
 
The ability of antibodies to bind to a single antigen with high specificity leads to their 
therapeutic power.  There are currently over 200 antibody based biopharmaceuticals 
under development, and 31 monoclonal antibody FDA-approved therapies (Strohl, 2009).  
Although monoclonal antibody therapies still are difficult to produce and deliver safely 
to patients, they remain a promising method in providing specific cures to certain 
diseases.  (Hale, 2006; Koths, 1995; Reichert, 2005)   
 
Research application stem around identification, location, and quantification of proteins 
of interest (Filpula, 2007). For example, antibodies are used in flow cytometry to 
differentiate cell types and life stage by the type of proteins they express (Brehm-Stecher, 
2004).  They are used in Western blot analysis to identify proteins separated by 
electrophoresis (Kurien, 2006).  ELISA assays use antibodies to quantify proteins (Reen, 
1994).  The techniques of immunohistochemistry and immunofluorescence can be used 
to examine protein expression in tissue sections or to locate proteins within cells in 
diagnostics (Brehm-Stecher, 2004; Boswell, 2007). 
 
Other suggested applications are treatment of wastewater (Costantini, 2007), counter-
bioterrorism and bio-defence, biosensors (Conroy, 2009) and the food industry.  
Antibodies (Joosten, 2003) and antibody fragments are also considered as components of 
a variety of consumer goods.  For example, antibody fragments could be used in 
shampoos to prevent formation of dandruff (Dolk, 2005), or in toothpaste to protect 
against cavities (Kupper, 2005). 
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1.2 Developing biopharmaceuticals  
 
Today, biopharmaceuticals account for between 10% and 15% of the world 
pharmaceutical market (more than $10 billions) (Ashton, 2001; DiMasi, 2007). 
Monoclonal antibody drugs represent a primary sector of the biopharmaceuticals market, 
this trend is likely to continue and grow in the coming years (Pavlou, 2005). The 
specificity of mAbs against antigens has tremendous clinical value, making them 
effective therapeutic agents. 
Blockbusters – drugs with $1 billion annual sales or more - constitute the “backbone” of 
the pharmaceutical industry, providing high revenue streams over relatively long periods. 
All the major pharmaceutical companies depend heavily upon blockbuster products. In 
that manner, leading companies underpin their corporate presence, influence and 
branding, high revenue flows, profitability and attractiveness to investors. Furthermore, 
specialised companies – especially in biotechnology – are increasingly involved with 
blockbuster and potential blockbuster products, both directly and as commercial partners. 
Current and potential blockbuster revenues are seriously threatened by patent expiry, 
regulatory hurdles, reduced R&D efficiency, increasing competition, formidable 
therapeutic challenges and healthcare payers influencing pricing (Wheelwright, 1994; 
Clark, 2004).  Nevertheless, there are strong drivers of growth including unmet 
therapeutic needs, rising incidence of many diseases, aging populations, rising living 
standards and fast-developing geographical markets. The future of current and potential 
blockbusters is therefore vitally important to all companies in the pharmaceutical sector, 
especially in this uncertain period of economic changes and pressures (Foot, 2010).  
Figure 1.3 is brief Gantt chart of a typical biopharmaceutical development timeline.  All 
pharmaceutical companies aim to launch their product as early as possible to generate 
profits (Struck, 1994). Getting a product onto the market before competitors is of 
particular importance since “first-to-market” often gain better recognition from 
customers (Wheelwright, 1994).  However this market domination effect will be over 
after patent protection expires (Schellekens, 2004).  Following the traditional trend, the 
launch of a biopharmaceutical will fall after the patent expires. In other words if the 
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product launches before patent expires, and the niche position of the drug in the market 
will last longer.  
 
 
1.2.1 Upstream processing 
 
 
The primary aim of the fermentation unit operation in antibody fragment production in 
E.coli is the cost–effective production of the antibody fragment by high productivity low-
cost fermentation, where productivity is the amount of product formed per unit volume 
per time.  A secondary aim is the design of the fermentation to allow facile and 
inexpensive downstream processing (DSP).  The usual strategy to fulfil this primary goal 
is the growth of the E.coli cells to high cell densities, and the optimisation of the amount 
of Fab’ produced per cell.   
 
Apart from fulfilling the economic criteria of antibody production, upstream processing 
also involves cell line development.  A well defined cell line co-produces the least 
amount of contaminants that might potentially interfere with the downstream processing.   
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Years 1 2 3 4 5 6 7 8 9 10 11 12 13 
 Patent               
Target identification               
Target assay construction                
target validation                
Phase I - safety                
Phase II efficacy safety                
Phase III - efficacy safety                
FDA approval                 
               
Process development                  
Pilot plant development                     
Process transfer and start                    
Figure 1.2 Gantt chart visualising the approval stages and development of an 
antibody in the biopharmaceutical industry.  
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1.2.2 Downstream process – purification strategies 
 
Downstream processing involves the use of a sequence of unit operation to isolate 
protein product from cell culture from fermentation. Advances have been made over the 
last century (Becker, 1983) and still evolving.  Design of downstream processing is 
highly dependant on the expression system, protein of interest, and location of expression.  
Here we will only consider processing steps relevant to the production of antibody 
fragments in the E.coli periplasm, the system of interest.  Cytosolic production and 
extensive solubilisation and re-naturation stages required for protein recovery from 
exclusion bodies are not considered as this has been found to be less cost-effective than 
periplasmic production (Farid, 2007). 
 
Processing may be divided into a number of stages including release of intracellular 
product, primary capture, purification, finishing and formulation.  In the capture step the 
product is isolated and concentrated before it is further processed.  In the purification 
section, bulk impurities are removed. The final purity is achieved in the polishing section.   
 
For this purpose several unit operations can be used which have different separation 
mechanisms and capacities.  In downstream processing of biological products, mainly 
chromatographic and membrane filtration units are used (Shukla, 2007). 
  
 
1.2.2.1 Separation of biomass 
 
In this thesis, downstream processing techniques for intracellular products are discussed. 
Recovery of proteins from E.coli fermentation broths begins with separation of the solids 
from the liquid phase of the fermentation broth, followed by chemical lysis of cells to 
release target protein that is contained inside the cells, finally removing the remaining 
cell debris.  The leading methods for this are centrifugation and microfiltration. 
 
 
Centrifugation separates on the basis of the particle size and density difference between 
solids and liquids or two liquids.  The density gradient is amplified through the 
application of centrifugal force by high-speed rotation.  In bioproessing centrifugation 
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can be used for the removal of whole cells, cell debris, sepheroplasts, and inclusion 
bodies from the liquid phase.  Therefore it can be used both for initial recovery of the 
cells/liquid from the raw fermentation broth and also later on for separation of post 
intracellular product release.  In the biotechnology industry three different types of 
centrifuge are commonly used: disc-stack, multi-chamber bowl, and tubular bowl 
centrifuges (Boychyn, 2004). 
 
Centrifugation is preferred over other harvesting technologies due to its scalability and 
economical operation for large volumes (typically 2-150,000 L/batch).  Large scale 
centrifugation acts as the primary harvesting step but cannot accomplish complete 
removal of cells and cell debris, which must be removed prior to chromatography (van 
Reis, 2001). 
  
 
Because of the incomplete removal of particulates from a commercial scale 
centrifugation, depth filtration step(s) need to be employed to remove residual cellular 
debris (Low, 2007).  Depth filtration refers to the use of a porous medium that is capable 
of retaining particulates throughout its matrix rather than just on its surface.  Depth filters 
employed in bioprocessing typically consist of a fibrous bed of cellulose or 
polypropylene fibres along with filter aid (diatomaceous earth) and binders.  The flat 
sheets are packed into single-use cartridges that can be stacked in housing and 
pressurized to drive fluid flow through the system (Jordan, 1996). 
 
Depth filters typically do not come with an absolute pore size rating unless they include a 
membrane layer at the end of the flow path.  The depth filter is followed by a filter with 
an absolute pore size rating that ensures the removal of solid particulates from the cell 
culture harvest supernatant.   
 
 
1.2.2.2 Primary Capture – Chromatography 
 
For purification of antibodies, different chromatographic techniques are used for the 
purpose of capturing protein products or polishing for quality.  The major types of 
chromatography for primary capture are affinity chromatography (Shukla, 2007) and ion 
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exchange chromatography.  Regardless of the type of chromatographic separation, all 
comprise of several steps.  Before the column can be used, it must be equilibrated to 
ensure that the conditions within the column are homogenous, that is all parts of the 
column are equilibrated to the same condition with lowest elution strength.  After 
equilibration, the column is loaded with the feedstock of choice.  The column is then 
washed to remove some impurities and unbound/loosely bound proteins, before the target 
protein is eluted from the column by a stepwise or continuous change of the elution 
strength of the mobile phase. Afterwards, the column is washed again to remove the 
remaining impurities.  Before the next batch can be processed, the column has to be 
regenerated and sanitised (Levison, 2003). 
 
 
 
  1.2.2.2.1 Affinity Chromatography 
 
Affinity chromatography can provide very high enrichment factors in one step due to its 
high selectivity nature.  For the purification of antibodies, the most common type of 
affinity ligands are immobilised bacterial cell wall proteins – e.g. staphylococcal protein 
A or streptococcal protein G.   
 
The interaction of these two proteins occurs primarily through the Fc region of the 
antibodies but can also interact through secondary binding sites.  Both Protein A and 
Protein G are available in recombinant forms in which non-essential regions have been 
removed leaving four binding sites for IgG intact. 
 
Feedstocks can be loaded into a Protein A column directly without conditioning due to 
the high selectivity of the resin and feedstocks are normally close to neutral pH.  The 
product is eluted from the column at low pH.  A wash step introduced between column 
load and elution is often at an intermediate pH and removes host cell proteins and other 
contaminants. Finally the column is stripped and regenerated using high concentrations 
of chaotropes such as urea or guanidine hydrochloride. However eluting at low pH means 
target protein will be exposed to low pH conditions and can result in the formation of 
soluble high molecular weight aggregates and/or insoluble precipitate formation during 
product elution.  High molecular weight aggregate formation can lead to a reduction in 
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product yield if a significant level of the product species aggregate (Cromwell, 2006).  
This also places an added burden on the polishing steps to achieve clearance since 
aggregate species can be potentially antigenic.  Insoluble aggregate formation can be the 
result of either the product species or impurities such as host cell proteins precipitating.  
Both cases increase the risk of reduction in column lifetime, and at the same time 
affecting the product activity (Shukla, 2007; Bermudez, 2004)  Regardless of the 
disadvantage the purity of the resulting eluant is >99 % pure. 
 
A disadvantage of protein A or protein G usage is that there is always a small degree of 
leakage of the protein ligand, these leaked ligands are harmful to patients if present in the 
final drug product.  For this reason, therapeutic products requires additional purification 
steps to remove these toxic ligands.  Moreover, there are non-specific interactions 
resulting in a contamination of the target protein with impurities that are retained by the 
affinity matrix due to hydrophobic or ion exchange effects.  The different bound species 
of proteins were eluted together with the target protein.  This reduces the selectivity and 
more importantly reduces the access of target proteins to the affinity matrix ligands, 
hence reduces the binding capacity of the matrix.  Another disadvantage of Protein A 
chromatography is the high cost of the matrix, which can be up to 10 times as expensive 
as conventional chromatographic supports (Sommerfeld, 2005).  The high cost of the 
resin often leads to an operating strategy in which a smaller Protein A column is cycled 
several times while purifying a batch of cell culture supernatant is loaded on a relatively 
smaller column (Shukla, 2010). 
 
 
 
 
 
1.2.2.2.2 Ion Exchange Chromatography 
 
Basis for ion exchange chromatography (IEX) is the competition of the protein and a salt 
for the binding sites on the surface of the ion exchanger.  The strength of binding is 
proportional to the charge of the protein for an oppositely charged ion exchanger.  The 
charge of the protein depends on the pH value of the solution.  The pH value at which net 
charge of the protein is zero is called isoelectric point (pI value). Ion exchangers with 
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negatively charged groups are cation exchangers because they bind positively charged 
proteins (cations) when mobile phase pH value is below pI value of the protein.  
Conversely, anion exchangers are positively charged.  Because of the nature of the matrix, 
protein and stationary phase are charged oppositely is determined by the pH value of the 
mobile phase (Newcombe, 2008). Salt concentration of the mobile phase will determine 
if protein binding occurs as both salt and protein compete for the charged sites of the 
stationary phase, even small amounts of salt ions in the feed solution can significantly 
lower the resin binding capacity in ion exchange chromatography (Cramer and Brooks, 
1992) 
 
For a platform process, an ion exchange step is used to reduce host cell protein impurities, 
high molecular weight aggregates, low molecular weight clipped species, DNA and 
leached Protein A that remain after the Protein A chromatographic step to acceptably low 
levels that assure safety of the product (Low, 2007; Shukla, 2007; Sommerfeld, 2005).  
In other words IEX is currently widely used as a polishing step rather than a primary 
recovery step. 
 
 
1.2.2.3 Nonaffinity process vs platform process 
 
A generic process which assumes that a pre-defined purification process works for all 
antibodies is called a platform process (Shukla, 2007).  Process development can often be 
the rate-limiting step in the introduction of biopharmaceuticals into clinical trials.  The 
increasing numbers of antibodies entering clinical trials, there is a clear driver for 
employing a templated approach to process development.   
 
In theory a platform approach can reduce process development effort, however 
significant physicochemical differences exist among different antibodies making this 
approach either impractical or resulting in a non-robust process.  
 
Within the upstream section the major optimisation potential is to increase the product 
titre.  This can be achieved by raising the specific production rate of the cells or by 
having a high cell number over a long fermentation period.    Purification processes for 
antibodies have improved progressively over the last 20 years, giving a more than 50-
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fold increase in cell culture productivity (Blanca Lain, 2009).  To cope with the upstream 
improvement, Protein A primary capture step needs to be able to handle the increasing 
antibody titre.  A typical protein A affinity chromatography resins have a dynamic 
binding capacity of around 40 g L  and depend highly on residence time, whereas recent 
developments have led to CEX resins with high dynamic binding capacity of 100 grams 
of protein per liter of resin. The cost of IEX resins are 10 times less expensive than 
protein A resins, this makes platform processes a less attractive choice financially 
(Sommerfeld, 2005). 
-1
 
Developments in antibody engineering capabilities have resulted in significant diversity 
in antibody-based therapeutics, allowing for fusion molecules, immunoadhesins, Fab and 
F(ab)2 structures which may or may not contain Fc portions or engineered bioaffinity 
sites, so that Protein A no longer provides a platform solution.  An upcoming trend of 
peptide based drugs will be good additional example of non-affinity products (Vlieghe, 
2010).  Furthermore, protein A shows some variability in binding to antibodies, which 
appears to be due to interactions with the variable region, for instance the presence of 
specific sequences in the heavy chain.  
 
Although production are mainly based on using an affinity process (platform process), 
due to the above reasons a non-affinity process needs to be adopted to satisfy the ever 
improving upstream development.   Several methods have been proposed and tested to 
increase the process capacity of the primary recovery step.  The affinity chromatography 
can be replaced by hydroxyapitite chromatography, ion-exchange chromatography and 
filtration (Subramanian, 2005). 
 
 
Ion exchange is certainly amenable to the large scale purification of antibodies and is 
used as the primary capture step in at least one commercial process.  Capacities are 
higher and cleaning and sanitisation steps are simpler, the chief trade-off is a greater 
burden on the subsequent steps for purification and clearance of host cell protein and 
potential virus contamination.  In a comparison between a protein A process and a three 
step non-affinity processes (Figure 1.4), similar levels of host cell protein clearance could 
be achieved by both approaches. There is much potential in non-affinity processes, only 
limited to intensive optimisation of binding and elution conditions (Alahari Arunakumari, 
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2007; G.M. Ferreira, 2007; Wang, 2008).  If a good and efficient optimisation routine is 
established to ensure the quality of the product from ion-exchange chromatography 
which can rival a protein A based process, a non-affinity process can be utilised more 
broadly (Follman, 2004).  In figure 1.5 a table listing the functions of the unit operation 
described above is presented. 
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Protein A 
chromatography 
 
Chromatographic 
polishing step 1 
 
Chromatographic 
polishing step 2 
 
Cation exchange 
Chromatography 
 
Anion exchange 
chromatography 
 
Hydrophobic 
interaction 
chromatography 
 
Feed stock 
preparation 
 
Figure 1.3 Two major routes for antibody purification from a feedstock; an affinity process (left) and 
non-affinity process. (righ 
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Table 1.2 Upstream and downstream unit operations and their 
corresponding functions. 
 
 
 
Unit 
operation 
 
 
Contaminants introduced 
 
 
 
Contaminants 
removed 
 
 
 
 
 
 
Fermentation 
(Low, 2007) 
Amino acid 
Inorganic salts 
Glucose 
Intact cells 
Cell debris 
Host cell proteins 
Viruses 
DNA 
Lipids 
Endotoxins 
Other culture medium 
compositions 
 
 
 
 
 
N/A 
 
Centrifugation 
(Low, 2007) 
 
 
Shear induced aggregates 
 
 
 
Intact Cells 
High MW cell debris 
 
 
 
Depth Filtration 
(Roush, 2008) 
 
 
Filter aid 
 
 
 
Low MW cell debris 
Low MW aggregates 
 
 
Dead end 
filtration 
 
 
 
 
 
Low MW cell debris 
Low MW aggregates 
Filter aid 
 
Protein A 
chromatography 
(Shukla, 2007) 
 
Leached protein A 
High MW aggregates 
 
Host cell protein 
Viruses 
Endotoxins 
 
 
Ion-exchange 
chromatography 
(Shukla, 2007) 
  
High MW aggregates 
Host cell impurities 
DNA 
Viruses 
Endotoxins 
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1.2.3 Validation 
 
 
The biopharmaceutical manufacturing industry is highly regulated having to meet strict 
regulations.  After the drug has been approved, most regulatory agencies such as the 
FDA require that the drug product be tested for its identity, potency, quality, purity and 
stability before it can be released for use (Doblhoff-Dier and Bliem, 1999).  Because of 
the above reason, process controls are crucial to ensure that a specific process will 
consistently produce a product which meets its predetermined specifications and quality 
attributes at various critical stages of a manufacturing process.  A quality by design 
approach was used to determine the process parameters to ensure lot-to-lot consistency 
(Geigert 1997); quality control, quality assurance and batch documentation thus form key 
parts of the in-process validation procedure for any biopharmaceutical.  A diagram 
explaining the chronological sequence of product development is presented in figure 1.3. 
 
 
Information obtained about the unit operation during development phase of a bioprocess 
is not enough to justify the setting of validation criteria.  Therefore the response of a 
process output to variations in input parameters is investigated in some detail before 
process validation in a process characterisation phase.  Defining the design space of 
bioprocess is crucial to validation, working within the space is not considered as change, 
however working outside of the space would initiate regulatory disapproval (ICH, 2006a).  
Setting the operating range to be too narrow would underestimate the accidental 
deviations of operating conditions in the bioprocess.  However if the range is too wide, 
the product might fail to meet the acceptance criteria.  
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1.2.4 Validation of chromatography 
 
Chromatography performance is affected by a wide range of variables, such as pH and 
ionic strength, linear velocity, column load volume and quality, ligand density, bed 
height, gradient slope. All these parameters are important to the outcome of the eluate. 
To investigate the effects of all these parameters will lead to large experimental designs 
and substantial analytical support as each experiment may have to be analysed with 
several assays to test for purity of the protein with respect to product variants, host cell 
contaminants and process impurities.  Apart from developing the optimised operation for 
chromatography, a series of experiments is also required to examine the sensitivity of the 
system.  In general validation of chromatography is to ensure the quality of the eluate is 
reproducible for every operating cycle and in addition the number of cycles the resin can 
endure before the batch of resin needs to be discarded (Müller-Späth, 2009). 
 
Due to the fact that there are many different parameters present that are likely to affect 
the performance of chromatography; validation requires the developers to perform 
extensive number of experiments to justify the quality of their products.  Because of this 
reason, methods need to be developed to reduce the experimental effort and at the same 
time provide enough evidence to ensure the robustness of the process.  
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Target and product 
discovery  
Process 
development 
(optimisation) 
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Figure 1.5 A typical path of a drug candidate will follow from identification 
to launch 
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1.3 Modelling  
 
1.3.1 Whole process modelling 
 
With an increasing number of international and national regulations, companies bringing 
new drugs to market face additional burdens of ensuring and improving quality, each 
being expensive and time-consuming activities. 
 
Modelling plays an important role in bioprocess development for design and scale-up. 
Predictive models can also be used in biopharmaceutical manufacturing to assist 
decision-making either to maintain process consistency or to identify optimal operating 
conditions (Gao, 2010). 
 
Modelling complete flowsheets requires purpose-built software such as Extend and Superpro 
designer. Simulations can be used to tackle many problems, from initial design and proof-of-
concept studies through operation (Gosling, 2005; Petrides, 1989) and validation.  The 
ultimate goal of modelling of a bioprocess is to develop more robust processes faster and at a 
lower cost resulting in higher quality products by comparing process alternatives (Rouf, 
2001).  Through modelling potential resource problem can be identified and anticipated 
before setup.   
 
 
1.3.2 Unit operation modelling 
 
Key unit operations of a bioprocess often determine the quality of the product produced 
by a process. The performance of these key unit operations is often determined by a large 
number of operating variables.  If the design and performance characteristics of these 
units can be compiled into a mathematical representation, then potential problems can be 
investigated through modelling, reducing the need for expensive experimentation. This 
will reduce the time and cost of process development and ensure the developed process is 
robust and has the ability to handle variability and deliver a predefined quality as regards 
yield, purity and productivity within the defined design space. (Gosling, 2005; Yu, 2008) 
In addition, accurate prediction of a unit operation allows accurate prediction of its 
economics hence the whole process economics.  
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A lot of mathematical models still require users to provide some experimental data as 
critical input data.  The quality of this data will often determine the usefulness of the 
model, but it has been shown that combining some experimental data with process 
models can improve their accuracy significantly.  If process models can reliably predict 
unit performance then they will undoubtedly gain wide spread use since the savings in 
time and resources can be substantial.   
 
1.4 Scale-down methods 
 
From the above sections, it is explained that due to the requirements of regulatory 
agencies and process optimisation, a large number of experiments are required to 
generate enough evidence to prove the robustness of the process. 
 
During the early stages of R&D, cell lines are not optimised hence target protein 
production is not expressed in large quantity.  Since target protein is scarce, the number 
of experiments that be conducted at normal laboratory scale is limited.  To alleviate this 
problem, smaller scale unit operations or innovative approach to obtain the necessary 
parameters for models can be used.  The ultra scale-down methods and high throughput 
screening are examples of such strategy.  The net result can be a reduction in the time 
needed to get a functioning process into a facility and the early resolution of other issues 
such as the sizing of ancillary process-support equipment.  Furthermore, given the 
relatively inexpensive nature of microscale experimentation, if a product fails 
subsequently in clinical trials, then the money spent using these devices in development 
studies can be written off more readily.  Because of these advantages, microscale 
approaches are seen increasingly as a powerful way to accelerate bioprocess development 
and have been applied to steps such as fermentation and microfiltration.  
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1.4.1 Ultra scale-down 
 
Ultra scale-down is a novel nonlinear scaling approach; this method reduces the volume 
of test material required whilst maintaining the relevance of data collection.  The 
experimental philosophy of USD methodology involves the characterisation of the 
critical regimes of a large scale unit operation and then using miniature devices to obtain 
data on the impact of the process material properties. An example of a successful 
utilisation of this method is demonstrated by (Boychyn, 2004; Chan, 2006).  The authors 
mimicked the performance of a process scale centrifuge using a bench top device.  This 
was done by reproducing the shear condition identical at the entry point of a process 
scale centrifuge using a rotating disc shear device, making the feed material constant 
across both scales.  This approach enables reliable centrifugation scale-down of several 
orders of magnitude.  There are other examples of ultra scale-down for different unit 
operations such as depth filtration, (Reynolds, 2003) and centrifugation using micro-titre 
plates. (Tait, 2009) 
 
The main purpose of the ultra scale-down method is to allow the experimenter to 
generate data at small scale with least amount of materials to predict performances of the 
unit operation at industrial scale.  The philosophy of the experimentation is to mimic the 
physics of the hardware and reproduce the quality of the feed material. 
 
1.4.2 High throughput screening 
 
High throughput screening is an experimentation method designed for drug discovery 
purposes.  This technique has a wide range of applications this includes ELISA, cell 
based assay development, protein stability and protein–protein interaction studies.  
(Fernandes, 1998; Capelle, 2007). 
 
High throughput microliter scale-down approaches reduce sample requirements by an 
order of magnitude - below the mL scale volumes employed at present for laboratory 
columns.  These microscale techniques ideally suited to accommodate the limited 
quantities of feed stocks that are available early in process development. The 
technology allows early stage evaluation of many process strategies in parallel, thus 
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reducing development costs and allowing later pilot work to be more highly focused 
upon the most feasible option (Bensch, 2005; Bergander, 2008; Chhatre, 2009).  In 
other words, this technique provides a platform to reduce the size of design spaces, 
filtering out the non-feasible options at an early stage.   
 
 
High throughput screening involves the use of micro-titre plates; each well of the 
plate(s) represents an independent experiment.  The multi-well nature of a 96 well-
plate the plate provides a design space for a series of discreet experiments.  Due to 
the size of the design space, the number of discreet experiments can be very large this 
leads to the need of a well defined analytical technique to process the large array of 
results obtained.   
 
1.5 Chromatography – scale down and modelling 
 
Adsorption of protein products under complex conditions i.e. real feedstock is regarded 
as a non-linear system. In the age of rapid development of biotechnology, preparative 
and large scale chromatography becomes increasingly important for product 
manufacturing; in addition, Unlike analytical chromatography, dispersion and mass 
transfer effects are often significant in preparative and large scale chromatography; this 
causes difficulty in predicting the performance of chromatography without intensive 
experimental work. 
 
Small preparative columns are very time consuming to experiment with and in addition, 
due to the size of these columns, the feed material requirement to complete the 
experimentation to obtain the desirable results remains high.   Because of the above 
reason high throughput screening is particularly useful in scouting conditions either for 
binding or elution stages of the unit operation (Mazza, 2002; Kramarczyk, 2008; Kelley, 
2008; Bensch, 2005).  There are also efforts in using this technology to aide the 
optimisation of the unit operation (Susanto, 2009; Susanto, 2008; Bergander, 2008; 
Wiendahl, 2008). 
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1.5.1 Modelling  
 
Because obtaining information experimentally through quality by design method is very 
time consuming and labour intensive even when using a high throughput screening 
(HTS) technique due to the size of the design space.  Mathematical models can be used 
to identify the sensitive parameters of the systems, this requires a well developed model 
that has the ability to represent the system sufficiently enough to simulate the 
performance of chromatography.  The main objective of modelling in this case is to 
reduce significantly the size of the design space.  Since the design space is reduced in 
size, experimental effort will also decrease for validation (Mollerup, 2009).  The 
adsorption of protein materials into the resin bead follows the two film theory developed 
by Lewis and Whitman in 1924.  In chromatography terms the film theory means that for any 
substance to reach the ligand in the porous resin particle it must first enter the stagnant film 
of the resin particle before it can diffuse into the intra-particle space.  The general rate model 
is a model that utilizes the film theory together with intra-particle diffusions to simulate the 
performance of chromatography.    There is also another model that takes into account 
protein-protein interaction of a system into account on top of the general rate model 
(Berninger, 1991;Whitley, 1991). 
 
Apart from adsorption theory of target proteins onto the resin, there are other parameters that 
need to be identified to complete the models.  Such as adsorption rates (Velayudhan, 1994), 
mass transfer coefficient (Persson, 2004; Liapis, 2008}, intra particle diffusivity (Kempe, 
2006; Tyn, 1990), axial dispersion (Farkas, 1979) and molecular diffusivity (Gallant, 2004).  
A lot of effort has been put into estimating the necessary parameters to complete the models 
and understanding their underlying meaning to the system.  For example confocal 
microscopy has been used to understand the intra particle diffusion (Susanto, 2007). 
 
Another way to estimate the parameters is by lumping the parameters in order to reduce 
the effort to estimate the necessary parameters for modelling (Martin, 2005) 
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1.5.2 Scale up 
 
Modelling not only serves as a performance prediction tool, it also provides opportunity 
to predict the performance of the unit operation at different scales.  A traditional way to 
scale up a chromatography column is by maintaining the column height while increasing 
the radius of the column.  By doing so, the residence time of the feedstock remains 
unchanged when the linear velocity is constant at both scales.  However, as the radius of 
the column increases, the wall support of the center of the resin decreases; this limits the 
maximum running flowrate to preserve the packing and structure of the resin bed.  The 
extent of compression of the resin correlates to the pressure drop with the aspect ratio of 
the packed beds and the superficial velocity (Stickel, 2001).  Using the Stickel rule to 
scale-down a column will result in a relatively long column (at least 30 cm), resulting in 
a relatively large column volume. 
 
1.6 Introduction to project 
 
 
From the above sections, the structure of an antibody and its potential use in the 
biopharmaceutical industry is presented.  There is a market for these therapeutic proteins; 
however the research and development together with the regulatory requirements hinders 
the commercialisation of such products.  Process validation by quality by design method 
for down-stream purification strategies requires extensive experimental efforts due to the 
large number of process variables.  It is necessary to develop methods to reduce the 
design space of the experiments and at the same time optimise the unit operation to 
identify the operating window. 
 
In this project an ultra scale-down approach for chromatography will be performed and 
discussed.  The feedstock used in the project will be a E.coli heat lysate (generated by 
heating during periplasmic extraction) containing Fab’ fragments and the resin of choice 
is a generic cation exchange resin.  The chromatography step serves as a primary capture 
step.  Performance of chromatography is judged by breakthrough curves because 
breakthrough curves represent adsorption of target protein onto the resin under column 
conditions.   
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The first aim of the project is to identify the parameters that are sensitive to the system 
followed by developing a general rate based model that can predict the performance of a 
laboratory scale chromatography under different condition. The condition of choice in 
this project is flowrate, because it is the easiest parameter to change at process scale and 
also this parameter will aid the optimisation of loading time. 
 
The second aim of the project is to discover the scale down opportunities of the model. A 
micro-scale tip column will be used to challenge the traditional geometric scaling rule.  
Breakthrough curves will be obtained using micro-scale tips and by using the 
breakthrough curves the scale up opportunities to predict the performance of laboratory 1 
mL scale from 40 μL micro-scale will be investigated. 
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Chapter 2 - Materials and Methods   
 
2.1. E.coli lysate feedstock preparation 
 
In this section, a full methodology for E.coli lysate feedstock preparation will be 
presented.  The key steps implemented to prepare the E.coli lysate are illustrated in 
figure 2.1. The cell feedstock preparation involves fermentation to grow E.coli cells 
for expressing Fab’ fragments because the Fab’ fragments are intracellular product. 
Centrifugation was implemented to recover the cells in the form of a cell paste.  The 
cell paste was then resuspended in a lysis buffer and heated to release the Fab’ 
fragments accumulated in the periplasm and at the same time break down some of the 
intracellular protein contaminants.  The cell debris and lysate mixture from the 
periplasmic extraction was spun down in a centrifuge to remove cell debris resulting 
in a heat clarified lysate.  The heat clarified lysate was then concentrated and 
conditioned to the right pH.  The conditioned E.coli lysate was filtered through dead 
end filtration before loading into an ion-exchange column. 
 
 
2.1.1. Chemicals 
 
All chemicals were purchased from Sigma-Aldrich Co. Ltd (Dorset, UK) unless 
otherwise specified.  All chemicals are of analytical grade.  These are tested where 
appropriate in the following sections.  
 
 
2.1.2. Fermentation 
 
A humanised Fab’ antibody fragment was produced by fed-batch E.coli fermentation.  
The E.coli cell strain is W3110 transformed with the plasmid pAGP-4. The protocol 
and cell strain was obtained from UCB Celltech and is strictly proprietary.  The 
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fermentation was carried out in a 20 L vessel (Applikon Biotechnology, Schiedam, 
Netherlands) 
 
The E.coli cells were first incubated at 30 0C in shake flasks before inoculated into 
the 20L vessel with 10L of SM6c defined media that contains the bare minimum 
nutritional requirements for E.coli cells.  The cells were controlled and monitored to 
grow until stationary phase.  After stationary phase was reached, isopropyl β-D-1-
thiogalactopyranoside (IPTG) was added to the cells to initiate Fab’ expression 
(detailed protocol is strictly confidential).  The cells express Fab’ antibody fragments 
under transcriptional control of the E.coli tac promoter. Each antibody chain was 
preceded by the E.coli ampA signal sequence to direct expression to the periplasmic 
space.  The expression of Fab’ was terminated when Fab’ fragments were detected in 
the media.  Samples were taken every two hours of the fermentation; cell growth was 
monitored using light microscopy at 380 nm whereas Fab’ fragments were quantified 
using protein G HPLC assay.   
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P-2 / BC-101
Centrifugation
 
Centrifugation 
 
  
Fermentation 
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dead end filtration 
      Centrifugation 
 
lysis 
Ion Exchange 
 
Figure 2.1 Steps to prepare E.coli lysate.  The steps in chronological 
order: fermentation, centrifugation, chemical lysis, second centrifugation, 
a diafiltration followed by a dead end filtration and finally ion exchange 
chromatography. 
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2.1.3. Centrifugation 
 
The cells were harvested from the fermenter and separated from the media by 
extraction; using a CARR P6 solid bowl centrifuge with automated solids discharge 
(Kendro, Asheville, NC, USA).  The centrifuge was operated at 15,200 rpm with a 
feed rate of 45 L h-1.  The centrifugation was done immediately after the completion 
of the fermentation to prevent product leaking into the cell broth.  The cell paste 
harvested was stored at -80 0C.  
 
2.1.4. Heat lysis 
 
A heat lysis step was used to release the periplasmic proteins; this was done by 
adding a detergent to dissolve the cell wall, making the cell “leaky”;  heating the 
lysate makes the non heat resistant proteins denature (the Fab’ fragments expressed 
by this system is heat resistant). Hence proteins are able to escape from the cells 
while keeping the cells intact.  This method of releasing intra-cellular product 
reduces the requirements of the subsequent down stream processing unit operations, 
however the Fab’ fragment release is only 40 % of total Fab’ fragments expressed.  
Although the Fab’ released is not 100%; the Fab’ fragments released is of higher 
purity compared to homogenisation where all whole cell proteins are being released; 
in other words less truncated versions of Fab’ fragments are present in clarified lysate.  
 
The harvested cell paste from centrifugation was resuspended in 10 L of lysis buffer 
consists of 100mM Tris-HCl and 10 mM EDTA adjusted to pH 7.4 with hydrochloric 
acid.  The mixture was then incubated in a 20 L vessel at 55 0C, agitated at 350 rpm 
overnight for 16 hours.  
 
2.1.5. Centrifugation 
 
The lysed cells were removed from the 20L vessel.  The Fab’ fragments from the 
perplasmic space were released into the lysis buffer.  To extract the product, 
spheroplasts and cell debris were removed by laboratory scale Beckman Avanti J-HC 
centrifugation (Beckman Coulter,UK) at 10,000 rpm for 45 min, the supernatant was 
collected as Fab’ fragment heat lysate. 
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2.1.6. Concentration 
 
 
A concentration step was performed to reduce the feed volume for easy storage and at 
the same time allowed leeway for dilution to reduce the conductivity of the clarified 
lysate for subsequent chromatography experiments. 
 
The conditions of the heat lysate was firstly adjusted by concentrating three-folds 
using a 0.1 m2 Pellicon 2 mini 10 kd cut off  cartridge filter mounted on a Proflux 
system (Millipore, Bedford, MA, USA).  The concentration was completed in a 
tangential flow manner; pressure was kept constant at 1 bar. (Diagram of the 
diafiltration system is shown in fig 2.2). All proteins were retained and recycled 
during the process while salts were eliminated through the permeate stream.  The 
retentate was collected and adjusted to pH 5.2 using concentrated HCl; the reason 
behind the pH adjustment will be explained in chapter 4.2.2. 
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Retentate 
Permeate 
Filter Reservoir  
Pump 
 
Figure 2.2 Flow diagram of the concentration of E.coli 
lysate using an ultrafiltration membrane.  Salts and water 
transmit through the filter and exit the system from the 
permeate stream whereas the Fab’ fragments and other 
proteins recycle into the reservoir. 
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2.1.7. Filtration  
 
During the process of diafiltration and pH adjustment, particulates were formed. It is 
necessary to remove these particulates prior to chromatography step, as these 
particulates will cause blockage the top frit of the column and at the same time 
interfere with the adsorption of protein onto the resin particles.  To remove these 
particulates; a dead end filtration step was performed using a 0.22 µm vacuum filter.  
The resultant filtrate is free from particulates and is ready to be loaded into a cation 
exchange column. In chapter 4.4 the composition of the particulates were analysed.  
The clarified lysate was stored in 50 mL aliquots in Falcon tubes (Greiner, 
Stonehouse, UK)  at -4 0C.  
 
 
2.2. Protein G assay  
 
Due to the complexity of the E.coli lysate, the assay technique needs to be specific to 
Fab’ fragments, in other words, the least amount of interference from non-Fab’ 
fragment proteins. Within the periplasmic space of the E.coli cell, the Fab’ fragment 
is the only protein that can bind to a protein G immunoglobulin-binding protein.  The 
Fab’ fragment by its nature is expressed without the presence of the Fc region but still 
has the ability to bind to protein G through secondary binding sites. Although this 
secondary binding site is not specific to Fab’ fragment, the binding is strong enough 
to maintain high binding capacity.  Using this specificity, the concentration of Fab’ 
fragment can be determined.   
 
To determine the concentration of Fab’ fragments in a sample, a 1mL HiTrap protein 
G HP (GE Healthcare) column was used on an Agilent 1200 HPLC system (Agilent 
technologies, Berkshire, UK).  The HiTrap column was first equilibrated with 5 CV 
of equilibration buffer consists of 50 mM di-sodium hydrogen phosphate adjusted to 
pH 7.4 with 85% phosphoric acid. After equilibration, 100 µL of sample was loaded 
into the column. After loading, 5 CV of equilibration buffer was used to wash away 
any unbound materials.  Straight after washing is elution; this was done by running 2 
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CV of elution buffer through the column.  The wash and elution step were repeated to 
ensure any bound materials were disassociated from the ligand.  To regenerate the 
resin, 5 CV of equilibration buffer was loaded through column. The whole cycle was 
run at a flowrate of 2 mL min-1 and the total time required to complete the analysis of 
a sample was approximately 9 minutes.  A chromatogram of the analysis was 
recorded from loading till regeneration.   Fab’ fragment was eluted at approximately 
3 minutes into the analysis. The concentration of Fab’ fragment in the sample is 
directly proportional to the peak area.  The peak area is integrated by Chemstation. 
(Agilent Technologies, Berkshire,UK).  The same method was used to intergrate the 
peak areas of the chromatogram throughout the project. 
 
2.2.1.1. Pure Fab’ fragments preparation 
 
The peak area from the Protein G assay alone is insufficient to determine the 
concentration of protein in a sample.  To translate peak area into concentration, a 
standard curve needs to be obtained.  Pure Fab’ fragments at different concentrations 
were used to obtain a standard curve.  After the standard curve was determined, the 
sensitivity of the assay was examined to aid the planning of the subsequent 
chromatography experiments.   
 
Pure Fab’ fragments were produced by purifying heat lysate with a Protein A column.  
A XK50 column was packed with 200 mL of rProtein A resin (GE healthcare) at 65 
mL min-1.  
 
To prepare the lysate for Protein A chromatography, 1 M of glycine was added to the 
lysate after the removal of all the cell debris from the heat lysate.  The pH of the 
glycine-lysate mixture was adjusted to pH 7.5 using 50% (w/v) sodium glycinate.  
The conditioned lysate was filtered through a 0.22 μm filter.   
 
The column was equilibrated with 5 CV of 50mM sodium phosphate buffer at pH 7.4.  
The purification was continued by loading conditioned lysate into the packed protein 
A column at 155 cm h-1.  Excess lysate was loaded onto the column to ensure the 
column was saturated.  The column was then washed with at least 5 CV of 
equilibration buffer until UV signal detected returned to zero.  A step elution was 
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achieved by passing 50 mM sodium phosphate buffer at pH 2.5 through the column 
until a distinct peak was observed.  The eluted materials were collected in 5 mL 
fractions. The column was then sanitised with 1 CV of 6M guanidine hydrochloride 
solution and immediately flushed with 10 CV of equilibration buffer.   
 
The most concentrated eluted fractions (maximum peak height using OD280) were 
pooled together; Tris was added to adjust the pH from 2.5 to 7.4.  The stabilised pure 
Fab’ was buffer exchanged into pH 5 sodium acetate with 1% sodium azide for long 
term storage. 
 
2.2.1.2. Fab’ fragment standard curve using HPLC  
 
 The purified Fab’ was quantified using an ELISA (protocol not included as 
experimentation was performed by Helen Baldacini) previously, with the 
concentration determined; a standard curve can be obtained using HPLC.  The 
purified Fab’ was diluted with 50 mM di-sodium hydrogen phosphate adjusted to pH 
7.4 (equilibration buffer to protein G column) into 10 μg mL-1, 20 μg mL-1, 50 μg 
mL-1, 100 μg mL-1, 200 μg mL-1, 300 μg mL-1, 400 μg mL-1 and 500 μg mL-1 
fractions.  These fractions were then analysed using the method described in section 
2.2.1.   
 
E.coli lysate consists of many different proteins and the interaction between these 
proteins is unknown, especially under different pH and conductivity.  An analysis 
was done under different pH and low conductivity for the purpose of screening the 
appropriate binding conditions for cation exchange chromatography. 
 
 
2.2.2. Precipitation analysis 
 
Particulates formed when lysate pH was reduced.  Particulates form as the net 
charge of the proteins in the lysate changes due to pH shift, hence promoting 
interaction between proteins.     The composition of the particulates was 
examined. The result aids the determination of lysate pH prior to the cation 
exchange step. 
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The E.coli lysate was separated into seven 10 mL aliquots.  The pH of the 
aliquots was adjusted to 2, 2.5, 3, 3.5, 4, 4.5 and 5 using HCl.  The pH adjusted 
E.coli lysates were spun down using a bench top centrifuge (Eppendorf) at 10,000 
rpm for 30 minutes to separate the solid and liquid phases.  The liquid phases 
were decanted into separate Eppendorf tubes for analysis.  The pellets left behind 
were rinsed with 10 mM sodium phosphate buffer of their corresponding pH to 
rinse off the remaining liquid phase that was not removed during decantation. 
Because the pellets were disturbed during the rinsing stage, the mixture was 
centrifuged at 10,000 rpm for 10 minutes. After the excess buffer was removed, 
1.5 mL of 10 mM phosphate buffer at pH 8.5 was added to each of the aliquots.  
The pellets and buffer mixtures were left on an Eppendorf thermomixer for 2 
hours to allow all the pellets to re-dissolve.   
 
The dissolved pellets and the liquid phases of the E.coli lysate were analysed 
using reducing sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE). 500 μL of each of the samples were separated into individual Eppendorf 
tubes.  500 μL of Tris-Glycine SDS sample buffer containing 1% 2-
mercaptoethanol was added to each of the Eppendorf tubes.  The conditioned 
samples were heated to 900C for 10 minutes. The Eppendorf tubes were briefly 
centrifuged for 10 seconds at 5000 rpm to re-collect the condensation  15 μL 
samples were then loaded into two separate Novex® 4-12% tris-glycine Gels 
(Invitrogen) and run simultaneously using the same power pack at 125 V for 90 
minutes. 
 
The gels were developed for 2 hours using Coomassie® G-250 SimplyBlue Safe-
Stain. (Invitrogen) The gels were then de-stained using deionised water overnight 
until distinct bands can be seen.   
 
The same protocol was used for all SDS-PAGE analysis done in this project.  For 
non-reducing gels, the 1% 2-mercaptoethanol was not added to the running buffer 
before heating.   
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2.3. Measuring chromatographic performance  
 
In this section methods used to determine the binding conditions of prepared E.coli 
lysate onto SP Sepharose FF resin and the method for obtaining the breakthrough 
data for modelling will be presented.   
 
2.3.1. Adsorption isotherm  
       
Adsorption isotherms were obtained to investigate the adsorption of Fab’ 
fragments on SP Sepharose FF resin with different net charges in the lysate; the 
net charge of Fab’ fragments were altered by adjusting the lysate pH. 
 
 
2.3.1.1.Dry resin weight analysis  
 
The resin dry weights were determined at different aspirate volumes.  This 
was to confirm, within the experimental space, the amount of resin taken 
from bulk resin suspension is directly proportional to the volume aspirated.  
Firstly the same volume of resin was repeatedly aspirated and dispensed to 
demonstrate the reproducibility of each batch system. Secondly different 
volumes of resin were aspirated and dispensed to prove that each batch 
adsorption system contains the correct amount of resin.  Particular attention 
was paid to error analysis at very small volumes.  10 mL of resin was 
poured inside a Falcon tube and then 20% ethanol was added to the Falcon 
tube up to 50 mL mark.  The Falcon tube was centrifuged at 4000 rpm for 
20 minutes.  The percentage of resin to ethanol was adjusted to 25% (v/v 
ethanol) by changing the volume of 20% ethanol.   
 
While agitating the mixture, 40 μL, 50 μL, 60 μL, 100 μL, 200 μL, 400 μL 
and 600 μL of the resin-ethanol suspension was slowly pipetted onto pre-
weighed weighing boats the volumes correspond to matrix volume of 10 μL, 
12.5 μL, 15 μL, 25 μL, 50 μL, 100 μL and 150 μL respectively. The same 
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volumes of deionised water were added to each of the weighing boats to 
spread the resin out into a flat sheet. The weighing boats were subsequently 
incubated inside a 450C oven for 2 hours to remove all moisture.  The 
weighing boats were then weighed to calculate the dried resin weight. 
 
 
 
2.3.1.2.Batch adsorption  
 
100 μL of resin suspension was dosed into 14 wells of a 96 filter well-plate 
(with 0.22 μm filter).  The well plate was centrifuged at 4000 rpm for 10 min 
to remove excess 20 % ethanol.  100 μL of 10mM sodium acetate buffer at 
pH 5.2 was added to the wells.   The excess equilibration buffer was removed 
by centrifugation at 4000 rpm for 10 min. 
 
The equilibrated resin cakes were then transferred into Eppendorfs (≤ 1mL 
experiments) and Falcon tube (> 1mL experiments).  100 μL of lysate was 
added into each well, transferring the resin into the Eppendorf tubes and 
Falcon tubes.  The pipette tips used were all wide bore to ensure all resin 
particles can be taken up by the tips.  Lysate was added to the transferred 
resin-lysate mixture to a total volume of 0.25mL, 0.5 mL, 0.75 mL, 1 mL, 5 
mL, 10 mL and 20 mL.  The individual containers were left overnight on a 
rocker.   
 
The fully saturated resin particles were separated from the lysate by 
centrifugation at 4000 rpm for 20 minutes.  The liquid phases were assayed to 
determine the concentration of Fab’ fragments.   
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2.3.2. Breakthrough curve 
 
 
2.3.2.1 Millilitre scale with HiTrap columns  
 
Chromatography was performed using a 1 mL HiTrap SP Sepharose FF 
column on an AKTA-Basic system (GE healthcare, Uppsala, Sweden).  
Breakthrough of Fab’ was determined at an operating flowrate of 1 mL min-1, 
1.5 mL min-1 and 2 mL min-1 which are equivalent to linear velocities of 310 
cm h-1, 232 cm h-1 and 155 cm h-1 respectively.  Fresh columns were used for 
each flowrates to nullify the effect of any irreversible interactions between 
feedstock proteins and resin due to column overloading.  All columns were 
equilibrated with 10 CV equilibration buffer composed of 20 mM sodium 
acetate at pH 5.2.   
 
Lysate prepared using method described in section 2.1 were allowed to 
defrost at 40C before being brought up to room temperature.  The room 
temperature lysate was diluted to 2 mS cm-1 using deionised water. The 
concentration of Fab’ lysate was assayed prior to loading. 
 
The conditioned lysate was loaded into the column. During loading, the 
column effluent was collected in fractions of 10 mL (10 CV).  The fractions 
were assayed for concentration of Fab’ fragments using the HPLC method 
described in section 2.2. 
  
 
2.3.2.2 Micro-scale with PhyNexus microtips 
 
The setup was aimed to utilize PhyNexus micro-tips in a traditional 
chromatography manner – downward unidirectional flow instead of aspirating 
and dispensing liquid from the micro-tips.  Chromatography was performed with 
a PhyNexus microtip with 40 μL of resin dosed in a 1 mL pipette tip.  The pipette 
tips are designed to be used with a liquid handling system such as Tecan® liquid 
handling system.  By using a liquid handling system the flow direction of the 
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mobile phase in the column becomes bi-directional.  The effects of adsorption of 
target protein on the stationary phase with bi-directional flow are unknown 
therefore a liquid handling system will not be used in this project.    
 
 
Ultra scale-down involves the mimicking of a unit operation running under the 
same conditions at larger scale.  To deliver a uni-directional flow into the micro-
tip a Harvard PHD 44/4400 programmable (Harvard apparatus, Kent) syringe 
pump and a 50 mL stainless steel syringe (Harvard apparatus, Kent) were used to 
run all experiments.  The setup of the experimental hardware is shown in figure 
2.3. 
 
 
Prior to the experiments, the micro-tips were first rinsed with 2 mL of ultra-pure 
water to displace all glycerol in the void space of the resin.  Breakthrough of Fab’ 
was determined at 0.259 mL min-1, 0.192 mL min-1 and 0.129 mL min-1.  These 
running flowrates were determined by keeping the linear velocity the same when 
scaling down from a 1 mL HiTrap column to a 40 μL PhyNexus  micro-tip.  New 
micro tips were used for each experiment.  All columns were equilibrated with 10 
CV equilibration buffer composed of 20 mM sodium acetate at pH 5.2.  
Feedstock preparation method is the same as the millilitre scale experiments and 
was described in the previous section.   
 
The experiment follows a traditional operation of a chromatography column – 
equilibration, load, wash, elute and re-equilibration.  Samples were collected from 
the effluent during loading at time intervals determined by the flowrate (refer to 
table 2.1 for calculated times). The effluent is collected into a 2 mL deep 96 well-
plate (Fischer Scientific, Leicestershire).  The fractions were assayed for 
concentration of Fab’ fragments using the HPLC method described in section 2.2. 
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Figure 2.3 A photo shoot of the setup of the micro-scale experiment.  In the image, a 
50 mL syringe is set onto the pump device and the syringe is connected to a 40 μL 
pipette tip.   
 
 
 
 
 
Table 2.1 Experimental and sample collection time for micro-scale breakthrough 
curves using a 40 μL micro-tip at different flowrates. 
Linear velocity 
(cm h-1) 
Flowrate from 
Syringe pump 
(mL min-1) 
Total time (min) 
35 mL loading volume 
time between 
fractions (min) 
500 μL samples 
310 0.259 135 1.90 
232 0.192 182 2.60 
155 0.129 271 3.85 
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2.4 Chapter Summary 
 
 
 The necessary experiments have been identified to optimize the adsorption 
system to obtain breakthrough curves for modelling purposes.  These include: 
o Determination of adsorption isotherms to compare binding conditions of 
Fab’ fragments onto SP Sepharose FF resin.   
o Method to Analyse the precipitation formed during pH adjustment of the 
clarified lysate containing Fab’ fragments 
 
 A method to obtain breakthrough curves at three different flowrates has been 
presented at: 
o 1 mL scale using a HiTrap column 
o 40 μL scale using PhyNexus micro tips scaling down from HiTrap using 
constant linear velocity 
 
In the next chapter the theory behind the isotherm and the method of data handling will 
be described.  The general rate model for analyzing the breakthrough curves will be 
presented and explained.  In addition, the correlations for estimating the transport 
parameters for the general rate model will be described. 
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3. Theoretical considerations  
  
In this chapter the theories and assumptions behind the adsorption isotherm, general rate 
model are presented.  In addition the calculation of a theoretical diameter used for 
modelling a PhyNexus tip is also presented. 
 
3.1 Isotherm 
 
An adsorption isotherm is defined as the function which connects the amount of 
adsorbate on the adsorbant with its concentration.  These isotherms are derived from a 
proposed kinetic mechanism with assumptions. 
 
1. the adsorbent is uniform, that is the binding sites are equal and identical 
2. the adsorbed molecules are inert and will not interact with other particles. 
3. all adsorptions occur by the same mechanism. 
4. at maximum adsorption a monolayer is formed, meaning that the adsorbate does not 
deposit on other adsorbed molecules.  There is no interaction between molecules that are 
attached to resin ligands. 
 
An example of an isotherm: 
 
eqd
eq
eq CK
CQ
Q 
)(max         (3.1) 
 
The above isotherm is another form of the Michaelis-Menten equation and is commonly 
known as the Langmuir isotherm. 
 
On the LHS of the equation is Qeq - the amount of material bound to the adsorbant. 
 
On the RHS of the equation, Qmax is the maximum binding capacity of the adsorbant, 
while Kd is the dissociation constant or Langmuir constant.  Ceq is the concentration of 
adsorbate at equilibrium. 
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3.1.1 Calculations for experimental isotherm 
 
 
The method to obtain an isotherm through batch adsorption is described in section 2.3.1.2 
however to obtain a high resolution isotherm there are a few considerations.  To obtain 
the Langmuir isotherm terms experimentally equation 3.2 is used. 
  
 
 
   ))(( Q 0eq
m
l
eq V
VCC       (3.2) 
 
 
Where for the Fab’ E.coli lysate system we have: 
 
Qeq is the amount of materials bound to the adsorbant. 
C0 is the Fab’ fragment concentration in the feed 
Ceq is the concentration of Fab’ at equilibrium of each batch system 
Vl is the volume of Fab’ E.coli lysate in each batch system 
Vm is the volume of matrix in each batch system 
 
 
Each batch experiment will yield at the end a liquid phase Fab’ fragment concentration 
Ceq. Using this value, Qeq can be calculated.  A set of batch adsorption experiments will 
give an idea of the adsorption power of the adsorbant expressed as speed (Kads or Kd) 
and point of saturation (Qmax).  This is done by using a least square based fit of equation 
3.1 for experimental values of Qeq vs Ceq . 
 
Concentration of the heat lysate used for obtaining the adsorption isotherm is crucial to 
the resolution of the experimental results.  It is necessary to obtain points on the 
adsorption isotherm especially at the lower end of the curve; this region explains the 
efficiency of the adsorption system, in other words it is an indication of how likely the 
Fab’ fragments adsorb onto the resin upon contact. 
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To obtain data points at the lower region of the isotherm a small Fab’ lysate volume to 
matrix volume ratio is required, conversely the upper region of the isotherm requires a 
large Fab’ lysate to matrix volume ratio.  While designing the experiment, the matrix 
volume should be as small as possible, this minimises the amount of Fab’ lysate required 
to complete a full set of experiment.  It is also important to note that the volume of 
matrix should be large enough to allow the absorbate size distribution to be close to 
normal. In addition the volume of matrix should always be smaller than the volume of 
liquid to ensure there is sufficient mixing during the batch incubation. Because of this 
reason, the concentration of the target protein in the solution cannot be too high.   A good 
balance between the Fab’ concentration of the lysate and the matrix volume is key to 
obtain a high resolution isotherm.  
 
 
 
3.1.2 Isotherm for a complex protein system 
 
The Langmuir isotherm in equation 3.1 is a single component Langmuir isotherm.  In 
other words there are no representations the protein influences of other proteins on the 
adsorption of the Fab’.  Although a multi-component Langmuir isotherm does exist, this 
isotherm states that the adsorption of the target protein is a function of the sum of all the 
adsorbed species in the system.  Not only is it generally not possible to characterize fully 
the different proteins in the adsorption system it is also not practical to isolate and obtain 
adsorption isotherms of each of these proteins.  The difficulty can be caused by the use of 
a complex feedstock; separating a large number of impurities from the feedstock might 
not be an easy task.  For the above reason, identifying the multi-component Langmuir 
isotherm was not a practical approach for the purposes of this project.   
 
Apart from the difficulty in identifying the individual protein isotherm, the assumptions 
of the Langmuir isotherm also cause major uncertainties.  For instance within a finite 
batch system, the mobile and stationary phases are confined in a container, the mobile 
phase composition changes rapidly as contact time increases. However when the 
feedstock is passing through a conventional chromatography column, fresh feedstock is 
constantly loaded into the column; the resin inside the column is always experiencing a 
constant mobile phase condition.    
 70
Alison Tang  Chapter 3-Theoretical considerations 
 
The accuracy of the isotherm depends on the amount of resin dosed into each batch 
system.  Because each batch system is a discreet experiment, there are errors between 
each isotherm data point.  Another source of error arises when trying to identify the 
actual amount of resin used; the equation calls for volume of matrices phase used; 
however, the volume dosed into each batch system is not the actual volume of resin that 
is due to the resin and the void space. The combined effect of the two sources of error 
explained above affects the volume of mobile phase to volume of stationary phase ratio 
which will greatly affect the value of Qeq calculated. 
 
For the above reasons, the values obtained from the finite batch isotherm might not 
necessarily represent a dynamic system under complex protein conditions; however, 
using isotherms, the adsorption of the target protein onto the stationary phase can be 
compared.  This is particularly useful to determine the right conditions for 
chromatography. 
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3.2 General Rate Model 
 
3.2.1 Predicting events within a column 
 
In reality, column conditions are not ideal; it is necessary to take into account a lot of 
variables to model a real column. However, a larger number of variables will increase the 
complexity of the modelling to describe events within a chromatography column.  To 
simplify the complexity of the model for more ready analysis, the column is assumed to 
be ideal. Therefore several assumptions are applied (Gu, Tsai et al. 1993). 
 
The assumptions are as follows: 
 
1. the column is isothermal and the physical and chemical conditions at 
any point of the chromatography column are the same. 
2. the mobile phase velocity is constant and is independent of 
concentration. 
3. the mobile phase compression is negligible. 
4. the column bed is homogenous, with resin particles packed evenly in 
the column. 
5. the packaging material is spherical and uniform;  i.e. every resin 
particle has same adsorption properties. 
6. the radial concentration gradient is negligible.  
7. there is local equilibrium of each component between the pore 
surface and the stagnant fluid in the macropores; in other words, no 
convective flow within the particle pores. 
8. mass transfer only occurs in an axial direction by convection and by 
axial dispersion. 
 
With these assumptions stated above, the general rate model was derived to model the 
chromatographic separation. This model is believed to be the most comprehensive one 
available. 
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 3.2.1.1 Continuity Equation in the flowing mobile phase 
 
 
Equation of mass balance between chromatography column and the external film around 
the resin bead particle: 
 
0)(
)1(3
,2
2



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K
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CD 

  (3.3) 
 
The first term on the LHS of the equation indicates the transport by axial dispersion in 
the mobile phase.  This term explains the diffusion of materials along the column with 
arbitrary dimension defined as Z.  The effect of this term is negligible if the flow rate is 
high. 
 
The second term takes into account the convective transport in the mobile phase along 
the column in the axial direction, which is the movement of the mobile phase driven by 
force/flow hence the term is a function of interstitial velocity v. 
 
The third term defines the accumulation in the mobile phase.  Change of concentration of 
protein in the bulk fluid occurs over time, i.e. as material progresses through the column. 
 
The last term of the equation represents the accumulation in the stationary phase, which 
is the rate of mass transfer through the external film relating the bulk fluid concentration 
to the concentration at the surface of the resin particles.     
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3.2.1.2 Continuity Equation inside the Macropores 
 
The equation describing the mass balance between the bulk fluid and the individual resin 
bead particle is: 
 
0)](1[)1( 22
*
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


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C pi
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p      (3.4) 
 
 
The first term on the LHS of the equation defines the accumulation on the surface of the 
stationary phase. This term represents the protein concentration outside the stagnant film 
of a resin bead particle. 
 
The second term represents the accumulation around the stagnant fluid in the macropores.  
This describes the diffusion of the protein product across the stagnant fluid phase. 
 
Finally the last term describes the radial diffusion inside the porous particle.  This term 
accounts for the diffusion of the protein product into the binding sites of the resin 
particles, with Db being the speed proteins travel into the intra-particle space of a resin 
particle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 74
Alison Tang  Chapter 3-Theoretical considerations 
3.2.1.3 Boundary conditions 
 
Solving the partial differential equations will give the relationship between the variables. 
Boundary conditions are used to complete the simulation of an ideal column by 
providing a finite solution. 
 
Initial and boundary conditions are: 
 
t = 0;  Cbi = Cbi (0,Z) ; Cpi = Cpi (0,R,Z)      (3.5) 
 
Initially there is no material fed into the column, therefore the concentration at any point 
of the column and the resin bead is defined as zero.  These conditions limit the calculated 
solutions for concentration to be positive values.   
 
When Z=0: 
 
))(( tCC
D
v
Z
C
fibi
bi
bi 

      (3.6) 
 
This assumes no accumulation at the beginning of the column where flux to the entrance 
equals flux from the entrance to the exit of the column.  In other words protein is not 
accumulated at the top of the column initially during loading when t=0; this is 
mathematically achieved by stating that concentration of bulk liquid minus the 
concentration of feed protein concentration profile as a function of time.  So for frontal 
adsorption 1))/)((( 0  CtCC fibi .   
 
When Z=L: 
 
0

Z
Cbi          (3.7) 
 
Assumes that by the column end, no adsorption will occur. 
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When R = 0:     
 
0

R
C pi          (3.8) 
 
The diffusion into the beads occurs uniformly from the bead surface into the particle.     
 
 
When R=Rp : 
)( , RpRpibi
pip
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
        (3.9) 
 
This assumption describes the maximum amount of protein product that can be diffused 
into the bead particle pores and at what speed protein diffuses into the particles. 
 
 
 
 
3.2.2 Application of the general rate model 
 
 
 
In this project, the general rate (GR) model (explained in sections 3.2.1) will be used in 
two different ways.  The first way is to use the GR model to simulate a breakthrough 
curve; this is a traditional use.  Users input the necessary parameters to complete the 
general rate model.  These parameters can either be estimated from experimental data or 
from empirical correlations.  Methods to estimate the parameters will be presented in 
chapter 3.2.6.   A diagram listing all the input parameters is shown in figure 3.1.   
 
 
The second way is to use the general rate model in an iterative manner.  This method 
involves the use of the least square method to estimate the general rate parameters best 
representing the performance of chromatography.  The performance of the 
chromatography is judged by the shape of a breakthrough curve.  In figure 3.2, the input 
and output of the method is presented.  
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                                     Inputs – GR model parameters 
 
• bead diffusivity Db 
• Film mass transfer coefficient k 
• Axial dispersion coefficient Dax 
• Particle porosity εp 
• Bed void fraction εb 
• Particle radius  
• Column diameter/height 
 
 
 
 
• Column diameter/height 
• Feed concentration  
• Flowrate 
• Adsorption kinetic ( K and K ) ads d
• Maximum binding capacity Qmax 
• Time scale  
 
 
 
 
General rate model 
Output  
Concentration of protein at the exit of 
the column i.e breakthrough data at 
input time point 
 
 
Figure 3.1 Inputs required to be identified to simulate a 
breakthrough curve with the general rate model.  
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General rate model 
Output  
 
Value of any parameters from the 
general rate model 
Input 1 - GR model 
  
All terms of the GR model that 
are not required as output 
Input 2 
 
Breakthrough data 
 
 
 
 
Figure 3.2 Inputs that are required to be entered into 
the general rate model to initiate a solving routine to 
calculate general rate parameters and adsorption 
kinetics.  Input 1 are the general rate parameters that 
are known for the system whereas input 2 is the 
breakthrough curve obtained experimentally.   
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3.2.3 Adsorption kinetics 
 
 
The adsorption kinetic equation is required to be used with the general model to describe 
the speed of adsorption of target protein onto the resin binding sites; hence the rate of 
change of target protein concentration in the bulk fluid phase can be calculated by the 
model.  Typically a Langmuir isotherm is used for describing the adsorption of Fab’ 
fragments to the matrix particles.  For a product capture step feed materials will contain 
multiple contaminants including several proteins which can adsorb to the column matrix.  
A competitive Langmuir isotherm is ideally required to describe the complex adsorption.   
 
For a complex feed material, the precise determination of all contaminants which may 
adsorb onto the column matrix and the associated isotherm constants would be 
impractical.  Given this degree of complexity and the fact that only breakthrough of Fab’ 
fragments from the column is specifically assayed; the breakthrough curve obtained 
using this method included the effect of other contaminant proteins on the binding of our 
target protein.  A simple reaction equation (equation 3.10) can explain the binding of the 
target protein (S) onto matrix particles (K).  
Kads 
KS (Qmax) K + S (3.10) 
Kd 
 
 
The rate of adsorption of Fab’ onto the resin is represented by Kads while the desorption 
constant is Kd the adsorption reaches equilibrium when Qmax is reached.  These three 
parameters were obtained by curve fitting instead of a traditional experimental method 
utilising the single component Langmuir isotherm.   
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3.2.4 Transport parameters 
 
Parameters required in the GR model include known parameter, such as column height 
and diameter, particle radius, molecular weight of product and flowrate.  Other 
parameters, such as void fraction, particle porosity and pore diameter can be estimated 
based on values reported in the literature.  Transport parameters such as film mass 
transfer coefficient (k), the axial dispersion coefficient and the effective intra-particle 
diffusivity, can be estimated using established correlations.  The effective intra-particle 
diffusivity, Db, was calculated using the correlation (Wallace W. Yau 1979). 
 
 
 
 )95.009.2104.21( 53  
m
b
DD , (3.11) 
 
 
Where, Dm is the molecular diffusivity, τ is the particle tortuosity and λ is the ratio of the 
molecular diameter, dm, of the component to the pore diameter of the particles.  The 
values of dm and Dm were estimated from the molecular weight (MW) of the component 
(Marshall 1978). 
 3
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The film mass transfer coefficient, k, was calculated using the correlation (Wilson and 
Geankoplis 1966): 
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where v is the interstitial velocity , Rp is the particle radius and εb is the bed void fraction.   
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The axial dispersion, Dax, coefficient was estimated by initially calculating the value of 
the Peclet number valid for flowrates of low Reynolds number (Chung and Wen 1968; 
Ting 1995) 
 
 
 
bpR
LPe 
1.0
(3.15) 
 
 
where L is the column length.  The value of Dax, was then calculated from the definition 
of Peclet number of axial dispersion
axD
vLPe  , giving Dax = 1.95 x 10 -7 m2s-1, which is 
of the same order of magnitude as values used in other modelling studies.  For 
simulations of breakthrough carried out at different flowrates Dax was assumed to be 
directly proportional to the linear flow rate since eddy diffusivity is the dominant 
mechanism of axial dispersion, and hence the Peclet number remains constant with 
changing flowrate over this range.  
 
Values of εb reported in the literature for columns packed with SP Sepharose range from 
0.29 – 0.42 (DePhillips and Lenhoff 2000).  A value of 0.35 was assumed for simulations 
in this work.  Values of εp for uptake of proteins in SP Sepharose matrix beads are also 
reported in the literature; however, because this is the accessible particle porosity, the 
value will depend on size of the binding protein.  A value of εp = 0.65 was used based on 
diffusion of lysozyme in SP Sepharose FF matrix (Dziennik, Belcher et al. 2005).  The 
value for particle tortuosity was derived based on the relation 
 
p
p


22  (Kramarczyk, 
Kelley et al. 2008) giving τ = 2.8.  The value τ is used in the determination of Db, giving 
Db = 1.6 x 10-11 m2s-1.  Allowing for differences in protein size, this value agrees well 
with the measured value of Db of approximately 4 x 10-11 m2s-1 which was obtained for 
uptake of lysozyme into SP Sepharose FF matrix particles from solutions of low ionic 
strength and low protein concentration (Chang and Lenhoff 1998).  A median value for 
matrix particle diameter of 90 µm was used in all simulations. 
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3.3 Breakthrough curve  
 
In order to obtain a full breakthrough curve assumptions need to be made to calculate the 
amount of E.coli lysate required to saturate a 1 mL Hitrap column. 
 
Assuming SP Sepharose FF resin has a saturation binding capacity of 120 mg Fab’ fragments 
mL-1 matrix and the E.coli lysate feed stock contains 0.15 mg mL-1 of Fab’ fragments.  The 
saturation binding capacity is assumed to be three times the dynamic binding capacity 
(40 mg Fab’ fragments mL-1 matrix).  The amount of Fab’ lysate required to saturate the column, 
bringing the breakthrough curve up to 100% requires 800 mL of feedstock.   
 
The resolution of the breakthrough curve depends on the number and volume of fractions 
collected during the experiment.   
 
 
3.4 Calculations for HiTrap column and PhyNexus microtips 
 
 
 
To mimic the performance of a HiTrap column with a PhyNexus tip, the column 
attributes need to be calculated.  The following calculations show the scale down 
strategies used for a PhyNexus tip. 
 
A PhyNexus micro-tip is in the shape of a frustum of a cone.  The mid cross sectional 
area is used to calculate the running linear velocity and to transform the frustum into a 
cylindrical shape using the mid point of the frustum as the average point.  The length of 
the resin bed of a 40 µL and the top and bottom radius of the bed is 3 mm and 2 mm 
respectively. The radius at the 4.5 mm point of the frustum is calculated to be 0.125 cm.  
The calculation is shown in figure 3.4.  This value can be used to calculate the cross 
sectional area of cylinder and the corresponding volumetric flowrate (equation 3.16) 
running at the same linear velocity as used at the 1 mL scale.  
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A typical linear velocity for adsorption is around 100 cm h-1.  The cross sectional area of 
a 1 mL HiTrap column is 0.385 cm2.  This makes the corresponding volumetric flowrate 
0.88 mL min-1.  A flowrate of 1 mL min-1 was used for all the experiments to simplify 
subsequent experiments when changing volumetric flowrates.  The calculation of 
volumetric flowrate from linear velocity is shown in equation 3.16.  The corresponding 
volumetric flowrates at different linear velocities and scale are shown in table 3.2. 
 
 
 
Linear velocity  x  cross sectional area = volumetric flowrate     (3.16) 
      (cm h-1)                      (cm2)                         (mL h-1)   
 
 
 
The volume of the frustum of a cone is given by:  
 
  ))((
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The volume of the frustum = volume of frustum (A) and volume of frustum (B) 
 
 
3 mm 
2 mm
r2
h1 
h2 
A 
B 
 
 
 
 
 
 
 
 
 
 
Because the intersection point is in the middle of the frustum, therefore  
 
 
 
h1 = h2 = 4.5 mm          (3.18) 
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Using equation 3.18, the value for r2   was calculated to be 1.25 mm.    
 
Figure 3.3 calculations for the mid sectional radius of a conic frustum 
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3 mm 
2 mm
9 mm 
7mm
25mm 
 
 
 
 
Figure 3.4 Geometry of a 1mL HiTrap column (left) and the resin bed of  
a 40 μL PhyNexus microtip (right).  (drawing not to scale) 
 
 
 
 
Table 3.1 Volumetric flowrates for operating PhyTip and HiTrap 
columns at specific linear velocities. 
Linear velocity 
(cm h-1) 
Flowrate into PhyTip 
(mL min-1) 
Flowrate on HiTrap column 
(mL min-1) 
310 0.259 2.0 
232 0.192 1.5 
155 0.129 1.0 
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 85
 
 
 
3.5 Chapter summary  
 
 
In this chapter: 
 
 The assumptions behind the general rate model are explained. 
 The reasons behind a multi-component isotherm not being a reasonable tool to 
represent a complex feedstock are explained. 
 The application of the general rate model in the project is presented 
 The method of estimating parameters required to complete the general rate model 
for individual adsorption system is presented. 
 Assumptions made for the PhyNexus tips to correct for its shape – a truncated 
cone are detailed. 
 
Experimental data will be presented in Chapter 4 while the modelling results will be 
shown in Chapter 5.     
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4. Experimental Results   
 
4.1 Introduction 
 
The main purpose of the works presented in this chapter is to optimise the adsorption 
system of Fab’ fragments onto a generic cation exchange resin by identifying a condition 
(pH and conductivity) where Fab’ fragments readily bind to the resin upon contact. By 
using an optimised system to obtain breakthrough curves the results can fully represent a 
system running at its full potential.  
 
Firstly, an assay technique was developed to quantify the amount of Fab’ fragments in a 
sample.  Secondly, batch adsorption method was used to obtain isotherms to visualise the 
adsorption efficiency at different feedstock conditions.  Last but not least, using the 
optimised feedstock condition to obtain breakthrough curves and at the same time 
evaluating the system serving as a primary capture step. 
 
4.2 Assay technique 
 
The purpose of the assay is to quantify the amount of Fab’ in a sample.  A good assay 
technique should be able to detect the target protein at a low concentration while 
maintaining accuracy.  In addition the assay should not be affected by other non-target 
protein species.   
 
In this section, a calibration curve will be presented. The calibration curve obtained will 
be used for determining the concentration of Fab’ fragments throughout the project.  The 
calibration curve was repeated three times using the pure Fab’ standard solution prepared 
from the same purification run.  
 
Pure Fab’ fragment samples were analysed using the method described in section 2.2.1.  
Samples were diluted to concentrations of 20 μg mL-1, 50 μg mL-1, 100 μg mL-1, 200 μg 
mL-1, 300 μg mL-1, 400 μg mL-1 and 500 μg mL-1.  The peak areas integrated were 
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plotted against concentration and are shown in figure 4.1.  The R2 value of the linear 
trend is 0.995 while the slope is 24.2 
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Figure 4.1 Standard curve of pure Fab’ fragments with 
area (mAU*t) plotted against concentration (μg mL-1).  A 
linear trend line was fitted across the average of two sets of 
experimental data.  The R2 value of the trend line is 0.998.  
The error bars represents the standard deviation of the two 
sets of data. 
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 4.1.2. Lysate  
 
 
The sensitivity and effectiveness of the assay with a complex protein matrix were 
confirmed by testing the method using E.coli lysate.  The initial concentration of the 
lysate was determined to be 510 μg mL-1 using the method described in section 2.2.1 and 
the calibration curve obtained in section 4.1. The lysate was diluted to 1/10, 1/15, 1/30, 
1/100 and 1/200 of its original concentration.  The result is shown in figure 4.3.  The R2 
value of the linear trend is 0.967 and the slope is 26.3 1
*
gmL
Aum
  .   
 
 
From both of the calibration curves obtained using pure Fab’ and lysate, the slopes are 
24.2 and 26.3 respectively.  In figure 4.2, a set of calculations to convert signal from the 
HPLC to Fab’ fragment concentration were shown.  
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From pure Fab’ standard curve: 
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From E.coli lysate standard curve: 
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Figure 4.2 Calculation of concentration of Fab’ fragment 
containing samples using standard curves obtained from 
using pure and E.coli lysate samples 
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Figure 4.3 Standard curve (area (mAU*t) vs concentration 
(μg mL-1)) of E.coli lysate at 50 μg mL-1, 35 μg mL-1,  17 μg 
mL-1,  5 μg mL-1 and 2.5 μg mL-1. A linear trend line passing 
through origin was fitted across the average of three sets of 
data points. The R2 value of the trend line is 0.968.  Error 
bars represents standard deviation of three sets of data.   
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 4.2.  Batch adsorption 
 
The aim of this section is to determine the right condition for adsorption of Fab’ 
fragments in E.coli lysate onto SP Sepharose FF resin.  This was done by obtaining 
isotherms, comparing the shapes and estimating the adsorption rate from them.  Dry resin 
weight was also investigated to ensure the batch adsorption experiments were conducted 
accurately. 
  
 4.2.1. Dry resin weight 
 
The method described in section 2.4.1.1 was used to conduct experiments using 
50% (v/v ethanol) and 25% (v/v ethanol) resin.  For 50 % (v/v ethanol) resin, 
due to the high viscosity of the suspension, the resin beads were difficult to 
aspirate accurately even with a wide bore pipette tip. If resin was aspirated 
equally and accurately, the percentage of liquid to resin should be maintained, 
but liquid phase of the emulsion reduced during the course of the experiment, 
this suggests that 50% (v/v water) resin is too challenging to dose accurately by 
hand.  To reduce the viscosity, a higher ratio of liquid to resin volume was used. 
The experiment was repeated using 25 % (v/v ethanol) resin, because liquid to 
resin ratio is increased, dosing is less challenging and the percentage of liquid to 
resin remains unchanged throughout the experiment.       
 
The dry resin weight was measured at different dosed volume. The results are 
summarised in table 4.1 and figure 4.4.  The R2 value of the trend line is >0.99; 
this shows that at 25% (v/v water) resin can be dosed accurately by hand 
especially at smaller volumes.  It is also observed that at low viscosity, resin 
particles are less likely to stick to the sides of pipette tips causing major 
experimental error especially at small volumes. 
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Table 4.1 Summary of dry resin weight experiment.  The table shows the 
pipetted volume of resin emulsion, its corresponding matrix volume at 25% 
(v/v), the dry resin weight and mass of matrix per volume of matrix pipetted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pipetted volume 
(μL) 
matrix volume 
(μL) 
Dry matrix mass,  
average of 4 repeats 
(±s.d.)   (mg) 
Matrix mass / 
Volume pipetted 
      (mg  μL-1) 
40 10 1.40 ± 0.245 0.035 
50 12.5 1.50 ± 0.245 0.0300 
60 15 1.73 ± 0.222 0.0288 
100 25 3.68 ± 0.450 0.0368 
200 50 6.48 ± 1.27 0.0324 
400 100 13.8 ± 0.891 0.0345 
600 150 19.5 ± 2.67 0.0325 
Average           0.0329 
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Figure 4.4 Graph showing the dry resin weight against the volume 
of 25% resin emulsion dosed.  A trend line was drawn across the 
average of each data set. The R2 value of the linear trend line 
passing through origin is 0.998. Error bars are standard deviation of 
the four repeats.   
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4.2.2. Isotherm 
 
Based on the result from section 4.2.1., 20 μL of resin was used, that is dosing  
80 μL of resin suspension.  Because SP Sepharose FF resin size ranges from 45 – 165 μm, 
assuming that the resin size is normally distributed, choosing a larger sample size in this 
case pipetted volume, the size distribution of resin will be closer to normal compared to 
smaller volumes; hence the number of binding sites available in a batch system is 
proportional to a packed bed column. 
 
Isotherms were obtained with E.coli lysate conditioned to pH 5 and pH 7 using the 
method describe in section 2.4.1.2. The result from the isotherms can be used to compare 
the pH effect on adsorption of Fab’ fragments onto SP Sepharose FF resin.  The results 
were shown in figure 4.5.  The isotherm obtained using E.coli lysate at pH 7 was wider 
than pH 5; this showed that at pH 5 adsorption is faster and more efficient. In other 
words Fab’ fragments are more likely to adsorb to the resin particles upon contact. 
 
Focusing on the isotherm obtained at pH 7 (figure 4.5), the maximum binding capacity is 
when the graph reaches a stationary point, this point is observed to be at around 40 mg 
mL-1, however when fitting the Langmuir isotherm through the data points, the 
maximum binding capacity is 186 μg mL-1, which is far from normal.  This binding 
capacity cannot be true because the binding capacity of a pure model protein such as 
lysozyme and BSA is around 110 mg mL-1.  It is impossible for a complex feedstock to 
achieve a binding capacity higher than 110 mg mL-1. 
 
Because of the nature of the isotherm, a different equation (refer to equation 4.1) was 
used to fit the data points. This equation is another form of the Langmuir isotherm with a 
correction factor n, giving a sigmoidal shape.  The maximum binding capacity of Fab’ 
fragments reduced to a more reasonable value of 43 μg mL-1.   
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The equation used to fit the isotherm data: 
 
 
n
eq
n
d
n
eq
eq CK
CQ
Q 
)( max  in the form  of nn
n
xb
axy                                           (4.1)  
 
 
For the isotherm at pH 5 (figure.4.6) the Langmuir trend is sufficient to fit the data points.  
The Qmax value was fitted to be 56.3 mg mL-1. 
 
 
From the results above, not only the maximum binding capacity (Qmax) varies according 
to pH, the adsorption rate varies greatly with feed pH.  Judging by the Ka value, the rate 
of initial adsorption of pH 5 almost 100 fold higher than pH 7 meaning that at pH 5, Fab’ 
fragments are more readily adsorbed onto resin particles; hence pH 5 is a better binding 
condition for Fab’ onto SP Sepharose FF strong cation exchange resin;  this decisions 
was further reinforced by the fact that at pH 7 the value of Kd was 100 fold higher than at 
pH 5 meaning that at pH 7 the force of the adsorption is not strong enough to sustain the 
binding causing the bound materials to “leach” from the resin.   As the liquid pH reduces 
the Fab’ fragment becomes more positively charged.  The trend obtained from the 
isotherms proved that the net charge of Fab’ fragments is an important factor to allow 
effective adsorption onto SP Sepharose FF resin. A study was performed to confirm that 
pH 5 is the lowest possible pH to operate at without serious loss of yield.  The study will 
be presented in the next section. 
 
 
 
 
 
 
 
 
 95
Alison Tang                                                  Chapter 4 - Experimental Results  
 
 
 
 
 
0 0.2 0.4 0.6
0
10
20
30
40
C
eq
, mg mL-1
Q
eq
, m
g 
m
L-
1
Langmuir fitting 
Sigmoidal fitting 
 
 
Figure 4.5 Isotherms of E.coli lysate at (+) pH 7 fitted using Langmuir 
isotherm and sigmoidal trends.  Data points are average of two set of 
data while the error bars are standard deviation of the two set of data.  
(Some of the error bars are smaller than the data point marker) 
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Figure 4.6 Isotherms of E.coli lysate on SP Sepharose FF at (+) pH 5 
and (○) 7.  The pH 5 isotherm was fitted using Langmuir isotherm 
while the pH 7 isotherm was fitted with a sigmoidal trend.  Both trend 
lines are passing through the average of the two sets of experimental 
data.  The error bars are standard deviation of the two set of 
experimental data. (Some of the error bars are smaller than the data 
markers) 
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Table 4.2 Summary of isotherm parameters (Qmax, Kd, Ka and n) 
obtained through curve fitting of experimental isotherms.   
  
 
pH 5 pH 7 
Qmax 
(mg mL-1) 
56.3 43.0 
Kd 
(mL mg-1) 
0.0671 6.47 
Kads (Kd-1) 
(mg mL-1) 
14.3 0.155 
n  1.83 
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4.4. Characterisation of E.coli lysate  
  
As pH reduces, proteins from the E.coli lysate precipitate.  SDS page and affinity HPLC 
were performed to confirm the composition of the particulates and the supernatant phases. 
An analysis was done using the method described in section 2.3.1.   
 
In the reducing SDS-page gel images (figure 4.7) the supernatant and the particulates 
were analysed at different pH values.  At pH 5 the majority of the Fab’ fragments remain 
in the supernatant phase. However when pH is reduced below 5, the Fab’ lysate becomes 
more turbid due to rapid protein precipitation. SDS Page and affinity HPLC both 
confirmed that Fab’ fragments were present in the particulates at low pH (figure 4.7).  In 
addition, at low conductivity, Fab’ fragments are more prone to precipitate, as shown in 
figure 4.8.  Fab’ fragment concentration in liquid phase significantly decreases at pH 
lower than 5 (2 mS cm-1) while at 15 mS cm-1 the Fab’ fragment concentration did not 
drop significantly until pH is lower than 2.   
 
Binding of the target protein on a cation-exchange resin requires the feedstock pH to be 
lower than the isoelectric point (pI). The Fab’ fragments (A33) used in this project has a 
pI of ~8.3, at a pH lower than the pI, the net charge of Fab’ fragments is positive.  
Binding of Fab’ fragments on a cation-exchange resin will be stronger when the net 
charge is stronger.  From the studies described above, the lowest pH achievable is 5, in 
other words pH 5 is the operating edge of the system, beyond this pH, significant Fab’ 
fragments will be loss due to precipitation.   
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Figure 4.7  Comparison of the composition of E.coli lysate at different pH 
values using reducing SDS page.  The top image shows the composition of 
dissolved particulates and the bottom image shows the liquid phases 
composition at various pH values. 
 
 
 
M
W
 la
dd
er
  
Ly
sa
te
   
P
ur
e 
Fa
b’
  
pH
 2
  
pH
 2
.5
  
pH
 3
  
pH
 3
.5
  
pH
 4
  
pH
 4
.5
  
pH
 5
 
 100
Alison Tang                                                  Chapter 4 - Experimental Results  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8 Concentration of Fab’ fragments in supernatant phase of 
clarified E.coli lysate at (▲) 2 mS cm-1 and (■) 15 mS cm-1 at 
different pH.  The original concentration of the clarified E.coli 
lysate was 495 μg mL-1 before pH adjustments.  The error bars are 
assuming 5% error from the assay. Some of the error bars are 
smaller than the data point markers.  The trend lines drawn across 
the data points are used to guide the eyes (trend line not model fit). 
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4.5. Breakthrough curves  
 
In this section, breakthrough curves are presented at 1 mL millilitre-scale and 40 µL 
micro-scale.  At millilitre-scale, breakthrough curves were obtained at 310 cm h-1, 232 
cm h-1, and 155 cm h-1. In addition, breakthrough curves obtained under weak isotherm 
conditions are shown.  At micro-scale, a set of breakthrough curves were obtained under 
the same linear velocities as for the millilitre-scale.  A method to alleviate assay artefact 
was developed to define a baseline for the breakthrough curves.   
 
 4.4.1 Millilitre-Scale 
 
The conditioned E.coli lysate for breakthrough experiments contains 150 μg mL-1 of Fab’ 
fragments; the solution pH was 5.2 and the conductivity was 2.0 mS cm-1.  These 
conditions were shown to be optimal for binding to a strong cation exchange in previous 
sections (refer to section 4.3).    
 
Breakthrough experiments were performed using the method described in chapter 2.4.2.  
E.coli lysate was loaded into a 1 mL Hitrap column until the column was almost 
saturated.  The effluent was collected in fractions and analysed using affinity HPLC.  
The Fab’antibody fragment peaks from the HPLC chromatograms were integrated. The 
peak areas of the fractions were divided by the peak area of Fab’ antibody present in the 
raw feedstock. The resulting values were plotted against volume of feed loaded into the 
column, resulting in a normalised breakthrough curve of Fab’ antibody fragment. 
 
 
To demonstrate the importance of pH on the adsorption of Fab’ fragments onto SP 
Sepharose FF strong cation resin, breakthrough curves for feed solutions adjusted to both 
pH 7.0 (figure 4.9) and pH 5.2 (figure 4.10) were obtained. 
 
From the pH 7.0 breakthrough curves, no distinct baselines were observed, breakthrough 
occurs as soon as feed material passes through the column even at linear velocity lower 
than 100 cm h-1 (0.5 mL min-1) this suggests that adsorption is very slow, in other words, 
the isotherm is weak.  Moreover, the rate of rise of the breakthrough curves is flowrate 
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dependent; this further suggests that the binding condition is unfavourable.  The poor 
adsorption is caused by the weak net charge of Fab’ fragments at pH 7, which leads to a 
weak driving force for Fab’ fragments to enter the stagnant film of the resin particles, 
and hence slow diffusion of Fab’ fragments into the infrastructure of the resin particles.  
To increase the surface net charge of Fab’ fragments, the lysate was reduced to pH 5.2.  
Although according to section 4.3 the operating edge is pH 5, using a slightly higher pH 
give a leeway to counter error from the pH probe and at the same time preventing major 
Fab’ fragment loss during feedstock preparation.   
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Figure 4.9 Breakthrough curves of Fab’ antibody in E.coli lysate at 
pH 7.0 running through a HiTrap 1mL SP Sepharose FF column at 
(■) 72.5 cm h-1 (0.5 mL min-1) and (♦) 155 cm h-1 (1 mL min-1).   
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For the breakthrough curves obtained using lysate at pH 5.2 (refer to figure 4.10), distinct 
baselines can be observed, however, the baselines are elevated.  The extent of elevation 
is the same across all linear velocities; this suggests that the phenomenon is not an 
adsorption problem but rather, is an assay artefact. To confirm this speculation, eluate 
from the protein G HPLC was collected and analysed using SDS-PAGE.  From figure 
4.11, four distinct bands can be seen, apart from the 54 kDa band representing Fab’ 
fragments; there are also bands at 150 kDa and two bands at around 25 kDa.  The SDS-
PAGE showed that not only Fab’ fragments can bind to protein G ligands, but also other 
proteins. Judging by the sizes, the smaller molecular weight ~25 kDa bands can be 
fragments of the Fab’ fragments and the larger molecular weight can be caused be 
aggregates or truncated (aggregated fragments of Fab’ fragments) versions of Fab’ 
fragments.   
 
The protein G assay quantifies Fab’ fragments by absorbance measurements of the eluate 
from the affinity column. All non-functional Fab’ fragments bound onto the protein G 
column will affect the result of the assay and hence potentially overestimate the amount 
of Fab’ fragments in a sample.  The other non Fab’ fragment bands from the SDS-PAGE 
image (refer to figure 4.11) can be due to the presence of truncated versions of Fab’ that 
were either expressed by the cells or formed by degradation or could be due to 
aggregation.     
 
The elevated breakthrough can be caused by the presence of these proteins in the effluent 
of the ion-exchange column.  In other words these truncated versions of Fab’ fragments 
cannot bind effectively to a strong cation exchanger but have the ability to bind to a 
protein G ligand thus “corrupting” the raw breakthrough curve data. 
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Figure 4.10 Breakthrough curves of Fab’ antibody in E.coli lysate at pH 
5.0 running through a HiTrap 1mL SP Sepharose FF column at (●) 155 
cm h-1 (1 mL min-1), (+) 232 cm h-1 (1.5 mL min-1) and (▲) 300 cm h-1  (2 
mL min-1).   
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Figure 4.11 SDS-PAGE image illustrating the composition of 
eluate from a protein G column loaded with E.coli Fab’ lysate. 
Lane 1 is the protein molecular weight ladder while lane 2 is 
the eluate from the protein G column. 
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Figure 4.12 SDS-PAGE study of Fab’ separation from 
E.coli lysate using with SP Sepharose FF strong cation 
exchange resin.   
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From the SDS-Page in fig.4.12 the Fab’ fragment band represented by the 49 kDa band is 
absent from the cation exchange effluent. The only explanation for this is Fab’ fragments 
were adsorbed by the cation exchange resin. If Fab’ fragments were absent from the 
initial flow through materials from the column, the detected peak from the protein G 
assay can be due to the presence of truncated Fab’ fragments, since Fab’ fragments are 
the only IgG components expressed by the strain of E.coli used.  This is proved by figure 
4.11, showing the species of protein that the protein G assay can detect in E.coli lysate.  
For the above reason, it is suggested that the elevated breakthrough obtained using 
protein G assay method is an artefact.  There are seven main species of protein present in 
the E.coli lysate (figure 4.12. lane 3) and only three species of proteins present in the 
eluate.  Cation exchange chromatography not only serves as a primary capture step in 
this system, but also has the ability to remove truncated versions of Fab’ fragments of a 
smaller molecular weight and some contaminant proteins of a higher molecular weight.   
 
Because the breakthrough curves shown in figure 4.10 include the breakthrough of 
another species of protein, a strategy to eliminate the assay artefact from the 
experimental data needs to be developed to bring the baseline down to zero. 
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To bring the baseline of the breakthrough curves to zero, the following logic was used: 
 
Assume that   
0C
C  is the breakthrough of Fab’ fragments and truncated/aggregated 
version of Fab’ fragments measured from the protein G assay. 
 
Let 
0P
P be the actual Fab’ fragment breakthrough at any given time. 
 
P is the concentration of Fab’ fragment flowing through the column and  
 
P0 is the total Fab’ in the sample. 
 
The actual breakthrough of Fab’ fragments (P) is the difference between the measured 
amount of Fab’ fragments and the amount of truncated/aggregated Fab’ fragments (a); 
 
 P = C-a; P0  = C0 –a 
 
Combining the equations; 
 
aC
aC
P
P


00
      (5) 
 
or writing in terms of the breakthrough curve 
)(
1
1
00
a
C
C
aP
P   (6) 
 
For the system used in this project there were 10 % impurities in the sample therefore     
a = 0.1 C0 
 
)1.0(
9.0
1
00

C
C
P
P  (7)  
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The strategy described above was applied and the results are shown in figure 4.13.  
Breakthrough occurs after 200 mL, 240 mL and 280 mL of feed was being loaded into 
the column at 2 mLmin-1, 1.5 mL min-1 and 1 mL min-1 respectively. The corresponding 
linear velocities are 310 cm h-1, 232 cm h-1 and 155 cm h-1 respectively. Unlike 
breakthrough curves of pure proteins, the binding capacities are not the same at different 
flowrates, in other words the area above curves are not identical across different 
flowrates.  
 
From the breakthrough curves, binding capacities increase when linear velocity decreases.  
In addition, as resin-feedstock contact time (loading time) increases, the binding 
capacities increases. For the same amount of E.coli lysate loaded into the column, more 
Fab’ fragments were adsorbed at a slower flowrate compared to a faster flowrate.  
 
The reason behind this phenomenon requires further investigation.  The investigation 
was done in the next chapter with the aid of modelling.  
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Figure 4.13 Breakthrough curves of Fab’ antibody in E.coli lysate at 
pH 5 running through a HiTrap 1mL SP Sepharose FF column at 
(□) 155 cm h-1, (○) 232 cm h-1  and (◊) 310 cm h-1.  The breakthrough 
curves were adjusted to define a baseline, eliminating the assay 
artefact caused by Fab’ like contaminants with the equation 1.7.  A 
line was drawn across the data points to visualise the trend.  The 
error bars are representing a 10% error for all data points obtained. 
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4.4.2 Micro-scale  
 
 
In this section, the breakthrough curves obtained using micro tips (PhyNexus Inc, San 
Jose, USA) will be presented.   
 
The breakthrough curves were obtained using the method described in section 2.5 each 
set of experiments were repeated three times.  In figures 4.14, 4.15 and 4.16, the raw data 
and the corrected version of the breakthrough curves obtained at 310 cm h-1, 232 cm h-1 
and 155 cm h-1 were shown respectively.  The mean values for three repeats of each set 
of data were calculated and are shown in figure 4.17.   
 
Constant linear flowrate was chosen as the scale-up strategy. With the liquid flowing 
speed around the beads remained unchanged, the adsorption of Fab’ fragments on the 
resin particles can be compared at a different scale, in addition this strategy reduces the 
time required to obtain the experimental breakthrough curves.  Whereas if the residence 
time is constant, the running flowrate will be slower for a shorter column, in this case 
below 100 cm h-1, a flowrate that is slower than recommended for use with columns at 
industrial scale. 
 
From figure 4.14, the breakthrough curves show similar trends compared to HiTrap 
breakthrough curves (refer to figure 4.13).  This includes the elevated breakthrough 
baseline and the increased binding capacity when operating at lower flowrates.   
 
To compare the millitre-scale and micro-scale breakthrough curves, instead of plotting 
concentration ratio against loading volume, the concentration ratio was plotted against 
column volume (figure 4.15). By plotting the breakthrough curves in such manner, 
column sizes are taken into account as it not only it nullifies the effects of scale 
difference in both sets of experimental data it also allows the comparison between 
adsorption of Fab’ fragments onto the columns with different geometries.   
 
From figure 4.15, the breakthrough curves obtained using micro-scale tips are less sharp 
compared to millilitre-scale column experimental data, in other words the dynamic 
binding capacities are different across different scales for identical linear velocities.  This 
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trend is observed when feed residence time in the column decreases, in this case at 155 
cm h-1 the feed residence times for a 1 mL HiTrap and 40 µL PhyNexus tip are 60 
seconds and 19 seconds respectively.  Although the shapes of the breakthrough curves at 
both scales are different, the maximum binding capacity should remain the same at the 
same linear velocities for this system and the experimental results are supporting this 
theory.  A more detailed analysis of the maximum binding capacities will be presented in 
the next chapter.   
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Figure 4.14  Breakthrough curves of Fab’ antibody in E.coli lysate 
at pH 5 running through a 40 μL PhyNexus microtip at 310 cm h-1. 
The raw data is shown in the top graph (a) while the adjusted 
breakthrough curves are shown in the bottom graph (b).  The 
breakthrough curves were adjusted to define a baseline, 
eliminating the assay artefact caused by Fab’ like contaminants 
with the equation 1.7. 
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Figure 4.15 Breakthrough curves of Fab’ antibody in E.coli 
lysate at pH 5 running through a 40 μL PhyNexus microtip at 
232 cm h-1. The raw data is shown in the top graph while the 
adjusted breakthrough curves are shown in the bottom graph 
(b).  The breakthrough curves were adjusted to define a 
baseline, eliminating the assay artefact caused by Fab’ like 
contaminants wi
 116
th the equation 1.7. 
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Figure 4.16 Breakthrough curves of Fab’ antibody in E.coli 
lysate at pH 5 running through a 40μL PhyNexus microtip at 
155 cmh-1. The raw data is shown in the top graph while the 
adjusted breakthrough curves are shown in the bottom 
graph (b).  The breakthrough curves were adjusted to define 
a baseline, eliminating the assay artefact caused by Fab’ like 
contaminants with the equation 1.7. 
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Figure 4.17 Breakthrough curves of Fab’ antibody in E.coli lysate at 
pH 5 running through a 40 μL PhyNexus microtip with SP 
Sepharose FF resin at ( ) 310 cm h-1, (+) 232 cm h-1  and ( ) 310 
cm h1.  The data points represent the mean value of data points of 
three repeats. 
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Figure 4.18 Comparison between breakthrough curves of Fab’ 
antibody in E.coli lysate at pH 5 running through a 40 μL 
PhyNexus microtip and 1 mL HiTrap column with SP 
Sepharose FF resin.  The breakthrough curves were obtained 
at 310 cm h-1(blue), 232 cm h-1(green) and 155 cm h-1(red).  
Millilitre scale are represented by (□) (+) and (◊) while micro-
scale data are shown as (○) ( ) and ( ). 
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4.6 Conclusion – Experimental results 
 
 
An assay technique was developed and the error of the assessed as around 5%.  The 
feedstock conditions were examined and the operating edge was identified. The 
adsorption of Fab’ fragments onto SP Sepharose FF strong cation exchange resin is 
strongest at pH 5, below pH 5 a significant amount of Fab’ in the feedstock will be 
precipitated.  Although at a lower pH value the net charge of the Fab’ fragments in the 
feedstock is stronger, the major loss of Fab’ fragments below pH 5 suggested that pH 5 is 
the lowest achievable pH for this system.   
 
The condition identified was used to obtain breakthrough curves at millilitre-scale using 
1 mL HiTrap columns and at micro-scale using 40 µL PhyNexus micro-tips.  A strategy 
was developed to bring the elevated baseline of the breakthrough curves down to zero. 
The elevation of the breakthrough curves were caused by the assay over-estimating the 
amount of Fab’ fragments due to the presence of truncated/aggregated versions of Fab’ 
fragments;  it appears  that 10% of the detected Fab’ fragments from the assay are 
truncated/aggregate Fab’ fragments. 
 
The ability of the system to serve as a primary capture step was also investigated.  Not 
only does the system have the ability to capture Fab’ fragments efficiently, it also has the 
ability to separate some of the truncated versions of Fab’ fragments. This capability is 
observed through the SDS page image (Figure 4.12) obtained; in the analysis two protein 
species of a smaller molecular weight (around 25 kDa) are absent from the eluate (lane 
5); the same proteins species were observed from Protein A eluate (Figure 4.11) meaning 
that these small molecular weight proteins are in fact truncated versions of Fab’ 
fragments. 
 
In the next chapter, the breakthrough curves at millilitre-scale and micro-scale will be 
used to gain a further understanding of chromatography; translating the description of the 
adsorption system into mathematical relationships by considering the physical processes 
in the column in terms of the diffusion and mass transfer constants. 
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5. Results II - Modelling   
 
5.1. Introduction 
 
In this chapter attempts will be made to translate chromatographic performance into 
mathematical terms using the general rate model both at 1 mL scale and at 40 μL scale.  
The breakthrough curves obtained from chapter 4 were used throughout the chapter. 
 
At 1 mL scale, one experimental breakthrough curve will be used to calculate parameters 
best representing the chromatographic system. The calculated parameters will then be 
used to predict breakthrough curves of a different flow rate. The accuracy of the model 
will be determined by the agreement between the prediction and the experimental data.  
A strategy was created to modify the general rate model to include theoretical 
assumptions. 
 
At 40 μL scale, the modified general rate model was tested to confirm the accuracy of the 
model moreover to establish a link between the micro-scale and millilitre –scale.  The 
ultimate aim of the activity is to allow the model to predict breakthrough curves at 
different flowrates and at different scales.   
 
A guide is provided in the next section to summarise the findings of all the modelling 
activities.  This summary seeks to draw out the most important findings with reference to 
their location in the main text of the chapter.  This is provided because some of the stages 
of the model development, which necessarily to be abandoned, still provided key insights 
into the physical effects of the adsorption system. 
 
 
  
 
 
 
 
 121
Alison Tang  Chapter 5: Results II - Modelling 
 
5.1.1 Reading guide  
 
The aim of this reading guide is to summarise the findings explained in the main text of 
this chapter in simpler terms. The guide lists out the steps of the development of the 
model cross references the corresponding sections in the main text where a more detailed 
explanation is provided together with clues and reasoning behind all the changes made to 
implement all the findings made into the final developed version of the general rate 
model.  
  
The breakthrough curve obtained at 310 cm h
-1 
at millilitre-scale was fitted using the 
general rate model using the isotherm parameters (Q
max
, K
d 
and K
ads
) as the variables. 
The result of the fitting was unsatisfactory (pg 122-123).  
 
A sensitivity analysis was completed by manually changing the values of mass transfer 
coefficient (K), bead diffusivity (D
b
) and axial diffusivity (D
ax
). The analysis suggested 
that mass transfer coefficient and bead diffusivity have the largest impact on the shape of 
the predicted breakthrough curve (pg 124).  
 
The number of fitted parameters was increased from three to five to also include D
b 
and 
k. However the result was still unsatisfactory (pg 128).  
 
The sensitivity analysis was revisited and it was identified that the bead diffusivity could 
be a function of time. An exponential decay equation as a function of time was added to 
the general rate model to describe the rate of change of bead diffusivity. The addition of 
this equation allowed a good fit of breakthrough curves at one flowrate but could not 
predict breakthrough curves at slower flowrates (pg 130-132).  
 
This equation did not take into account the influence of flowrate on diffusivity. The 
exponential decay equation was modified to be a function of flowrate and time, in other 
words of the amount of material loaded onto the column. This version of general rate 
model can successfully fit and predict breakthrough curves at millilitre-scale (pg 133-
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135).   Hence the fouling of resin which affects the diffusivity of the Fab’ fragments is 
governed by the total amount of contaminants entering the resin.  It seems that this is a 
rapid process that is controlled by the actual amount loaded onto the column rather than 
time of exposure. 
 
The model developed was used to fit and predict breakthrough curves at micro-scale. 
However, while the model can fit and predict breakthrough curves at micro-scale the 
fitted parameters cannot be transferred to the millilitre-scale. Tests were conducted to 
examine the effects of bed voidage and bead diffusivity trend to help establish a link 
between both scales (pg 136 – 144).  
 
The bead diffusivity decay equation was modified to be a function of saturation of beads 
in the column. The newer version of the model was used to fit and predict millilitre-scale 
breakthrough curves to verify the model (pg 144-145). This version of the model can fit 
and predict millilitre-scale. But at micro-scale bed voidage changes as flowrate changes 
(pg 145-154).  
 
The equation describing bead diffusivity decay was modified to be a function of 
saturation per layer of resin. This version of the general rate model has the ability to fit 
and predict breakthrough curves at both scales; in addition it has the ability to predict 
breakthrough curves at millilitre scale using parameters obtained from micro-scale (pg 
155-167). 
 
 
5.2. Modelling of 1 mL scale data 
 
The modelling uses the breakthrough curves described in chapter 4.4.1obtained using a 1 
mL HiTrap column. To translate a breakthrough curve into mathematical terms, the 
general rate model (refer to chapter 3.2.1 for the model) was used to back calculate the 
values of the parameters which gave a least square best fit to the experimental 
breakthrough curve.  The fitting of the experimental breakthrough curves was carried out 
using COMSOL - MATLAB finite element solver. The model iteratively solves for the 
parameters which best fits the breakthrough data input in a least square sense.  The limits 
of the solving routine were set from 0 to 1000, allowing the model to search freely for a 
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solution between these limits.  The wide limit range was given to test the ability of the 
model.  If the model truly is capable of representing a system in terms of all the physical 
parameters, the constraints will not affect the output. 
 
The data was first fitted with three parameters, maximum binding capacity Qmax, 
adsorption coefficient Kads and the dissociation constant Kd as solving variables while 
the rest of the parameters were set to literature values or calculated using empiric
correlations (refer to chapter 3.2.4 and 3.2.5 for the parameters). The experimental 
breakthrough curve obtained at a flow rate of 2 mL min
al 
-1 experimental data was chosen 
as the fitted breakthrough curve due to the fact that it is obtained under the fastest 
flowrate out of the set of data. It is believed that at a faster flowrate feedstock variability 
caused by prolonged loading is lower compared to the other two breakthrough curves 
obtained under slower flow rates.   
 
The fitted values are presented in table 5.1. The result of the fitting is compared against 
the experimental result in figure 5.1.  Figure 5.1 also showed that by obtaining the values 
of the adsorption kinetics alone is not enough to represent the system, it is speculated that 
other parameters contribute to the shape of the breakthrough curves.   
 
 
From the results from the previous section (section 5.2), it is shown that the model based 
on adsorption kinetics is insufficient to represent a chromatography system under 
complex conditions.  The general rate model needs to be modified to address the effects 
of a multi-component system.  In the following sections a study will be carried out to 
search for the dominating parameters that determine the shape of the breakthrough 
curves; bead diffusivity, axial dispersion coefficient and mass transfer coefficient are 
investigated in these sections.   
 
5.2.1. Preliminary test of Sensitive parameter sensitivities  
 
Bead diffusivity, axial dispersion and mass transfer coefficient were investigated; these 
parameters were chosen because the values used in the previous sections were estimated 
from literature correlations by assuming the feedstock behaves in the same manner as 
model proteins or water and it is possible that the values are not applicable for complex 
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systems.  These three parameters were chosen to be investigated because they are most 
likely to be affected by the binding competition between proteins on the resin particles.  
The investigation will be done by increasing and decreasing the parameters by two times 
of the literature values to observe their effects on the overall shape of a breakthrough 
curve.  The adsorption parameters (Qmax, Kads and Kd) from table 5.1 were used for all 
the tests.   
 
 
Bead diffusivity is defined as the speed of protein travels within the infrastructure of the 
resin particles.  The higher bead diffusivity the faster the adsorption hence delaying 
breakthrough of Fab’ fragments.  From figure 5.2a a better match at the lower region of 
the breakthrough curve is observed. Conversely when bead diffusivity is lowered, Fab’ 
fragments cannot enter the pores of the resin particles efficiently, causing a wider 
breakthrough curve.  From figure 5.2 b, when the bead diffusivity is reduced to half 
(3.5e-11 ms -1) of its original value, a better match can be observed at the upper region of 
the breakthrough curve but the match is worse at the lower region. 
 
Axial dispersion is defined as fluid movement caused by diffusion and 
turbulence/convection. In chromatography terms, the higher the axial diffusivity, the 
greater the zone spreading along the fluid flow direction. This parameter was used to 
evaluate if flow regime has an effect on the breakthrough curves.  From figure 5.2 c, 
axial dispersion has little effect on the overall shape of the breakthrough curve, and 
therefore fluid flow pattern is not a dominating factor in this system. 
 
Mass transfer coefficient (k) is defined as the speed of protein travelling from bulk fluid 
phase to the stagnant film around resin particles.  The speed of mass transfer is higher at 
slower flowrate and lower at faster flowrates.  Mass transfer coefficient has slight effect 
at the lower end of the breakthrough curve (figure 5.2 d) but no observable effect 
towards the upper end;  this suggests that mass transfer of Fab’ fragment is fast, the Fab’ 
fragments are congested in the stagnant film of the resin particles waiting to enter the 
pore. 
 
To conclude the analysis above, bead diffusivity and mass transfer coefficients have the 
most influence on the shape of the breakthrough curves.   
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Table 5.1 Adsorption kinetic parameters fitted from the general rate model 
using the HiTrap experimental breakthrough curve obtained at 2 mL min-1 
Qmax 
(mol m-3 matrix skeleton) 
Kads 
(m3 mol-1 s-1) 
Kd 
(s-1) (10)-3 
 
1.94 
 
4.69 
 
2.78 
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Figure 5.1 Comparison of model fit of the breakthrough curve using three fitted 
parameters. Qmax, Kads and Kdis – see table 5.1 and experimental data (-●-) obtained 
using load rate of 2 mL min-1 on a 1 mL HiTrap column.  The error bars are based on 
10% error of experimental data. A line is drawn across data points to guide the eyes. The 
R2 of the fit is 0.987. 
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Figure 5.2 Graph showing the effects of bead diffusivity, axial 
dispersion and mass transfer coefficient on the shape of a 
breakthrough curve.  Calculated (□) and experimental (●) data for 2 
mL min-1     breakthrough curve with 5 fitted parameters with 
modifications to bead diffusivity, axial dispersion coefficient and 
mass transfer coefficient. (Qmax, Kads, Kdis, Db and K)  
 
(a) Bead diffusivity value is multiplied by 2 
(b) Bead diffusivity value is divided by 2. 
(c) Axial dispersion coefficient multiplied by 2. 
(d) Mass transfer coefficient is multiplied by 2. 
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5.2.2 Increasing fitted parameters 
 
 
With the sensitive parameters identified, the next step is to increase the number of 
parameters to be fitted by the general rate model.  The additional fitted parameters are 
bead diffusivity (Db) and mass transfer coefficient (k) and on top of that adsorption 
kinetic parameters.  Bead diffusivity appraises the speed with which Fab’ fragments 
travel within the pores of the resin and also the effect of competition of Fab’ fragments 
with other species of proteins that have similar charges. The mass transfer coefficient 
accounts for the rate of Fab’ fragments enter the film around resin particles. 
 
The fitted parameters are shown in table 5.2 and figure 5.3.  The result shows the fitting 
of the breakthrough curve using five different variables calculated by the model. 
Comparing figures 5.1 and 5.3, the fitting using five parameters showed a slight 
improvement but still not significant enough to give a satisfactory fitting.  From figures 
5.2 (b) and 5.2 (c), a smaller value of bead diffusivity will lead to a better fitting at the 
top part of the breakthrough curve, while bigger value will lead to a better fitting at the 
lower end of the breakthrough.  This suggests that there is a possibility that bead 
diffusivity changes as more material was being loaded into the column.  Because the data 
of a full breakthrough curve is being fitted and parameters calculated are fixed values; 
the progressive loading effect is not included.  A solution to solve this problem is to 
modify the general rate model to include as expression for the bead diffusivity change as 
the feedstock contact time with the resin increases. 
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Table 5.2 Parameters fitted from the general rate model using the 
millilitre-scale experimental breakthrough curve obtained at 2 mL min-1.  
The five fitted parameters are Qmax, Kads, Kd, Db and K. 
skeleton) 
 
 
 (mol m
 
 
 
 
Qmax 
-3
 matrix 
Kads 
(m3 mol-1 s-1) 
Kd 
(s-1) (10)-3 
Db 
(10-11) 
k 
(m s-1) (10-4) 
 
3.87 
 
0.939 
 
3.88 
 
18.7 
 
15.8 
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Figure 5.3 Model fitting of experimental breakthrough curve using five fitted 
parameters (Qmax, Kads, Kdis, Db and K). The breakthrough curves were obtained at 
a loading rate of 2 mL min-1 on a 1 mL HiTrap column.  Graph showing the (□) 
fitting and (●) experimental data for the 2 mL min-1 breakthrough curve. The R2 of 
the fit is 0.987. 
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5.2.3 Including effects on adsorption during loading  
 
 
To account for the fact that bead diffusivity decreases as more proteins were being 
loaded into the column, the bead diffusivity term is expressed as a decay equation 
(equation 5.1), instead of a fixed value of 7e-11 ms-1 obtained from literature assuming 
Fab’ fragments behave similarly as water. 
 
 
Db = 7 x 10-11(e-at)      (5.1) 
 
 
The equation will account for the bead diffusivity drop as contact time increases; the rate 
of decrease is determined by variable ‘a’ - a function of loading time.  With this equation 
added to the general rate model and the number of fitted parameters increased to five - 
bead diffusivity constant and mass transfer coefficient, (Qmax, Kads, Kdis, a and K) the 
fitting of the experimental data greatly improved (refer to table 5.3 for fitted values and 
fitting from figure 5.4). This suggests that bead diffusivity changes as more material is 
being loaded into the column. This effect is most likely caused by protein species with 
charges similar to Fab’ fragments; as the beads are more saturated by Fab’ fragments and 
other contaminants, the repulsion force increases hence hindering movement of Fab’ 
fragments into the resin particles and this leads to slower binding.  
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Table 5.3 Five parameters fitted from the general rate model using the 1 
mL scale experimental breakthrough curve obtained at 2 mL min-1.  The 
general rate model has been modified to include bead diffusivity decay 
over time equation (5.1). The five fitted parameters are Qmax, Kads, Kd, a
and K. 
 
skeleton) 
 
 
 
Qmax 
(mol m-3 matrix 
Kads 
(m3 mol-1 s-1) 
Kd 
(s-1) (10)-3 
a 
 (s-1) (10-5) 
k 
(m s-1) (10-4) 
 
1.81 
 
5.06 
 
0.839 
 
6.54 
 
6.59 
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Figure 5.4 Model fitting of experimental breakthrough curve using 
five fitted parameters and equation 5.1 at 1 mL scale (Qmax, Kads, 
Kdis, Db and K).  The experimental data was obtained using a 
loading rate of 2 mL min-1 on a 1 mL HiTrap column.  Graph 
showing the (□) fitting and (●) experimental data for 2 mL min-1 
breakthrough curve. The R2 value of the fitting is 0.999. 
 
 
 
 131
Alison Tang  Chapter 5: Results II - Modelling 
 
 
5.2.4  Using modelling to predict chromatographic performance 
 
A good fitting for a 2 mL min-1 (310 cm h-1) breakthrough curve was achieved (refer to 
figure 5.4) using the diffusivity equation 5.1. The next step is to test the prediction ability 
of the model using the parameters calculated by the model using one breakthrough curve 
(refer to table 5.3). Mass transfer coefficient and axial dispersion coefficient change as 
linear velocity changes, these two parameters were calculated using literature 
correlations (refer to chapter 3.2.4 and 3.2.5 for the equations).  The prediction of 1.5 mL 
min-1 (232 cm h-1)  and 1 mL min-1 (310 cm h-1)  were compared against the experimental 
data in figures 5.5a and 5.5b respectively.   
 
From figures 5.5a and 5.5b, the predictions of the breakthrough curves are not matching 
the experimental results.  The predicted breakthrough curves deviate from the 
experimental curves as linear velocity increases, this suggested that flowrate influence is 
absent in one of the fitted parameters.  Assumptions need to be made to improve the 
prediction ability of the model.   
 
The shape of the breakthrough curve can be altered by changing the adsorption isotherm 
parameters (Qmax, Kd and Kads), but adsorption of protein onto a resin particle is 
independent of flowrate; by doing so implies that the properties of the resin changes.  
Changing adsorption kinetic parameters to improve the prediction is far from sensible 
and will turn the activity into a curve fitting game.  
 
From the previous section (section 5.2.3), we concluded that bead diffusivity decreases 
as more materials are being loaded into the column.  In equation 5.1, bead diffusivity is 
correlated to time only. If linear velocity changes, the bead diffusivity decay rate will 
also change because different amount of feedstock will be loaded into the column at a 
given time.  To account for the change of loaded volume, the bead diffusivity decay rate 
equation is changed to equation 5.2. 
 
 
Db = 7 x 10-11(e-aQt)      (5.2) 
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Bead diffusivity is now a function of feedstock flowrate and time, in other words it is 
related to the amount of materials loaded into the column.  The result of the fitting is 
shown in figure 5.6a and the fitted results are presented in table 5.4.  Predictions of the 
1.5 (232 cm h-1) mL min-1 and 1 mL min-1 (155 cm h-1) are shown in figures 5.6b and 
5.6c respectively.  The fitting of the 2 mL min-1 breakthrough curve is almost perfect 
while the predictions are showing very good match at the lower end of the breakthrough 
curves (<50% breakthrough) in both flowrate predictions.  
 
The upper region of the breakthrough curve predictions showed a progressive 
disagreement when predicting slower flowrates, this might due to the fact that at slower 
flowrates, protein within the pores of the resin particles have time to rearrange to a more 
efficient alignment before more Fab’ fragments enter the pores.  This causes the resin 
appear to have a higher binding capacity compared to a faster linear velocity.  However 
in the general rate model, this re-arrangement of bound material is not accounted.   
 
The model has the ability to use one single breakthrough curve to obtain the necessary 
parameters to represent the system.  This is done by using the model to calculate 
parameters for the adsorption system from a breakthrough curve. With the calculated 
parameters the breakthrough curve of other flowrates can be predicted. 
 
 
 
Table 5.4 Five parameters fitted from the general rate model using the 1 mL scale 
experimental breakthrough curve obtained at 2 mL min-1.  The general rate model 
has been modified to include bead diffusivity decay over time equation (5.2). The 
five fitted parameters are Qmax, Kads, Kd, a and K. 
 
 
Qmax 
(mol m-3 matrix skeleton) 
Kads 
(m3 mol-1 s-1) 
Kd 
(s-1) (10)-3 
a 
(103) (mL-1) 
k 
(m s-1) (10-4) 
 
4.84 
 
4.46 
 
0.844 
 
7.12 
 
1.22 
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Figure 5.5 Predicted (-□-) breakthrough curves of 232 cm h-1 (a) and 
155 cm h-1 (b)  using equation 5.1 (see table 5.3 for values) compared 
against millilitre-scale experimental data (-●-). The prediction was 
done by using the parameters obtained by fitting a 310 cm h-1 
breakthrough curve.  The error bars are assuming 10% 
experimental error from a HiTrap column. The R2 value for graph a 
and b are 0.974 and 0.607 respectively. 
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c 
b 
a   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6  Model fitting of 310 cm h-1 (a) and predicted (-□-) 
breakthrough curves of 232 cm h-1 (b) and 155 cm h-1(c) using 
equation 5.2 (see table 5.4 for values) compared against 
millilitre-scale experimental data (-●-). The prediction was done 
by using the parameters obtained by fitting a 310 cm h-1 
breakthrough curve.  The error bars are assuming 10% 
experimental error from a HiTrap column. The R2 value for 
graph a, b and c are 0.999, 0.997 and 0.970 (0.983 at 55% 
breakthrough) respectively.  
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5.3 40 μL scale 
  
A model that is capable of predicting breakthrough curves across different flowrates for a 
millilitre-scale column has been developed; the next step is to test the model’s ability 
using 40 μL scale experimental data i.e. to calculate a set of parameters best representing 
the system and also the ability to predict breakthrough curves at different flowrates and 
scales.   
 
In this section, the modified general rate model will be used to fit the breakthrough 
curves obtained at 40 μL scale using PhyNexus microtips.  The effects of bed voidage on 
the adsorption kinetic parameters, the bead diffusivity decay rate will be investigated.  
The bead diffusivity trends at both scales were investigated to provide opportunities to 
predict 1 mL scale breakthrough curves using 40 μL scale experimental data.   
 
 
 5.3.1 Calculating parameters using general rate model 
 
The breakthrough curve obtained using the fastest linear velocity (310 cm h-1) was used 
to solve for adsorption parameters. The result of the calculation is shown in table. 5.5. 
 
The simulations of the fitted parameters are shown in figure 5.7.  Although the fittings 
are showing agreements with the experimental data, the values obtained are not agreeing 
with parameters calculated using 1 mL scale experimental data.  Theoretically for the 
same feedstock Qmax, Kads and Kd should be the same regardless of column size and 
linear velocity.   
 
It is observed that the PhyNexus tips are less densely packed compared to a HiTrap 
column; increasing running flowrate will cause the bed to compress, therefore the effect 
of packing was investigated to determine if the adsorption parameters will agree with the 
1 mL scale values. 
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In table 5.6, the calculated parameters were shown, however as the bed voidage increases, 
the fitting and predictions (figure 5.8) showed no improvements, more importantly the 
adsorption parameters were not agreeing with 1 mL scale data. 
 
Bed voidage directly affects the fitted results of the adsorption parameters; because the 
void fraction represents the number of binding sites available for adsorption. Once the 
correct voidage is defined, the fitted adsorption parameters can be accurately determined.  
The adsorption parameters maximum binding capacity, adsorption rate and desorption 
rate (Qmax, Kads and Kd) are expressed in terms of dry resin weight, in other words the set 
of parameters are resin specific and can be applied to different columns with different 
packing conditions.  To further investigate the effect of packing on the breakthrough 
curves, the bed voidage was set to be one of the fitted parameters, increasing the number 
of fitted values to six (table 5.7).   
 
From the simulations (figures 5.9) the fitting and the predictions of different 
breakthrough curves are showing good matches with the experimental data.  As voidage 
decreases maximum binding capacity Qmax decreases, however, adsorption rate (Kads) 
and desorption rate (Kd) values are changing, which should not be the case since these 
two values are resin specific and are also independent to number of binding sites 
available. The rate of protein adsorbed on to the matrix should be the same in any case, 
given that the resin and the feed conditions are the same. 
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Figure 5.7 Model fitting (-)of 310 cm h-1 (a) breakthrough 
curves of 232 cm h-1 (b) and 155 cm h-1 (c) using equation 5.2 
(see table 5.4 for values) compared against 40 μL scale 
experimental data (◊). The prediction was done by using the 
parameters obtained by fitting a 310 cm h-1 breakthrough 
curve. The error bars on the experimental data represent the 
standard deviation of three repeats. The R2 value for graph a, 
b and c are 0.990, 0.979 and 0.900 respectively.  
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Table 5.5 Parameters iteratively calculated by the same general rate model 
used for the 1 mL scale experimental data and equation 5.2.  Bed voidage 
was kept at 0.35. 
 
Qmax 
(mol m-3 matrix skeleton) 
Kads 
(m3 mol-1 s-1) 
Kd 
(s-1) (10)-3 
Constant a 
(103) (mL-1) 
k 
(m s-1) (10)-4 
 
1.48 
 
4.66 
 
0.036 
 
14.075 
 
6.91 
 
 
 
Table 5.6 Parameters iteratively calculated by the same general rate model 
used for the millilitre-scale experimental data using equation 5.2, with the 
bed voidage set to 0.45. 
 
Qmax 
(mol m-3 matrix skeleton) 
Kads 
(m3 mol-1 s-1) 
Kd 
(s-1) (10)-3 
Constant a
(103) 
k 
(m s-1) (10)-4 
 
1.75 
 
7.75 
 
0.19 
 
4.92 
 
10.9 
 
 
 
 
 
 
 
 
 
 
Table 5.7 Parameters iteratively calculated by the modified general rate 
model fitting for six different parameters and equation 5.2. Bed voidage 
(εb), maximum binding capcity (Qmax), adsorption rate (Kads), desorption 
rate (Kd), bead diffusivty constant (a) and mass transfer coefficient (k). 
 
 
Voidage 
(εb) 
Qmax 
(mol m-3 matrix 
skeleton) 
Kads 
(m3 mol-1 s-1) 
Kd 
(s-1) (10)-
3
 
Constant a 
(103) 
k 
(m s-1) (10)4 
 
0.1 1.19 3.3 0.54 51 3.4 
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2 value for 
graph a, b and c are 0.990, 0.979 and 0.900 respectively 
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Figure 5.8 Model fitting (-) of 310 cm h-1 (a) breakthrough curves
232 cm h-1 (b) and 155 cm h-1 (c) using equation 5.2 and with bed 
voidage set at 0.45 (see table 5.6 for values) compared against 40 μL 
scale experimental data (◊). The error bars on the experimental data
represent the standard deviation of three repeats. The R
 140
Alison Tang  Chapter 5: Results II - Modelling 
 
c 
b 
a  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9 Model fitting of 310 cm h-1(a) and predicted (-) 
breakthrough curves of 232 cm h-1 (b) and 155 cm h-1(c) using 
equation 5.2 (see table 5.7 for values) compared against 40 μL scale 
experimental data (◊). The prediction was done by using the 
parameters obtained by fitting a 310 mL cm h-1 breakthrough curve 
with six variables. The error bars on the experimental data represent 
the standard deviation of three repeats. The R2 value for graph a, b 
and c are 0.992, 0.994 and 0.953 respectively. 
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The ultimate goal of the model is to predict breakthrough curves across different scale; 
therefore its scale up ability needs to be investigated before we can conclude that the 
model is completed.  Assuming the adsorption parameters (Qmax, Kads and Kd), bead 
diffusivity profile and mass transfer coefficient remain unchanged for a larger 
chromatography column, the parameters obtained at a smaller-scale should be applicable 
to a larger scale and vice versa.  However according to the prediction in figure 5.10,   the 
parameters did not serve the purpose of representing the adsorption of Fab’ fragments 
onto the matrix, hence there is a mismatch between predicted and experimental 
breakthrough curves at a different scale. 
 
Judging by the C/C0 vs column volume plot (Chapter 4.4.2 figure 4.15) the breakthrough 
curves are quite similar regardless of the fact that the 40 μL scale breakthrough curves 
are less sharp compared to the 1 mL scale; the breakthrough curves should give similar 
Qmax values, however from the fitting of the general rate model this was not the case.  
From the 1 mL scale experimental data, the fitted Qmax was 4.84 mol m-3(56 mgfab’ mL-1) 
whereas using the same curve fitting routine the result for the 40 μL scale experimental 
data, the Qmax is 1.19 mol m-3 (13.7 mgfab’ mL-1).  This suggests that the model does not 
have the ability to accurately relate adsorption to column size.  Further investigation in 
the model needs to be done to improve the scalability of the model. 
 
The first parameter investigated was the bead diffusivity-the decay equation introduced 
to relate bead diffusivity to volume of feedstock loaded.  As the column size decreases, 
the amount of feed required to saturate the column decreases in other words the time 
required to bring the breakthrough curve up to full saturation will decrease.  If the bead 
diffusivity constant ‘a’ remains the same at all scales, the different loading volume will 
alter the bead diffusivity profile due to the nature of the equation.  Figure 5.11 the bead 
diffusivity trend at 1 mL and 40 μL scale is presented.  In the graph it is assumed that the 
40 μL scale breakthrough curve has the same bead diffusivity constant and adsorption 
parameters as the 1 mL scale breakthrough curve. The trend of the bead diffusivity at 40 
μL scale is different from the 1 mL scale; this implies that the resin particles behave 
differently in micro- scale, but this cannot be true for an identical system running at the 
same linear velocity. 
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Figure 5.10 Scale up prediction of a 1 mL scale breakthrough 
curve running at 310 cm h-1 using parameters obtained from 40 μL 
scale running at the same linear velocity with equation 5.2.  (+) is 
the predicted breakthrough curve and (    ) is the experimental 
breakthrough curve. 
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s
-1 (10
12) 
 
Figure 5.11 A comparison between breakthrough curves and 
bead diffusivity at 1 mL and 40 µL scale using the equation 
.  40 μL scale breakthrough curve is 
compared against the bead diffusivity (---) and the same 
comparison method was used on the millilitre-scale data (-). 
The values for ‘a (bead diffusivity constant)’ were set at 7.12 x 
10
 aQT
b exD
 11107  
3 at both scales. 
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5.4 Bead diffusivity as a function of bead saturation 
 
To alleviate this problem the bead diffusivity equation was altered to correlate bead 
diffusivity to the amount of materials loaded per volume of resin beads, in other words 
the bead diffusivity is correlated to the saturation of the beads.   
 
))(1(11 2107 hr
aQT
b
cbexD 

     (5.3) 
 
 
Because the equation is altered, the 1 mL scale data was fitted again using this new 
correlation to ensure the assumptions made are still valid.  The fitted results are shown in 
table 5.8.  The simulations and predictions of the 1 mL scale breakthrough curves are 
presented in figures 5.12.   
 
The predicted breakthrough curves agree with the experimental data.  Apart from Kd and 
constant a, the values of the adsorption parameters Q
max
, K
ads 
and k are almost identical 
(with less than 10% deviation) to the values calculated when using equation 5.2. The 
reason behind different calculated K
d 
and constant a are to be investigated. 
 
 
 
 
 
Table 5.8 Parameters iteratively calculated by the general rate model with bead 
diffusivity equation 5.3 for a millilitre-scale column are shown in row 1.  Row 2 
parameters are copied from table 5.4 for comparison. 
 
Voidage 
(εb) 
Qmax 
(mol m-3 matrix skeleton) 
Kads 
(m3 mol-1 s-1) 
Kd 
(s-1) (10)-3 
Constant a 
(10-3) 
k 
(m s-1) (10)-4 
 
0.35 
 
4.82 
 
4.40 
 
0.541 
 
4.604 
 
1.94 
 
0.35 
 
4.84 
 
4.46 
 
0.844 
 
7.12 
 
1.22 
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c 
b 
a  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12 Use of model fitting of breakthrough data for 1 mL scale column to predict the 
effect of change of flowrate. Model based on equation 5.3 was used to obtain the 
adsorption parameters from an experimental breakthrough curve ran at 310 cm h-1(a) (see 
table 5.8 for values).  Trend lines are drawn by eye through experimental and predicted 
data points.  Predicted (-□-) breakthrough curves of 232 cm h-1 (b) and 155 cm h-1(c)  were 
compared against 1 mL scale experimental data (-●-).  The error bars are based on 10% 
experimental error. The R2 value for the fit of experimental and modelled/predicted data 
graphs a, b and c are 0.999, 0.997 and 0.970 respectively. 
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Using equation 5.3 the 40 μL scale breakthrough curve was evaluated using different bed 
voidage values to investigate the influence of this parameter on the fitted solutions.  The 
values are shown in table 5.9.  As voidage increases the Qmax values increases. This is 
due to the fact that as more resin particles are present in a unit volume space, the 
maximum binding capacity needs to decrease to satisfy the breakthrough profile; whereas 
when the amount of resin decreases per unit volume, the value of the maximum binding 
capacity of the resin needs to be bigger to satisfy the adsorption profile.  The adsorption 
and desorption rates (Kads and Kd) and bead diffusivity (Db) are approximately the same
regardless of the voidage and Q
 
ters 
f 
 
te 
 
max values, which reflects the theory of resin specific 
parameters – the adsorption kinetics of resin under the same buffered conditions should 
remain unchanged.  The deviation can also be caused by resin lot to lot variations; this 
variation can potentially affect the resin bead flow characteristics and binding capacities. 
 
It is useful to compare the adsorption kinetic parameters obtained at 1 mL scale in table 
5.8 with the fitted parameters derived for various bed voidage values in table 5.9; when 
the voidage is set at 50%, the adsorption kinetics (Qmax, Kads, Kd) are in closest 
agreement to the 1 mL scale data.  Because the matching adsorption kinetic parame
were obtained through trial and error of the voidage value, it is necessary to confirm i
the model agrees with this value.  This is done by setting the bed voidage value as one of 
the parameters to be fitted on top of the other five parameters, bringing the total number
of fitted parameters to six.  The results are also shown in the last line of table 5.9.   From 
the fitted results, the bed voidage of the micro-tip is estimated at 0.54; the adsorption ra
(Kads) and desorption rate (Kd) calculated are very close to the rest of the simulations as 
shown in table 5.9, thus suggesting that the intra-particle adsorption is similar and 
independent of voidage.  
 
After obtaining a set of parameters by fitting an experimental breakthrough curve, the 
ability of the model to predict breakthrough curves at different flowrates was 
investigated.  The predictions were carried out by keeping the adsorption parameters, 
bead diffusivity constant and bed voidage (Qmax, Kads, Kdis, a, k and εb)the same as show
in the last line of table 5.9 while changing the mass transfer coefficient according to 
literature correlation (refer to section 3.2.6 equation 3.14 for the correlation). The fitting 
and predictions are shown in figures 5.13.   
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Table 5.9 Fitted parameters for a breakthrough curve obtained at 0.258 mL min-1 in a 40 μL column 
using the general rate model with a bead diffusivity equation correlated to the amount of material 
loaded into the column.  Maximum binding capacity, adsorption rate, desorption rate, bead 
diffusivity constant and mass transfer coefficient (Qmax, Kads, Kdis, a and k) were fitted with the bed 
voidage set at 0.35, 0.45 and 0.5.  The values presented in the  last row of the table are obtained by 
having the model to fit for six variables- namely the maximum binding capacity, adsorption rate, 
desorption rate, bead diffusivity constant mass transfer coefficient and bed voidage (Qmax, Kads, Kdis, 
a, k and εb) 
 
 
Voidage 
(εb) 
Qmax 
(mol m-3 matrix 
skeleton) 
Kads 
(m3 mol-1 s-1) 
Kd 
(s-1) (10)-3 
Constant 
a 
(10-3) 
k 
(m s-1) 
(10)-4 
0.35 2.95 4.05 0.729 2.08 7.60 
0.45 4.00 4.00 0.609 1.97 3.09 
0.5 4.88 4.34 0.729 1.82 1.91 
0.54 5.33 4.27 0.450 1.66 3.30 
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Figure 5.13 Use of model fitting of breakthrough data for a 40 µL scale column to predict the effect 
of change of flowrate. Model based on equation 5.3 was used to obtain the adsorption parameters 
(including bed voidage) from an experimental breakthrough curve obtained from a 40 µL column 
ran at 310 cm h-1(a).  The parameters (see table 5.9-row five for values) were then used to predict (-
) breakthrough curves of 232 cm h-1 (b) and 155 cm h-1(c) compared against 40 μL scale 
experimental data.  The error bars on the experimental data represent the standard deviation of 
three repeats. The R2 value for the fit of experimental and model predicted data for graphs a, b 
and c are 0.994, 0.991 and 0.961 respectively. 
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5.5 Understanding the physics of a microtip  
 
From figure 5.13 the disagreement between the experimental and predicted breakthrough 
curves below 50% breakthrough gets bigger as the linear velocity decreases.  However 
this trend was not observed when predicting the performance of 1 mL scale breakthrough 
curves (refer to figures 5.12); this suggests that there is a flowrate dependent variable in 
the 40 μL scale system and is reflected from the simulations in figure 5.13.   
 
The disagreement between the predicted and experimental breakthrough curves only 
showed in 40 μL scale data and more importantly after introducing equation 5.3.  This 
suggests that the change is caused by bead diffusivity being a function of volume of 
matrix in the column. To confirm this, the bead diffusivity constant was altered manually 
to investigate the effect of this parameter on the shape of the breakthrough curves at 
different flowrates.  In figure 5.14 the predictions of 310 cm h-1 and 232 cm h-1 
breakthrough curves obtained by changing the values of the bead diffusivity constant “a” 
are shown and the values are presented in table 5.10.  The study is to test that the 
parameter that caused the disagreement between the experimental and predicted 
breakthrough curve is included in the bead diffusivity equation.  In theory the value of 
bead diffusivity constant “a” will not change for an identical system, this is due to the 
fact that for an identical system the rate of protein entering the intra-particular space of 
the resin particles should be independent of the column size.    
 
From the above study, it is suggested that a flowrate dependent variable is included in the 
bead diffusivity decay equation.  Since the equation is a function of flowrate, loading 
time, bed voidage and bed dimensions therefore the flowrate dependent variable must be 
one of these parameters.  Because flowrate and loading time are known variables; this 
suggests that bed voidage or bed height is the key element; a match between the 
experimental and the predicted breakthrough curve can be achieved by changing either or 
both of these two values.  An explanation for this is the packing condition of the 
PhyNexus tips.  The tips were manufactured to have a fixed amount of resin instead of in 
the form of a packed bed.  As resin particles inside PhyNexus tips are not restricted by 
top and bottom frits, packing conditions within the tips change as flowrate changes, 
making bed voidage (εb) a function of flowrate.  In addition as flowrate increases, the 
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extent of compression in the bed will also increase, causing bed voidage to decrease as 
flowrate increases.  The reduced bed voidage reduces the ability of liquid to gain access 
to the binding sites of the resin particles; the reduction of liquid – resin contact also 
reduces protein – resin contact hence reduces adsorption.  In figure 5.15 the bed voidage 
was altered and values of bed voidage (refer to table 5.11) were scouted until the R2 
value is as close to 1 as possible.  It is observed that the bed height does not change as 
the flowrate increases.  The values obtained in table 5.11 are obtained assuming that the 
bed height is constant. 
 
 
 
 
 
 
 
Table 5.10 Fitted parameters of a 0.258 mL min-1 (310 cm h-1) breakthrough curve 
and scouted values of constant a at 0.192 mL min-1 (232 cm h-1) and 0.129 mL min-1 
(155 cm h-1) .  The fitting was done by using the general rate model with a bead 
diffusivity equation correlated to the amount of material loaded into a 40 μL scale 
column.  The bed voidage in all the fitting/predictions are kept at 0.54. (equation 
5.3) 
 
 
 
 
 
 
 
 
 
 
 
 
Linear velocity 
(cm h-1) 
Qmax 
(mol m-3 matrix 
skeleton) 
Kads 
(m3 mol-1 s-1) 
Kd 
(s-1) 
(10)-3 
Constant a 
(10-3) 
k 
(m s-1) 
(10)-4 
310 5.33 4.27 0.450 1.66 3.30 
232 5.33 4.27 0.450 1.89 3.30 
155 5.33 4.27 0.450 2.00 3.30 
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Figure 5.14 Effect of change of bead diffusivity relationship on model fitting of 
breakthrough data for 40 uL scale column to predict the effect of change of flowrate. 
Model based on equation 5.3 was used to obtain the adsorption parameters of an 
experimental breakthrough curve of a 40 uL column ran at 310 cm h-1(a). The 
parameters were then used to predict breakthrough curves of 232 cm h-1 (b) and 155 cm 
h-1(c) with bead diffusivity constant changing according to flowrate.  The predictions are 
(see table 5.10 for values) compared against 40 uL scale experimental data. The error 
bars on the experimental data represent the standard deviation of 3 repeats. The R2 
values for graph a, b and c are 0.994, 0.993 and 0.980 respectively. 
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Table 5.11 Fitted parameters of a 0.258 mL min-1 (310 cm h-1) breakthrough 
curve and scouted values of constant a at 0.192 mL min-1 (232 cm h-1)  and 0.129 
mL min-1 (155 cm h-1).  The fitting was done by using the general rate model with 
a bead diffusivity equation correlated to the saturation of the column (equation 
5.3). 
 
 
 Linear 
velocity 
(cm h-1) 
 
voidage 
    (εb)  
 
Qmax 
(mol m-3 
matrix 
 
 
 
 
 
 
 
 
 
 
 
skeleton) 
Kads 
(m3 mol-
1 s-1) 
Kd 
(s-1) 
(10)-3 
Constant a 
(10-3) 
k 
(m s-1) 
(10)-4 
310 0.54 5.33 4.27 0.450 1.66 3.3 
232 0.56 5.33 4.27 0.450 1.66 3.3 
155 0.58 5.33 4.27 0.450 1.66 3.3 
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Figure 5.15 Effect of change of bed voidage relationship on model fitting of 
breakthrough data for 40 uL scale column to predict the effect of change of 
flowrate. Model based on equation 5.3 was used to obtain the adsorption 
parameters (including bed voidage) of an experimental breakthrough curve of a 
40 uL column ran at 310 cm h-1(a). The parameters were then used to predict 
breakthrough curves of 232 cm h-1 (b) and 155 cm h-1(c).  The predictions are (see 
table 5.10 for values) compared against 40 uL scale experimental data. The error 
bars on the experimental data represent the standard deviation of 3 repeats. The 
R2 values for graph a, b and c are 0.998, 0.992 and 0.983 respectively. 
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5.6 Scale-up predictions  
 
ng at 
10 cm h-1 and the prediction of the 1 mL scale is far from the experimental data.   
 
 data, 
d to the value obtained from 1 mL scale and the results are 
own in figure 5.17.    
ale 
ing the ability of the model in predicting breakthrough 
urves across different scales. 
 
A model that has the ability to represent a chromatographic system at 1 mL scale and 40 
μL scale has been developed.  The next step is to test whether the calculated parameters 
from the 40 μL scale experimental data can be used to predict the performance of a 1 mL
scale column.  In figure 5.16 a prediction of the millilitre-scale breakthrough curve was 
obtained using the set of parameters calculated from a 40 μL scale experiment runni
3
 
Referring back to the calculated parameters of 1 mL scale and 40 μL scale in tables 5.8 
and 5.9 row 5 respectively, the adsorption kinetics parameters (Qmax, Kads, Kdis) are very
similar, the only parameters that showed a significant difference is the bead diffusivity 
constant (a); as for mass transfer coefficient, it is proven in section 5.2.1.1.1 that twice 
the magnitude will not have any significant influence in the shape of the breakthrough 
curve.    To test if bead diffusivity constant is the main cause of the bad predictions of the 
1 mL scale breakthrough curves from parameters obtained from 40 μL experimental
the value of “a” is altere
sh
 
 
With the value of constant “a” altered, the predicted breakthrough curves of 1 mL scale 
from 40 μL scale parameters are improved; A summary of the values of the parameters 
used in all predictions is presented in table 5.12.  It is necessary to investigate the reason 
behind the change of constant “a” while predicting breakthrough curves from 1 mL sc
to 40 μL scale, hence gaining a better understanding of chromatography through the 
model and at the same time test
c
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0 
across experimental data points (●). The error bars on the experimental data assumes a 
10% experimental error. The R2 value for the prediction is 0.136. 
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Figure 5.16 Prediction of a 1 mL column (□) breakthrough curve at 310 cm h-1 using 
parameters obtained from a 40 μL scale column at the same linear velocity (refer to table 
5.1 for values).  The prediction was done by using the parameters obtained by fitting a 31
cm h-1 40 μL scale breakthrough curve with five variables. Trend lines are drawn by eye 
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at 1 mL scale is assumed to be the same as the fitted value presented in table 5.8. 
Scale 
Voidage 
(εb)  
(c ) matrix skeleton) 
(m l-
Constant a 
(10-3) 
Table 5.12 Values of the parameters for breakthrough curve predictions at 1 mL  
and 40 μL scale.  The fitting was done by using the general rate model with a bead 
diffusivity equation (equation 5.3) correlated to the saturation of the column and 
40 μL scale breakthrough curve running at 310 cm h-1. The value of constant “a” 
 Linear 
velocity 
m h-1
Qmax 
(mol m-3 
Kads 
 mo3
1 s-1) 
Kd 
(s-1) 
(10)-3 
k 
(m s-1) 
(10)-4 
40μL 0.54 310 5.33 4.27 0.450 1.66 3.30 
40μL 0.56 232 5.33 4.27 0.450 1.66 3.30 
40μL 0.58 155 5.33 4.27 0.450 1.66 3.30 
1 mL 0.35 310 5.33 4.27 0.450 4.69 3.40 
1 mL 0.35 232 5.33 4.27 0.450 4.69 3.40 
1 mL 0.35 155 5.33 4.27 0.450 4.69 3.40 
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g equation 5.3.  The error bars on the 
. The R2 values for graph a, b 
and c are 0.996, 0.995 and 0.972 respectively. 
Figure 5.17 Predicted 1 mL column breakthrough curves (□) at 310 cm h-1, 232 cm h-1 
and 155 cm h-1 parameters obtained by fitting a 40 μL micro-tip experimental 
breakthrough curve (●) at 310 cm h-1 but changing values of bead diffusivity constant
“a” from 1.66 to 4.69 x 10 -3.  The predictions are assuming linear velocities of 310 cm
h-1(a) 232 cm h-1 (b) and 155 cm h-1(c) and usin
experimental data assumes a 10% experimental error
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5.6.1 Bead diffusivity as a function of saturation of bead layer 
.  
 
 
se 
 the calculated value; however the extent of the effect of this assumption is 
nknown.  
d 1 
ile is 
e 
r 
ntact time) then the rate of change of bead diffusivity will be similar (see 
gure 5.19 b). 
ble 
 
 
It is observed that the predictions of the 1 mL scale breakthrough curves are slightly 
different from the experimental data (refer to figure 5.17) after changing the value of “a”
The disagreement is very likely caused by error while solving for the adsorption kinetic 
parameters using experimental data obtained using 40 μL micro-tips.  The differences in
the calculated adsorption kinetics are likely caused by the dimension of the tip, i.e., the
conic shape of the micro-tips and also the pressure difference within the column.  The 
model assumes that the micro-tip is cylindrical instead of a frustum of a cone but for the 
model the radius of the cylinder is set at the middle of the frustum of the cone.  Becau
of the above assumption, the actual linear velocity at the entry point of the column is 
slower than
u
 
The reason behind the differences between the values of constant “a” at both 40 μL an
mL scale requires further investigation.  In figures 5.18 and 5.19, the bead diffusivity 
profiles calculated using different values of constant “a” are shown.  From figure 5.18 
when bead diffusivity is a function of bead saturation, the rate of change of the prof
very similar.  However when constant “a” for 1 mL scale was altered to match the 
breakthrough curves (in section 5.6), the bead diffusivity profiles are very different at 
both scales (Refer to figure 5.19a).  The differences between the bead diffusivity profil
is because bead diffusivity was ploted against column volume. The time taken to load 
one column volume of feedstock into a 1 mL column is longer than a 40 μL micro-tip; in 
other words the resin in a 1 mL column will be in contact with the feedstock for a longe
period of time compared to a 40 μL micro-tip.  If the bead diffusivity profile is plotted 
against time (co
fi
 
Looking at the magnitude of constant “a”, the values of this parameter seems to be 
correlated to the bed height of the columns.  The height ratio between a 1 mL HiTrap 
column to a 40 μL microtip is 2.78 (Refer to chapter 3.4 for dimensions).  From ta
5.12 the value of “a” for 1 mL scale and 40 μL scale is 1.69 x10-3 and 4.69 x10-3 
respectively and the ratio between the constant “a” for 40 μL to 1 mL is 2.775, this 
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suggests that there is possibility that there is a height influence in equation 5.3.  To 
confirm the height influence, the height term was taken out from equation 5.3; the bead 
diffusivity will be correlated to the volume of feedstock loaded per layer of resin.  This 
new equation (equation 5.5) provides the model with the saturation profile of a layer of 
sin instead of the column as a whole.  
 a1 x h is the new value for bead diffusivity constant  
 
re
 
 
If
 
))(1(
)(
11 2
1
107 hr
QTha
b
cbexD 

     (5.4) 
 
))(1(11 2
1
107 cb r
QTa
b exD


     (5.5) 
 
n using either equation 5.3 or 5.5. The re-calculated value for 
onstant “a” is 1.86 x 10-1. 
.5 
sing 
d values of 
onstant “a” using equation 5.5 for both scales are shown in table 5.13. 
 
 
The value of constant “a” was re-calculated using equation 5.5 by maintaining the bead
diffusivity profile obtained when fitting the experimental breakthrough curve at 40 μL 
(310 cm h-1) using equation 5.3, this is based on the assumption that the bead diffusivity 
profile will not change when the equation changes; the re-calculation of constant “a” will 
keep the trend identical whe
c
 
 
If the bead diffusivity equation 5.3 is genuinely affecting the predictions because it is a 
function of column height; then the re-calculated value of constant “a” using equation 5
should remain unchanged in order to calculate the correct bead diffusivity profile for 1 
mL scale.  In figure 5.22 are the simulations of the 1 mL-scale breakthrough curves u
the calculated constant “a” and the adsorption parameters.  The calculate
c
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e same 1.66 x 10 -3 at 1 mL scale (- - -) and 40 
μL scale (-). 
Figure 5.18 Bead diffusivity profile calculated with 
equation 5.3 at 1 mL and 40 μL scale with no correction
to the value of constant “a”.  The value of constant “a” 
was calculated by fitting the 40 μL scale breakthrough
curve (310 cm h-1) using equation 5.3 as the bead 
diffusivity decay equation.  The value of constant “a” 
was kept th
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4.69 x 10-3 at 40 μL scale (-).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 200 400 600 800
0
20
40
60
80
Column volume
be
ad
 d
ffu
si
vi
ty
, m
 s
-1
 (1
0-
12
)
0 100 200 300 400
a 
75
Figure 5.19 Bead diffusivity profile calculated with 
equation 5.3 at 1 mL and 40 μLscale with corrections 
the value of constant “a”.  The value of constant “a” 
was kept the same 1.66 x 10 -3 at 1 mL scale (- - -) and 
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Figure 5.20 Bead diffusivity profile calculated with equation 
5.5 at 1 mL and 40 μL scale both scale shares the same value 
for constant “a”.  The value of constant “a” was calculated by 
fitting the 40 μL scale breakthrough curve using equation 5.5 
as the bead diffusivity decay equation.  The value of constant 
“a” was kept the same (1.86 x 10-1) at 1 mL scale (- - -) and 40 
μL scale (-).   
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 correlated to the amount 
of material loaded into the column. (equation 5.3)  
Scale 
(cm -1) 
(m -3 
s  
(m3 mol-1 s-1) -1
-3
Constant 
(10-1
(m s-1) (10)-4 
Table 5.13.  Re-calculated value of constant “a” at 40 μL and predicted 
parameters at 1 mL scale using equation 5.5. The set of values are based on 
the fitted parameters shown in table  5.11. The fitting was done by using the 
general rate model with a bead diffusivity equation
 Linear 
velocity 
 h
Qmax 
ol m
matrix 
keleton)
Kads Kd 
(s ) 
(10)  
a 
) 
k 
40μL 310 5.33 4.27 0.450 1.86 3.30 
1 mL 310 5.33 4.27 0.450 1.86 3.40 
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 x 
ictions in graph a, b 
and c are 0.996, 0.995 and 0.972 respectively. 
a 
b 
c 
Figure 5.21 Predicted 1 mL column breakthrough curves at 310 
cm h-1, 232 cm h-1 and 155 cm h-1 with bead diffusivity constant re
calculated using equation 5.5.  The value of constant “a” is 1.86
10-1.  The error bars on the experimental data assumes a 10% 
experimental error.  The R2 value for the pred
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From the above study, the effect of bead diffusivity being a function of height is 
confirmed.  Because the study was done with parameters estimated from an assumption, 
it is necessary to test whether the model has the ability to calculate the values that match 
the assumptions with the new bead diffusivity equation (equation 5.5).  The result of the 
fitting using a modified model (with equation 5.5 instead of 5.3) is shown in figure 5.2
and the corresponding values for the fitted parameters are shown in table 5.14.  From 
figure 5.22 the model still has the ability to fit the breakthrough curves correctly and 
more importantly the fitted value of constant “a” matches the value estimated through 
calculation; in addition, the adsorption parameters calculated are very similar to the on
2 
es 
alculated using the model with equation 5.3 (Comparing table 5.14 and 5.9 row 5).   
 
 
s will not require any correction faction to achieve the 
ccuracy shown in figure 5.21. 
c
 
Because the parameters have shown similarities, it is very confident that the prediction of
breakthrough curves of other flowrate will follow the same rules described above and in
addition, the scale up prediction
a
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voidage of the fitting is set to 0.54. 
The fitted p .9 row 5 (1 mL scale) is
e t w for arison
 
 
 
 
 
 
Table 5.14 Fitted parameters from the general rate model with the 
bead diffusivity equation modified to correlate to the saturation of a 
resin layer (see equation 5.5). The 
arameters from table 5
hird ro
 presented 
on th  comp . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.22 Model fitting (-) of 40 μL scale experimental 
breakthrough curve using five fitted parameters and 
equation 5.5. The fitted parameters (Qmax, Kads, Kdis, Db 
and K) were obtained by fitting an experimental 
breakthrough curve ( ) at a loading rate of 310 cm h-1.  
The error bars on the experimental data represent the 
standard deviation of 3 repeats. The R2 value of the fitting 
is 0.998 
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r of the general rate model in terms of its ability to 
present an adsorption system; this was done by first testing for the parameters that are 
odel; turning 
 
h the 
m 
and 0.415 x 
using 
e modified general rate mode, it is possible to predict the performance of 
) by 
h the model, it is identified that the 
system used in the project is an intra-particle diffusion limiting system while mass 
transfer of Fab’ fragments into the stagnant film of the resin particles have very little 
effect on overall performance of chromatography.   
5.7 Conclusion 
 
 
 
In this chapter, a method to modify the general rate model was presented.  The 
modification improved the powe
re
sensitive to the system, followed by implementing assumptions into the m
ideas into mathematical terms.  
 
The improved general rate model was used to predict the performance of 
chromatography at different linear velocities and different scales.  A 1 mL HiTrap 
column and a 40 μL PhyNexus microtip were used in the studies.  Through the studies, it 
is concluded that the system is sensitive to bead diffusivity; this parameter decays in an
exponential manner and is correlated to the amount of materials being fed throug
column and in addition, the maximum binding capacity, adsorption rate, de-sorption rate 
and mass transfer remains unchanged regardless of flowrate and scale. The maximu
binding capacity, the adsorption rate, the de-sorption rate and the mass transfer 
coefficient of the system is approximately 56 mg mL-1 resin, 0.08  mL mg-1 s-1 
10-3  s-1  and  2.32 x 10-4 m s-1 respectively. All these values were estimated by the 
general rate model with one single breakthrough curve.  It is also confirmed that 
th
chromatography under different combinations of flowrate and scale (1 mL and 40 μL
obtaining all necessary parameters from one breakthrough curve at 40 μL scale. 
 
The model not only has the ability to predict chromatographic performance but also 
allows the understanding of chromatography. Throug
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Chapter 6 – Case studies   
 
6.1 Introduction 
 
 
In this section, the model will be put to test with two different systems.  The first system 
is an E.coli homogenate with nuclease co-expressing with Fab’ fragments which has a 
similar pI to Fab’ fragments.  The second system is a diluted E.coli  homogenate with 
cytochrome c spiked into the solution.   
 
The first system is a more complex one compared to that used in chapter 4 and 5 but it is 
four times more dilute (Fab’ fragment concentration in feedstock is 35 μg mL-1).  The 
feedstock contains more whole cell proteins and a nuclease expressed by the cells.  The 
nuclease has an isoelectric point of 9.3 and hence this protein has similar binding 
properties as Fab’ fragments onto a cation exchange resin.  Using this system the effects 
of binding of Fab’ fragments in the presence of a major competitor at similar 
concentration will be investigated.  This system mimics cation exchange chromatography 
as a primary capture step operating in a high titre process. 
 
The second system is a semi-artificial system. The cytochrome c concentration is four 
times higher than the Fab’ fragment concentration of the feedstock used for studies 
conducted in chapters 4 and 5; in addition, the molecular weight of cytochrome c (~12 
kDa) is around four times smaller than Fab’ fragments. The main purpose to use this 
system is to test the ability of the model to represent a different adsorption system with a 
target protein different in size and concentration.  This system mimics a high titre process. 
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6.2 Case study I 
 
 
 
A breakthrough curve using the Fab’ fragment – nuclease homogenate was obtained at 
310 cm h-1 with a micro-tip and is presented in figure 6.1. The method used to obtain the 
breakthrough curve is identical to the protocol presented in chapter 2.3.2. The nuclease is 
a stronger binding competitor compared to Fab’ fragments judging from the earlier 
breakthrough of Fab’ fragments (see figure 4.13). 
 
The model developed in chapter 5.6.1 was used to calculate the values of the parameters 
(Qmax, Kads, Kd and constants a and k) that best represent this adsorption system.  The 
values of these parameters are shown in table 6.1.   
 
From the values obtained, Qmax significantly decreased while constant “a” increased 
when comparing to the values obtained with a feedstock with less competing protein 
(chapter 5.4.Table 5.11). This suggests that the ability of the resin to adsorb Fab’ 
fragments is significantly reduced because the nuclease has a stronger binding power 
compared to Fab’ fragments. The value of constant “a” is larger than the system used 
chapter 5 means that the diffusion of the Fab’ fragments into the intra particle space is 
decaying faster.  This can be explained by the fact that the nuclease attaches 
preferentially to the binding sites, making Fab’ fragments harder to gain access into the 
intra-particle space hence binding c
in 
annot be achieved. 
 
This case study not only proved that the model has the ability to solve for a solution best 
representing a system that is different from the one used during development. It also 
helped to gain a better understanding of the chromatographic adsorption system.  In the 
presence of a highly competitive protein, the binding capacity of Fab’ fragments is 
significantly lower; in addition the adsorption rate is slower and the rate of decay of bead 
diffusivity is higher than the non-nuclease expressing system.  The modelled parameters 
suggest that nuclease in the feed stream hinders the binding of Fab’ fragments onto the 
resin particles. 
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Figure 6.1 Breakthrough curve obtained using E.coli homogenate containing Fab’ fragments and SP 
Sepharose FF resin.  This strain of E.coli cell expresses nuclease and Fab’ fragments.  The top graph 
shows a breakthrough curve with no data treatment to remove the artefact caused by aggregation.  
The bottom graph is a breakthrough curve with the baseline correction strategy introduced in 
chapter 4.4.  The correction factor chosen is 10%. 
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Table 6.1 Fitted parameters of a Fab’ fragment – nuclease homogenate.  The 
parameters are obtained by fitting five parameters with the general rate model 
developed in chapter 5. The fitted parameters obtained from chapter 5.4 table 
5.11 are shown in row 3 for comparison 
Qmax 
(mol m-3 matrix skeleton) 
Kads 
(m3 mol-1 s-1) 
Kd 
(s-1) (10)-3 
Constant a 
(m-1) 
k 
(m-1) (10-4) 
 
1.07 
(13 mg mL-1) 
 
11.23 
(0.22 mL mg-1s-1) 
 
0.817 
 
 
5.52 
 
 
9.01 
 
 
5.33 
(56 mg mL-1) 
 
4.27 
(0.08 mL mg-1s-1) 
 
0.450 
 
1.66 
 
3.3 
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Figure 6.2 Fitting of the E.coli homogenate breakthrough 
curve.  The experimental breakthrough points (+) are 
compared against the fitted breakthrough trend (-).  The R2 
value of the fitting is 0.997.   
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6.3 Case study II 
 
 
A breakthrough curve was obtained using micro-tips and cytochrome c in a diluted E.coli 
homogenate.  The concentration of cytochrome c is 0.4 mg mL-1.  This system is 
designed to mimic a feedstock with high target protein to contaminant ratio.   
 
Chromatography was performed using a protocol similar to the one described in chapter 
2.3.2 but with minor changes.  Because the pI of cytochrome c is around pH 11, the 
homogenate was adjusted to pH 7 instead of pH 5 stated in the protocol.  The fraction 
size of each well in this experiment is 200 μL.  Cytochrome c does not have a specific 
assay for quantification; however this protein can be detected between wavelengths 410 
nm to 440 nm.   Because the proteins in the homogenate can also be detected at these 
wavelengths therefore early elevation of the breakthrough curves is observed (refer to 
figure 6.2 a).  To alleviate this problem, the optical density of the background protein 
needs to be taken into account; using equation 6.2 breakthrough curve for cytochrome c 
can be calculated and is shown in figure 6.2b.  
 
 
 
ODfractions  - OD homogenate  = OD cytochrome c     (6.1) 
 
ogenatefeedstock
ccytochrome
ODOD
OD
P
P
hom0 
      (6.2) 
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b 
a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3 Breakthrough curves of cytochrome c at 310 cm h-1.  
Figure a and figure b are breakthrough curves with and without 
baseline correction respectively.  The breakthrough curves are 
obtained with a micro-tip with 40 μL SP Sepharose FF resin. 
The graphs are showing two repeats of the same experiment. 
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The breakthrough curve used for fitting is the average of the two experimental 
breakthrough curves showed in figures 6.2.  The model developed in chapter 5 does not 
have the ability to solve for the solution.  The R2 value of the fitted solution (not shown 
here) is negative meaning that the model cannot represent the experimental data.  This 
suggests that another assumption needs to be implemented into the model to take into 
account the extra effect caused by the change of feedstock.   
 
In this system, the target protein concentration is higher and there are less competitors in 
the feedstock to the binding sites.  This can turn the system into a mass transfer limiting 
and bead diffusivity limiting system.  This implies that the target protein accumulates 
around the stagnant film of the resin particles waiting to diffuse into the pores of the 
resin particles; the rate of mass transfer is higher than the bead diffusivity rate, therefore 
when more feedstock flows around the resin particles the target protein cannot enter the 
saturated stagnant film.  From the above assumption, mass transfer is a function of 
feedstock loaded into the column and can also be a function of resin saturation.  To 
implement the above assumption into the model a similar equation as the bead diffusivity 
decay equation introduced in chapter 5 was used (refer to equation 6.3). 
 
 
 
))(1(3 2109 cb r
bQT
exk 

      (6.3) 
 
 
 
 
 
The initial value of 9 x 10-3 (T=0) is estimated based on the results obtained in chapter 5, 
assuming the mass transfer rate is ten-folds faster than a “dirtier” feed stream.  This 
method of estimation was used because the mass transfer coefficient estimated through 
literature correlations (equation 3.13 and 3.14) is far from real (3.28 x 10 -6 m s-1).  It is 
necessary to devise a better estimating method for this initial value; however in this case 
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study the main focus is to show that a dynamic system is unlikely to be represented by 
using fixed value for some of the parameters.   
 
The fitting of the breakthrough curve is shown in figure 6.3 and the values of the 
parameters are shown in table 6.1.   From figure 6.3, after the introduction of the mass 
transfer decay equation to the general rate model, the fitting greatly improved.  This 
showed that mass transfer of the system is reducing as the amount of feedstock is being 
loaded into the column.  Through the positive result from this fitting, it is concluded that 
the assumption made is very likely to be true.   
 
 
Through this case study, it suggests that it is still necessary to test the model with more 
systems to verify its sensitivity; it is very likely that there are other parameters still not 
included in the model that are crucial to a certain adsorption system. 
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Table 6.2 Parameters fitted from the general rate model with decay 
equations for bead diffusivity and mass transfer coefficient 
Qmax 
(mol m-3 matrix skeleton) 
Kads 
(m3 mol-1 s-1) 
Kd 
(s-1) (10)-3 
Constant a 
(m-1) 
b 
(m-1)  
 
32 
(72.3 mg mL-1) 
 
1.2 
(0.0968 mL mg-1s-1)
 
0.78 
 
0.238 
 
2.56 
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Figure 6.4 Fitting of a cytochrome c breakthrough curve 
using the general rate model implemented with bead 
diffusivity decay and mass transfer decay equations.  The 
fitting was done by having the model to fit for five 
parameters (Qmax, Kads, Kd, a, b).  The error bars represent 
the standard deviation of two repeats.  The R2 value of the 
fitting is 0.990. 
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Chapter 7 - Conclusion  
 
7.1 Modelling using USD method 
 
The modelling method used in this project uses the general rate model to calculate in an 
iterative manner parameters from breakthrough curves. Because breakthrough curves are 
used, the parameters calculated through this method can better represent the system 
compared to a finite batch method due to the fact that the experimental data are obtained 
in column conditions instead of discreet experiments.  In addition, the method provides a 
one step evaluation of an adsorption system, reducing the amount of effort required to 
estimate required inputs to complete the general rate model.   
 
Traditionally the film mass transfer coefficient and the effective intra-particle diffusivity 
need to be estimated through correlations.  This is especially the case with intra-particle 
diffusivity, where the correlation requires the user to estimate λ, tortuosity and molecular 
diffusivity. Details of these parameters were presented in theoretical consideration 
(Chapter 3.2.5).  With the modelling method used in the project, all these parameters do 
not need to be calculated, but fitted by the general rate model as lumped parameters. 
 
 
It is useful to summarise the modelling methodology used in the chapter 6.  After 
obtaining the breakthrough curve, the data was entered into the original version of the 
general rate model to solve for the adsorption parameters (Qmax, Kd and Kads).  The 
quality of the fitting was evaluated by re-entering the parameters into the general rate 
model.  Because the fitting was not satisfactory, the assumptions of the model were 
revised.   
 
The first assumption studied was the values of the transport parameters.  Because these 
parameters were taken from literature, the values obtained might not be applicable to the 
system.  The fitting and evaluation routine was repeated with increased number of 
parameters (Qmax, Kads, Kd, Db  and K) and re-assessed using the fit-evaluate routine. 
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The second assumption is to introduce another concept into the model, because the 
parameters that are sensitive for the breakthrough curve have been identified.  Moreover, 
from the previous fit-evaluate routine a fixed value for these parameters cannot represent 
the system.  This suggested that new functions needed to be introduced to relate these 
parameters into the model.  In this case a time dependent function was introduced into 
the model to define changes of bead properties during loading. A fit-evaluate routine was 
used again to determine if the function improves the ability of the model to fit the 
experimental data.   
The development of the model follows can be divided into three stages.  First, fit the 
breakthrough curve and evaluate the goodness of fit.  Second, if the fit is not satisfactory, 
identify the assumptions in the model that could possibly cause the mismatch between 
experimental data and modelled data.  Third, correct the assumptions in the general rate 
model to better represent the system.  This design cycle was applied three times to 
complete the model and is shown in figure 7.1.  The model was tested with breakthrough 
curves obtained at different flowrates and further developed using the fit – evaluate 
routine for modification.  A summary of the procedure is also illustrated in figure 7.1.  
The model was confirmed to be capable of predicting different flowrates at both scales 
separately after performing the routine describe in figure 7.1.   This section of the 
modelling activity included the bead diffusivity decay as resin beads become more 
saturated during loading. 
 
The next step taken was to evaluate the ability of the model to predict breakthrough 
curves from micro-scale data to millilitre scale data.  In figure 7.2 a development 
pathway of the model for scaling-up purposes is presented.  The development method 
follows the fit-predict-evaluate-revise assumption routine;  the developed model after 
two correction routine has the ability to use one breakthrough curve at micro-scale to 
calculate the adsorption and transport parameters; using the set of parameters to predict 
breakthrough curves at different flowrates between the two scales.   
 
For other systems such as mixed mode chromatography and hydrophobic interaction 
chromatography due to the natures of different adsorption systems, it is difficult to set up 
a generic modelling routine.  The parameters to be changed might be different but the 
idea of the modelling will be similar.  The first step is to attempt to fit one breakthrough 
curve with the general rate model; modifying the model if necessary according to the 
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bead chemistry and transport parameters then verify the model by predicting the 
breakthrough curves of the same scale (as describe by figure 7.1).  Second, use the model 
with the capability to represent the chemistry of the adsorption system to predict the 
breakthrough curves at a different scale; the modification of the model in this case is to 
establish a link between the two scales based on the physics of the columns (as shown in 
figure 7.2). 
 
 
In more simple terms, the model at is system-specific.  In case of a different adsorption 
system, the variable parameters defined in the model might need to be redefined but it is 
uncertain which parameter(s) will be dominant for different adsorption system.   A lot of 
work still required to be done to give a generic model. 
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Breakthrough run 1 
General rate model 
 
 
 
Figure 7.1 Development pathway of the general rate model to fit and predict 
breakthrough curves at millilitre scale data. 
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General rate model 
Judge for quality – both 
fitting and predictions at 
different flowrates 
Acceptable? 
Predict breakthrough curves 
at millilitre scale 
Revise modelling assumptions 
to increase the void fraction 
used for fitting.
Yes 
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volume of column  
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assumptions at micro-scale 
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Breakthrough run at 
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Figure 7.2 Development pathway of the general rate model to fit and predict 
breakthrough curves at millilitre scale data from micro-scale data. 
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7.2 millilitre scale vs micro-scale 
 
A 1 mL SP sepharose FF column requires 0.12 g of Fab’fragments to saturate whereas a 
40 μL PhyNexus micro-tip requires around 5.3 mg of Fab’ fragments to saturate; in other 
words feedstock enough for one 1 mL column is enough to complete more than 20 runs 
with a 40 μL micro-tip.   
 
Apart from the smaller feedstock volume requirement, the scale- up method broke the 
traditional geometric rule using a small scale column with a smaller internal diameter and 
shorter bed height. Using the constant linear velocity scale as scaling factor, the time 
required to complete a small scale experiment is shorter.  13 hours is required to saturate 
a 1 mL column at 155 cm h-1 whereas it only requires 4.5 hours to saturate a 40 μL 
micro-tip.   
 
 
Although the project proved that the ultra scale-down method using a micro-tip to mimic 
a millilitre scale column is successful, the model still requires further verification to test 
for its sensitivity towards other parameters.  A more detailed description of future work 
is presented in chapter 8. 
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Chapter 8 – Future Work  
 
 
 
8.1 Improving the model 
 
 
 
From the results chapter (chapter 5), the ultra scale-down method using a PhyNexus micro-
tip is successful. The breakthrough curves obtained using the method described in chapter 
2.3.2 using micro-tips represents the system running under column conditions.  Using the 
model and method developed in chapter 5, it is possible to predict the performance of a 
laboratory scale millilitre scale columns from results obtained using micro-tips.  This ultra 
scale-down method offers potential for early discovery of full scale chromatography and 
now requires further verification.   
 
 
There are many other parameters that require attention in chromatography.  A list of these 
parameters is listed in table 8.1.   It is necessary to test if the model has the ability to take 
into account the effects of some of the crucial variables such as target protein concentration 
and molecular weight of target protein.  As demonstrated in case study I a different system 
under different conditions will give rise to different limiting factors to the performance of 
chromatography. Because the model was developed using E.coli lysate, it is best to test these 
two variables using the same contaminant composition but without the Fab’ fragments.  This 
can be done by first passing the crude heat lysate through a Protein A or Protein G column to 
capture all the Fab’ fragments present in the lysate resulting in a Fab’ fragment free E.coli 
lysate.  Using this method, a similiar background protein profile is achieved.  Target protein 
can be spiked into this background lysate to create a new feedstock to obtain breakthrough 
curves.  With this strategy, the target protein concentration and type of protein can be altered 
to investigate the effect of binding under these changes.  Through the experiments described 
above, the ability of the model to take into account the effects brought to the system by the 
target protein can be investigated.   
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It will also be interesting to investigate other types of chromatography with the model.  For 
example, affinity chromatography, hydrophobic interaction chromatography and mixed 
mode chromatography.  Understanding these different types of chromatography with the 
aide of the model is beneficial to the design of a new purification strategy for a new 
feedstock. 
 
All the above suggestions involve improvements of the model through different feedstock 
hence protein profile.  Another useful function is the ability to use the model for prediction 
of scale-up.  Currently the model can predict performance of a 1 mL column from a 40 μL 
micro-tip, however work still needs to be done to enable the model to predict breakthrough 
curves at XK 16 or even larger scale.  In addition through development of the model, there 
are opportunities to gain a better understanding of the physics of both the column and the 
adsorption kinetics. 
 
 
 
Table 8.1 Variables that have influence in the performance of chromatography 
 
 
 
 
 
 
 
 
 
 
 
 
Feedstock Resin 
pH 
Ionic strength 
Temperature 
Molecular weight of target protein 
Target protein concentration 
Protein aggregation 
Ligand density 
Particle porosity 
Resin size  
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8.2 Understanding chromatography through the modelling 
 
 
The beauty of the micro-tip ultra scale-down method is its ability to mimic chromatography 
under column conditions.  Through modelling the performance of chromatography will be 
translated into mathematical terms. Making use of both experimental and modelling 
advantage, the behaviour of adsorption of target protein under the influence of pH, ionic 
strength and the presence of aggregation can be compared.   
 
Combining this technology with design of experiment (DoE) approach, a series of 
breakthrough curves can be obtained using micro-tips running at different ionic strength and 
pH.  The breakthrough curves will reflect the adsorption kinetics of the target protein under 
complex protein environment and column conditions; which can be visualized by fitting the 
breakthrough curves against the general rate model developed in this project.  By doing the 
activity described above, a trend can very likely be observed from the fitted adsorption 
kinetic parameters.  The trend can then be translated into a mathematical model for the 
general rate model to enable the prediction of adsorption under the influence of ionic 
strength and pH. 
 
 
8.3 Re-design of the small scale experimental system 
 
At present the syringe pump device can only hold one stainless steel syringe; all 
experimentation is limited to one micro-tip.  To alleviate this problem, a flow distributor can 
be attached to the device to allow three or more micro-tips to be connected to the syringe 
pump.  A sketch of the setup is shown in figure 8.1. The figure is showing two sets of 
syringe-connector system.   
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Syringes  2 x 3 channel flow distributor 
 
 
 
 
 
 
 
 
 
 
 
2x 3 channel flow distributor Syringe  
Lateral view 
Top down view 
 
 
Figure 8.1 A sketch of one syringe pump device connected to multiple PhyNexus microtips 
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Using the flow distributor, the flow from the syringe will be diverged into three identical 
streams; the internal diameter of the channels within the flow distributor need to be identical 
for the flow to evenly distribute to the individual micro-tip attached.   
 
With the addition of the flow distributor, repeats of the same experiment can be done co-
currently.  This reduces the experimental error caused by feedstock variation and most 
importantly the experimental throughput is increased by three times.  
 
The setup also allows resin screening under column conditions using PhyNexus micro-tips.  
This can be achieved by connecting different pre-equilibrated resin tips to the system.  The 
set of experiment will show the performance of each individual resin using the same 
feedstock running under the same flowrate. 
 
The disadvantage of the setup is it only allows flow coming from one syringe.  This means 
when switching from equilibration to loading buffer, the user will need to manually detach 
the syringe and reconnect the system with a syringe filled with feedstock.  In other words, 
this manual switching is necessary when switching between steps in a chromatographic 
cycle. 
 
 
 
 
8.4 Windows of operation 
 
Windows of operation (Zhou and Titchener-Hooker 1999) serves as a tool to aid the 
selection of feasible operating parameters within a design space.  The operating parameter 
chosen for chromatography are likely to be loading volume and running flowrate.  These 
parameters are chosen because they are the easiest to control and will directly affect the 
outcome of chromatography.   
 
A windows of operation can be drawn to visualise the performance of chromatography 
adsorption.  This can be done by using the model developed in chapter 5 to calculate the 
yield and throughput of an adsorption under different loading volumes and flowrate.  Yield 
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is the ratio of protein bound to the column to protein loaded into the column while 
throughput (g year-1) is defined as the materials produced per campaign year.  The equation 
of yield and throughput are shown in equations 8.1 and 8.2 respectively. 
 
 
 
 
Yield  = Amount of Fab’ in feedstock – amount of Fab’ in effluent                             (8.1) 
              Amount of Fab in feedstock 
 
 
Throughput = (amount of Fab bound)(loading time + wash +elute +re-equilibrate)-1   (8.2) 
 
 
 
 
In figure 8.2 an example of a window of operation of chromatography is shown.  Below the 
yield line is an operating area that will give a yield value higher than the success criteria 
while the area above the throughput line will give a throughput higher than the chosen value.  
The shaded area represents the operating window; within this area the success criteria are 
met (throughput and yield).   
 
If the model can successfully predict the performance of chromatography at different scale 
then logically the windows of operation can also be drawn to identify the operating window.  
If appropriate an economics model can then be implemented to estimate the cost and utility 
requirements of the unit operation. 
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Throughput 
Yield 
 
Figure 8.2 An example of a window of operation of a micro-tip.  Load 
and flowrate are the process parameters while throughput and yield 
are the success criteria.  
 
 
 
 
 
 
Appendix  
 
 
Raw data for matrix weight analysis 
 
 
Matrix volume 
10 μL 
Weighing boat Weighing boat + dried matrix Matrix dry weight 
0.6851 0.6865 0.0014 
0.6431 0.6445 0.0014 
0.6546 0.6563 0.0017 
0.5686 0.5697 0.0011 
Average  0.0014 
 
 
Matrix volume 
12.5 μL 
Weighing boat Weighing boat + dried matrix Matrix dry weight 
0.6661 0.6679 0.0018 
0.5802 0.5818 0.0016 
0.6329 0.6342 0.0013 
0.5947 0.596 0.0013 
Average  0.0015 
 
Matrix volume 
15 μL 
Weighing boat Weighing boat + dried matrix Matrix dry weight 
0.5725 0.5745 0.002 
0.6685 0.6701 0.0016 
0.6365 0.6383 0.0018 
0.6675 0.669 0.0015 
average  0.001725 
 
Matrix volume 
25 μL 
Weighing boat Weighing boat + dried matrix Matrix dry weight 
0.6298 0.6331 0.0033 
0.6829 0.6872 0.0043 
0.6574 0.6611 0.0037 
0.663 0.6664 0.0034 
average  0.003675 
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Matrix volume 
50 μL 
Weighing boat Weighing boat + dried matrix Matrix dry weight 
0.6168 0.6215 0.0047 
0.5956 0.6024 0.0068 
0.6332 0.6409 0.0077 
0.6626 0.6693 0.0067 
average  0.006475 
 
 
Matrix volume 
100 μL 
Weighing boat Weighing boat + dried matrix Matrix dry weight 
0.6605 0.6736 0.0131 
0.6711 0.6847 0.0136 
0.6406 0.654 0.0134 
0.5674 0.5825 0.0151 
average  0.0138 
 
Matrix volume 
150 μL 
Weighing boat Weighing boat + dried matrix Matrix dry weight 
0.622 0.644 0.022 
0.6344 0.6501 0.0157 
0.6078 0.6276 0.0198 
0.6462 0.6665 0.0203 
average  0.01945 
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         Parameters calculated from correlations for simulations in chapter 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Matrix and Bed Physical Parameters 
 
Molecular weight,(Da) 49000
Particle radius, Rp (m) 4.5 x 10-5 
Column diameter, (m) 7.0 x 10-3 
Column height, L (m) 2.5 x 10-2 
Bed void fraction, εb 0.35
Particle porosity, εp 0.65
Pore diameter, (m) 2.75 x 10-8 
  
Parameters estimated from correlations 
Molecular diameter, (m) 5.3 x 10-9 
Axial dispersion coefficient, Dax(m2s-1)  @ 310 cm h-1 1.95 x 10-7 
  @ 232.5 cm h-1 1.63 x 10-7 
  @ 155 cm h-1 1.05 x 10-7 
Film mass transfer coefficient, k (ms-1)   @ 310 cm h-1 1.8 x 10-5 
  @ 232.5 cm h-1 1.64 x 10-5 
  @ 155 cm h-1 1.42 x 10-5 
 
Effective intra-particle diffusivity, Dp (m2s-1) 1.6 x 10-11
               +Lambda,  λ 0.19 
               +tortuosity,   2.8 
               +Molecular diffusivity, Dm (m2s-1) 7.5 x 10-11 
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